0001493152-23-027320.txt : 20230809 0001493152-23-027320.hdr.sgml : 20230809 20230809152633 ACCESSION NUMBER: 0001493152-23-027320 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 46 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230809 DATE AS OF CHANGE: 20230809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Genvor Inc CENTRAL INDEX KEY: 0001792941 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100] IRS NUMBER: 832054746 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-234815 FILM NUMBER: 231154835 BUSINESS ADDRESS: STREET 1: 201 S. ELLIOTT ROAD, SUITE 538 CITY: CHAPEL HILL STATE: NC ZIP: 27514 BUSINESS PHONE: (984) 261-7338 MAIL ADDRESS: STREET 1: 201 S. ELLIOTT ROAD, SUITE 538 CITY: CHAPEL HILL STATE: NC ZIP: 27514 FORMER COMPANY: FORMER CONFORMED NAME: Allure Worldwide, Inc. DATE OF NAME CHANGE: 20191031 10-Q 1 form10-q.htm
0001792941 false Q3 --09-30 0001792941 2022-10-01 2023-06-30 0001792941 2023-08-11 0001792941 2023-06-30 0001792941 2022-09-30 0001792941 us-gaap:SeriesAPreferredStockMember 2023-06-30 0001792941 us-gaap:SeriesAPreferredStockMember 2022-09-30 0001792941 us-gaap:SeriesBPreferredStockMember 2023-06-30 0001792941 us-gaap:SeriesBPreferredStockMember 2022-09-30 0001792941 2023-04-01 2023-06-30 0001792941 2022-04-01 2022-06-30 0001792941 2021-10-01 2022-06-30 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-09-30 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2021-09-30 0001792941 us-gaap:CommonStockMember 2021-09-30 0001792941 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001792941 us-gaap:RetainedEarningsMember 2021-09-30 0001792941 2021-09-30 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2021-12-31 0001792941 us-gaap:CommonStockMember 2021-12-31 0001792941 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001792941 us-gaap:RetainedEarningsMember 2021-12-31 0001792941 2021-12-31 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-03-31 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-03-31 0001792941 us-gaap:CommonStockMember 2022-03-31 0001792941 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001792941 us-gaap:RetainedEarningsMember 2022-03-31 0001792941 2022-03-31 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-09-30 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-09-30 0001792941 us-gaap:CommonStockMember 2022-09-30 0001792941 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001792941 us-gaap:RetainedEarningsMember 2022-09-30 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-12-31 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-12-31 0001792941 us-gaap:CommonStockMember 2022-12-31 0001792941 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001792941 us-gaap:RetainedEarningsMember 2022-12-31 0001792941 2022-12-31 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-03-31 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-03-31 0001792941 us-gaap:CommonStockMember 2023-03-31 0001792941 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001792941 us-gaap:RetainedEarningsMember 2023-03-31 0001792941 2023-03-31 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-10-01 2021-12-31 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2021-10-01 2021-12-31 0001792941 us-gaap:CommonStockMember 2021-10-01 2021-12-31 0001792941 us-gaap:AdditionalPaidInCapitalMember 2021-10-01 2021-12-31 0001792941 us-gaap:RetainedEarningsMember 2021-10-01 2021-12-31 0001792941 2021-10-01 2021-12-31 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-03-31 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-03-31 0001792941 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001792941 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001792941 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001792941 2022-01-01 2022-03-31 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-04-01 2022-06-30 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-04-01 2022-06-30 0001792941 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001792941 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001792941 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-10-01 2022-12-31 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-10-01 2022-12-31 0001792941 us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001792941 us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001792941 us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001792941 2022-10-01 2022-12-31 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-03-31 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-03-31 0001792941 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001792941 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001792941 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001792941 2023-01-01 2023-03-31 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-04-01 2023-06-30 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-04-01 2023-06-30 0001792941 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001792941 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001792941 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-06-30 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-06-30 0001792941 us-gaap:CommonStockMember 2022-06-30 0001792941 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001792941 us-gaap:RetainedEarningsMember 2022-06-30 0001792941 2022-06-30 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-06-30 0001792941 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-06-30 0001792941 us-gaap:CommonStockMember 2023-06-30 0001792941 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001792941 us-gaap:RetainedEarningsMember 2023-06-30 0001792941 GNVR:PaycheckProtectionProgramMember 2020-04-09 0001792941 GNVR:NoteholderBMember 2022-10-01 2023-06-30 0001792941 GNVR:NoteholderAMember 2022-10-01 2023-06-30 0001792941 GNVR:NoteholderAMember 2023-06-30 0001792941 GNVR:NoteholderBMember 2023-06-30 0001792941 GNVR:NoteholderCMember 2022-10-01 2023-06-30 0001792941 GNVR:NoteholderCMember 2023-06-30 0001792941 GNVR:NoteholderDMember 2022-10-01 2023-06-30 0001792941 GNVR:NoteholderDMember 2023-06-30 0001792941 GNVR:NoteholderEMember 2022-10-01 2023-06-30 0001792941 GNVR:NoteholderEMember 2023-06-30 0001792941 GNVR:NoteholderFMember 2022-10-01 2023-06-30 0001792941 GNVR:NoteholderFMember 2023-06-30 0001792941 GNVR:NoteholderHMember 2022-10-01 2023-06-30 0001792941 GNVR:NoteholderHMember 2023-06-30 0001792941 GNVR:NoteholderIMember 2022-10-01 2023-06-30 0001792941 GNVR:NoteholderIMember 2023-06-30 0001792941 GNVR:NoteholderFMember srt:MinimumMember 2022-10-01 2023-06-30 0001792941 GNVR:NoteholderFMember srt:MaximumMember 2022-10-01 2023-06-30 0001792941 us-gaap:SeriesAPreferredStockMember 2022-08-10 0001792941 us-gaap:SeriesAPreferredStockMember 2022-08-02 2022-08-10 0001792941 GNVR:BradleyWhiteMember 2022-08-16 0001792941 GNVR:ClaytonYatesMember 2022-08-16 0001792941 GNVR:JesseJaynesMember 2022-08-16 0001792941 us-gaap:SeriesBPreferredStockMember 2022-10-19 0001792941 us-gaap:SeriesBPreferredStockMember 2022-10-19 2022-10-19 0001792941 2022-04-21 2022-04-21 0001792941 GNVR:ShareholderMember GNVR:StockIssuedForCashMember 2022-11-17 2022-11-17 0001792941 GNVR:ShareholderMember GNVR:StockIssuedForCashMember 2023-05-03 2023-05-03 0001792941 GNVR:ShareholderMember GNVR:StockIssuedForCashMember 2023-05-12 2023-05-12 0001792941 GNVR:ShareholderMember GNVR:StockIssuedForCashMember 2023-05-29 2023-05-29 0001792941 2023-06-14 2023-06-14 0001792941 GNVR:JaynesInvestmentLLCMember us-gaap:SeriesBPreferredStockMember 2022-10-19 2022-10-19 0001792941 GNVR:ACTHoldingsLLCMember us-gaap:SeriesBPreferredStockMember 2022-10-19 2022-10-19 0001792941 GNVR:LASBFamilyTrustMember us-gaap:SeriesBPreferredStockMember 2022-10-19 2022-10-19 0001792941 GNVR:JesseMichaelJaynesMember us-gaap:SeriesBPreferredStockMember 2022-10-19 2022-10-19 0001792941 GNVR:BradleyWhiteMember us-gaap:SeriesBPreferredStockMember 2022-10-19 2022-10-19 0001792941 GNVR:PJAdvisoryGroupMember us-gaap:SeriesBPreferredStockMember 2022-10-19 2022-10-19 0001792941 2021-10-01 2022-09-30 0001792941 us-gaap:InvestorMember 2022-10-01 2023-06-30 0001792941 GNVR:ConsultingAgreementsMember srt:ChiefExecutiveOfficerMember 2022-10-01 2023-06-30 0001792941 GNVR:ConsultingAgreementsMember srt:ChiefExecutiveOfficerMember 2022-10-01 2023-06-30 0001792941 GNVR:ConsultingAgreementsMember srt:ChiefExecutiveOfficerMember 2023-06-30 0001792941 GNVR:ConsultingAgreementsMember srt:ChiefExecutiveOfficerMember 2022-09-30 0001792941 GNVR:ConsultingAgreementsMember GNVR:ConsultantMember 2020-07-24 2020-07-24 0001792941 2021-09-01 2021-09-30 0001792941 us-gaap:ResearchAndDevelopmentArrangementMember 2023-06-30 0001792941 us-gaap:ResearchAndDevelopmentArrangementMember 2022-09-30 0001792941 us-gaap:InvestorMember us-gaap:SubsequentEventMember 2023-07-12 2023-07-12 0001792941 us-gaap:InvestorMember us-gaap:SubsequentEventMember 2023-07-12 0001792941 us-gaap:InvestorMember us-gaap:SubsequentEventMember 2023-07-13 2023-07-13 0001792941 us-gaap:InvestorMember us-gaap:SubsequentEventMember 2023-07-13 0001792941 us-gaap:InvestorMember us-gaap:SubsequentEventMember 2023-07-14 2023-07-14 0001792941 us-gaap:InvestorMember us-gaap:SubsequentEventMember 2023-07-14 0001792941 GNVR:JasonAdamsMember us-gaap:SubsequentEventMember 2023-08-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2023

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________ to ____________

 

Commission File Number: 333-234815

 

GENVOR INCORPORATED
(Exact name of registrant as specified in its charter)

 

Nevada   83-2054746
(State or other jurisdiction of incorporation)   (IRS Employer Identification Number)

 

201 S. Elliott Road, Suite 538

Chapel Hill, North Carolina 27514

(Address of principal executive offices)

 

(984) 261-7338

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☐ Yes ☒ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
  Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

 

As of August 11, 2023, the Company had 18,667,821 shares of common stock outstanding.

 

 

 

 

 

 

GENVOR INCORPORATED

INDEX

 

  Page
PART I. FINANCIAL INFORMATION  
   
Item 1. Financial Statements 3
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 4
Item 3. Quantitative and Qualitative Disclosures about Market Risks 7
Item 4. Controls and Procedures 7
     
PART II. OTHER INFORMATION  
     
Item 1. Legal Proceedings 8
Item 1A. Risk Factors 8
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 8
Item 3. Defaults Upon Senior Securities 8
Item 4. Mine Safety Disclosures 8
Item 5. Other Information 8
Item 6. Exhibits 9
     
SIGNATURES 10

 

2

 

 

PART I – FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

Genvor Incorporated

 

Index to Financial Statements

 

    Page
     
Condensed Consolidated Balance Sheets at June 30, 2023 and September 30, 2022 (unaudited)   F-1
     
Condensed Consolidated Statements of Operations for the three and nine months ended June 30, 2023 and 2022 (unaudited)   F-2
     
Condensed Consolidated Statement of Changes in Stockholders’ Deficit for the nine months ended June 30, 2023 and 2022 (unaudited)   F-3
     
Condensed Consolidated Statements of Cash Flows for the nine months ended June 30, 2023 and 2022 (unaudited)   F-4
     
Notes to Condensed Consolidated Financial Statements (unaudited)   F-5

 

3

 

 

Genvor Incorporated

Condensed Consolidated Balance Sheets

(unaudited)

 

   June 30,   September 30, 
   2023   2022 
ASSETS          
Current assets:          
Cash  $100   $296,386 
Other current assets   1,500    2,000 
Total current assets   1,600    298,386 
           
Fixed assets, net   16,192    17,565 
           
Total assets  $17,792   $315,951 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Current liabilities:          
Convertible notes payable  $1,179,500   $1,052,000 
Accounts payable and accrued expenses   133,958    516,658 
Due to related party   236,333    3,846 
SBA loan   48,750    48,750 
USDA CRADA liability   246,400    246,400 
Total current liabilities   1,844,941    1,867,654 
Non-current liabilities:          
Convertible notes payable, net of discounts   179,555    89,221 
Total non-current liabilities   179,555    89,221 
Total liabilities   2,024,496    1,956,875 
           
Commitments and contingencies (Note 6)   -    - 
           
Stockholders’ deficit:          
Preferred stock, $0.001 par value, 20,000,000 shares authorized          
Preferred stock - series A, 10 shares authorized, 9 and 9 shares issued and outstanding as of June 30, 2023 and September 30, 2022, respectively   -    - 
Preferred stock - series B, 2,500,000 shares authorized, 2,060,536 and 0 shares issued and outstanding as of June 30, 2023 and September 30, 2022, respectively   2,061    - 
Common stock, $0.001 par value, 300,000,000 shares authorized, 18,572,821 and 38,678,155 shares issued, issuable and outstanding as of June 30, 2023 and September 30, 2022, respectively   18,573    38,678 
Additional paid-in capital   14,876,859    14,608,815 
Accumulated deficit   (16,904,197)   (16,288,417)
Total stockholders’ deficit   (2,006,704)   (1,640,924)
           
Total liabilities and stockholders’ deficit  $17,792   $315,951 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-1

 

 

Genvor Incorporated

Condensed Consolidated Statements of Operations

(unaudited)

 

   2023   2022   2023   2022 
   For the Three Months Ended   For the Nine Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
                 
Revenue  $-   $-   $-   $- 
                     
Operating expenses                    
Professional fees   59,762    45,170    125,424    132,928 
Payroll related expenses   37,500    37,500    112,500    180,725 
Research and development   -    -    -    109,248 
Stock-based compensation   -    502,875    -    3,712,500 
Depreciation expense   458    458    1,374    1,374 
Other general and administrative expenses   51,352    59,500    178,637    163,987 
Total operating expenses   149,072    645,503    417,935    4,300,762 
                     
Operating loss   (149,072)   (645,503)   (417,935)   (4,300,762)
                     
Other income (expense)                    
Interest expense   (5,846)   (12,240)   (17,511)   (73,242)
Loss on debt settlement   -    -    -    (5,000)
Penalties   (30,000)   (30,000)   (90,000)   (90,000)
Amortization of debt discount   (30,111)   -    (90,334)   - 
Total other income (expense)   (65,956)   (42,240)   (197,844)   (168,242)
                     
Net loss  $(215,029)  $(687,743)  $(615,780)  $(4,469,004)
                     
Basic and diluted net loss per common share  $(0.01)  $(0.02)  $(0.03)  $(0.15)
Basic and diluted weighted average common shares outstanding   18,502,546    36,439,887    19,800,317    30,506,420 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-2

 

 

Genvor Incorporated

Condensed Consolidated Statements of Changes in Stockholders’ Deficit

For the Three and Nine Months Ended June 30, 2023 and 2022

(unaudited)

 

   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Total 
   Series A   Series B           Additional   Accumu-     
   Preferred Stock   Preferred Stock   Common Stock   Paid-in   lated     
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Total 
Balance, September 30, 2021   -   $-    -   $-    20,000,000   $2,000   $-   $(64,540)   (62,540)
Recapilitalization / RTO impact   -    -    -    -    -    18,000    8,546,798    (10,947,544)   (2,382,746)
Adjusted balance, beginning of period   -    -    -    -    20,000,000    20,000    8,546,798    (11,012,084)   (2,445,286)
Common stock issued for services   -    -    -    -    2,650,000    2,650    197,350    -    200,000 
Exercise of options   -    -    -    -    1,400,000    1,400    -         1,400 
Common stock issued for cash   -    -    -    -    1,475,020    1,475    736,035         737,510 
Net loss for the period ended December 31, 2021   -    -    -    -    -    -    -    (515,716)   (515,716)
Balance, December 31, 2021   -   $-    -   $-    25,525,020   $25,525   $9,480,183   $(11,527,800)  $(2,022,092)
Common stock issued for services   -    -    -    -    6,020,000    6,020    3,003,980    -    3,010,000 
Issuance of common stock for services   -    -    -    -    -    -    -    -    - 
Common stock issued for cash   -    -    -    -    280,000    280    139,720    -    140,000 
Common stock issued for debt conversion   -    -    -    -    688,675    689    336,884    -    337,573 
Payment for reverse capitalization   -    -    -    -    -    -    (150,000)   -    (150,000)
419 fund raising services   -    -    -    -    170,000    170    (170)   -    - 
Net loss for the period ended March 31, 2022   -    -    -    -    -    -    -    (3,265,545)   (3,265,545)
Balance, March 31, 2022   -   $-    -   $-    32,683,695   $32,684   $12,810,597   $(14,793,345)  $(1,950,064)
Founder shares issued                       1,855,888    1,856    (1,856)        - 
Common stock issued for services                       505,000    505    501,995         502,500 
Common stock issued for cash                       25,000    25    24,975        25,000
Common stock issued for settlement                       99,600    100    (100)        - 
Common stock issued to prior S-1 investors                       180,400    180    48,750         48,930 
Stock issued for debt conversion                       1,933,972    1,934    944,224         946,158 
Net loss for the period ended June 30, 2022   -    -    -    -    -    -    -    (687,743)   (687,743)
Balance, June 30, 2022   -   $-    -   $-    37,283,555   $37,284   $14,328,585   $(15,481,088)  $(1,115,219)
                                              
Balance, September 30, 2022   -   $-    -   $-    38,678,155   $38,678   $14,608,815   $(16,288,417)  $(1,640,924)
Conversion of common stock into Series B preferred stock   -    -    2,060,536    2,061    (20,605,334)   (20,605)   18,544    -    - 
Sale of common stock   -    -    -    -    300,000    300    149,700    -    150,000 
Net loss for the period ended December 31, 2022   -    -    -    -    -    -    -    (179,539)   (179,539)
Balance, December 31, 2022   -   $-    2,060,536   $2,061    18,372,821   $18,373   $14,777,059   $(16,467,956)  $(1,670,463)
Sale of common stock   -    -    -    -    50,000    50    12,450    -    12,500 
Net loss for the period ended March 31, 2023   -    -    -    -    -    -    -    (221,212)   (221,212)
Balance, March 31, 2023   -   $-    2,060,536   $2,061    18,422,821   $18,423   $14,789,509   $(16,689,168)  $(1,879,175)
Sale of common stock   -    -    -    -    125,000    125    74,875    -    75,000 
Conversion of note payable into common stock                       25,000    25    12,475    -    12,500 
Net loss for the period ended June 30, 2023   -    -    -    -    -    -    -    (215,029)   (215,029)
Balance, June 30, 2023   -   $-    2,060,536   $2,061   $18,572,821   $18,573   $14,876,859   $(16,904,197)  $(2,006,704)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-3

 

 

Genvor Incorporated

Condensed Consolidated Statements of Cash Flow

For the Nine Months Ended June 30,

(unaudited)

 

   2023   2022 
Cash flows from operating activities:          
Net loss  $(615,780)  $(4,469,004)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation expense   1,374    1,374 
Stock-based compensation   -    3,712,500 
Late fee capitalized into notes payable   90,000    90,000 
Loss on debt settlement   -    5,000 
Common stock issued for interest expense   -    2,500 
Amortization of debt discount   90,334    10,911 
Changes in assets and liabilities:          
Prepaid expenses   -    3,393 
Other current assets   500    - 
Accounts payable and accrued expenses   (150,214)   (27,076)
USDA CRADA liability   -    2,800 
Net cash used in operating activities   (583,786)   (667,602)
           
Cash flows from financing activities:          
Proceeds from notes payable   50,000    300,000 
Repayments of related party payable   -    (4,330)
Proceeds from sale of common stock   237,500    735,005 
Net cash provided by financing activities   287,500    1,030,675 
           
Net increase in cash   (296,286)   363,073 
           
Cash at beginning of period   296,386    72,315 
           
Cash at end of period  $100   $435,388 
           
Cash paid for interest  $-   $- 
Cash paid for taxes  $-   $- 
           
Non-cash investing and financing activities:          
Conversion of note payable into common stock  $12,500   $- 
Principal and interest settled through common stock issuance  $-   $1,135,946 
Accrued payroll settled through common stock issuance  $-   $125,750 
Right of use, lease asset and liability  $-   $13,480 
Prepaid costs for reverse capitalization recognized in additional paid-in capital  $-   $150,000 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-4

 

 

GENVOR INCORPORATED

Notes to Condensed Consolidated Financial Statements

June 30, 2023

(unaudited)

 

NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION

 

On May 27, 2022, Genvor Incorporated, formerly known as Allure Worldwide, Inc. (the “Company” or “Genvor” or “we”), a Nevada corporation, Genvor Acquisition, Corp., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”), and Genvor Inc., a Delaware corporation (“Old Genvor”), completed their previously announced merger transaction pursuant to which the Company acquired Old Genvor (the “Acquisition”), and Old Genvor became a wholly-owned subsidiary of the Company. The Acquisition was completed pursuant to an Exchange Agreement, dated as of January 11, 2021 (the “Acquisition Agreement”), pursuant to which Old Genvor was to be acquired by the Company as its wholly owned subsidiary and each share of Old Genvor common stock would be exchanged for a share of the Company’s common stock, and a merger agreement, dated March 2, 2022 (the “Merger Agreement”), pursuant to which Merger Sub merged with and into Old Genvor, with Old Genvor continuing as a wholly owned subsidiary of the Company and the surviving corporation of the merger, and each share of Old Genvor being converted into the right to receive a share of the Company (the “Merger”). After closing of the Merger, the Company was renamed “Genvor Incorporated”. Genvor develops plant-based defense technology designed to help farmers achieve global food security.

 

During May 2019, Old Genvor acquired Nexion Biosciences LLC (“NBLLC”) from a founder for nominal consideration as a wholly owned subsidiary. NBLLC was formed in the state of Delaware on December 28, 2018 (“inception”). The consolidated financial statements of the Company include the accounts of Genvor Incorporated, Old Genvor, and its wholly owned subsidiary NBLLC. Intercompany accounts and transactions have been eliminated upon consolidation.

 

Nature of Operations

 

The Company’s business plan is developing plant-based defense technology designed to help farmers achieve global food security. The Company’s technology was developed by two university scientists, Dr. Clayton Yates and Dr. Jesse Jaynes, who shared a mission to develop crop protection technology designed to defend against crop diseases effecting both animals and humans alike.

 

Basis of Presentation

 

The accompanying unaudited financial information as of and for the nine months ended June 30, 2023, and 2022 has been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, such financial information includes all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of our financial position at such date and the operating results and cash flows for such periods. Operating results for the nine months ended June 30, 2023, are not necessarily indicative of the results that may be expected for the entire year or for any other subsequent interim period.

 

Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been omitted pursuant to the rules of the U.S. Securities and Exchange Commission, or the SEC. These unaudited financial statements and related notes should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended September 30, 2022, as filed with the SEC.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany balances and transactions have been eliminated in the consolidation. The consolidated financial statements included herein, presented in accordance with United States generally accepted accounting principles (“GAAP”) and stated in United States dollars, have been prepared by the Company, pursuant to the rules and regulations of the Securities and Exchange Commission.

 

F-5

 

 

Liquidity and Going Concern

 

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. At June 30, 2023, the Company had an accumulated deficit of $16,904,197. For the nine months ended June 30, 2023, the Company recognized a net loss of $615,780 and had net cash used in operating activities of $583,786, with no revenues earned, and a lack of operational history. These matters, among others, raise substantial doubt about the Company’s ability to continue as a going concern.

 

While the Company is attempting to generate revenues, the Company’s cash position may not be significant enough to support the Company’s daily operations. Management intends to raise additional funds by way of additional public and/or private offerings of its stock. Management believes that the actions presently being taken to further implement its business plan and generate revenues provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to generate revenues and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate revenues. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Cash Flow Reporting

 

The Company follows Accounting Standards Codification (“ASC 230”), Statement of Cash Flows, for cash flow reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“indirect method”) as defined by ASC 230, Statement of Cash Flows, to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid debt instruments and other short-term investments with a maturity of three months or less, when purchased, to be cash equivalents. There were no cash equivalents as of June 30, 2023, and September 30, 2022.

 

The Company maintains its cash balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. At June 30, 2023, and September 30, 2022, $0 and $46,386, respectively, the Company’s cash balances were in excess of federally insured limits.

 

Fixed Assets

 

Furniture and equipment are stated at cost. Depreciation is provided by the straight-line method over the useful lives of the related assets, approximately seven years. Expenditures for minor enhancements and maintenance are expensed as incurred.

 

Stock-Based Compensation

 

The Company accounts for stock-based instruments issued to employees in accordance with ASC Topic 718, Compensation – Stock Compensation, and Certain Redeemable Financial Instruments. ASC Topic 718 requires companies to recognize in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees. The value of the portion of an award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line attribution method.

 

F-6

 

 

Fair Value of Financial Instruments

 

The book values of cash, accounts receivable, and accounts payable approximate their respective fair values due to the short-term nature of these instruments. The fair value hierarchy under GAAP distinguishes between assumptions based on market data (observable inputs) and an entity’s own assumptions (unobservable inputs).

 

The hierarchy consists of three levels

 

  ● Level one — Quoted market prices in active markets for identical assets or liabilities;
  ● Level two — Inputs other than level one inputs that are either directly or indirectly observable; and
  ● Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.

 

Determining which category an asset or liability falls within the hierarchy requires significant judgment. We evaluate our hierarchy disclosures each quarter.

 

Financial Instruments

 

The Company’s financial instruments include cash and cash equivalents, payables, and accrued interest and short-term and long-term notes payable and are accounted for under the provisions of ASC 825, Financial Instruments. The carrying amount of these financial instruments, as reflected in the accompanying consolidated balance sheet, approximates fair value.

 

Long-lived Assets

 

The Company’s long-lived assets and other assets (consisting of furniture, equipment and a patent) are reviewed for impairment in accordance with the guidance of the ASC 360, Property, Plant, and Equipment, and ASC 205, Presentation of Financial Statements. The Company tests for impairment losses on long-lived assets used in operations whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Recoverability of an asset to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. Impairment evaluations involve management’s estimates on asset useful lives and future cash flows. Actual useful lives and cash flows could be different from those estimated by management, which could have a material effect on our reporting results and financial positions. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals, as considered necessary. During the nine months ended June 30, 2023, and 2022, the Company had not experienced impairment losses on its long-lived assets.

 

Research and Development

 

The Company expenses the cost of research and development as incurred. Research and development expenses consist primarily of professional service costs associated with the development of the plant-based defense technology products. For the nine months ended June 30, 2023, and 2022, the Company had $0 and $109,248 in research and development expenses, respectively.

 

Patents

 

Any patent costs for internally developed patents will be expensed as incurred. Costs to maintain and defend patents are recorded as administrative expenses in the statement of operations.

 

Purchased patents are recorded at cost and reviewed for impairment in accordance with the guidance of the ASC 360, Property, Plant, and Equipment, and ASC 205, Presentation of Financial Statements.

 

Income Taxes

 

The Company accounts for income taxes in accordance with FASB ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and loss carryforwards and their respective tax bases.

 

F-7

 

 

Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income (loss) in the years in which those temporary differences are expected to be recovered or settled.

 

The effect of a change in tax rules on deferred tax assets and liabilities is recognized in operations in the year of change. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized.

 

Tax benefits of uncertain tax positions are recognized only if it is more likely than not that the Company will be able to sustain a position taken on an income tax return. The Company has no liability for uncertain tax positions as of June 30, 2023. Interest and penalties in any, related to unrecognized tax benefits would be recognized as interest expense. The Company does not have any accrued interest or penalties associated with unrecognized tax benefits, nor was any significant interest expense recognized during the nine months ended June 30, 2023.

 

Loss Per Share of Common Stock

 

Basic net loss per common share is computed using the weighted average number of common shares outstanding. Diluted earnings per share (“EPS”) include additional dilution from common stock equivalents, such as stock issuable pursuant to the exercise of stock options, warrants and convertible notes. Common stock equivalents are not included in the computation of diluted earnings per share when the Company reports a loss because to do so would be anti-dilutive for periods presented. The Company had total potential additional dilutive securities outstanding at June 30, 2023, and September 30, 2022, of 22,065,343 and 1,460,009, respectively.

 

Recent Accounting Pronouncements

 

In August 2020, the FASB issued ASU 2020-06, Debt with Conversion and Other Options, which simplifies accounting for convertible instruments. The new guidance eliminates two of the three models in ASC 470-20 that require separating embedded conversion features from convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation. The guidance is effective for fiscal years beginning after December 15, 2021. The Company is currently utilizing the guidance as applicable. There have been no material impacts on the Company’s financials.

 

Recently Issued Accounting Standards: Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

 

NOTE 3 – BORROWINGS

 

Commercial Loan

 

On April 9, 2020, the Company received a loan from the Small Business Administration pursuant to the Paycheck Protection Program (PPP) in the principal amount of $48,750. The note bears interest at a variable rate of approximately 1% and matured in April 2022; and it is currently in default. Forgiveness for the loan was applied for and is pending. The principal amount of the loan was based on the consulting agreement salary between Nexion Biosciences, Inc., organized in the state of Florida (NBFL) (a related party) and the CEO.

 

F-8

 

 

Notes Payable

 

From time to time, the Company’s subsidiary, Genvor Inc., enters into unsecured notes payable with individual investors. Only Noteholder E (below) has security in the form of a personal guarantee by the CEO and prior consultant (Note 6). The terms of these notes are listed below. Several of the notes are convertible into shares of the Company’s common stock as detailed in the following schedule.

 

                 Balance 
                 Convertible 
         Interest   Loan   into 
Noteholder  Origination  Maturity  Rate   Balance   Shares (c) 
Noteholder A (a)  2019  12/31/2021   0%  $217,000    N/A 
Noteholder B (a)  3/19/2019  4/29/2019   0%   540,000    N/A 
Noteholder C (a)  3/1/2019  2/29/2020   18%   32,500    N/A 
Noteholder D (d)  4/29/2019  unspecified   0%   300,000    30,000 
Noteholder E (a)  8/1/2019  8/31/2019   0%   37,500     N/A  
Noteholder F (a)(b)  2/27/2020  4/30/2020   0%   2,500    5,000 
Noteholder H  6/27/2022  6/27/2024   5%   300,000    1,000,000 
Noteholder I (c)  10/26/2022  12/31/2023   3%   50,000    400,000 
               1,479,500    1,435,000 
(d) Debt discount              (120,445)     
              $1,359,055      

 

(a) Past due at June 30, 2023
(b) Note is payable in a combination of $2,500 to $6,000 in cash and 5,000 to 15,000 share of common stock
(c) Convertible into common stock of the subsidiary, Genvor Inc.

 

The notes do not have default provisions except Noteholder B receives a default penalty of $10,000 each month the note goes unpaid.

 

Interest expense totaled $17,511 and $73,242, respectively, for the nine months ended June 30, 2023, and 2022, including default penalties. Late fees totaled $90,000 and $90,000, respectively, for the nine months ended June 30, 2023, and 2022.

 

NOTE 4 – STOCKHOLDERS’ DEFICIT

 

Preferred Stock

 

The authorized preferred stock of the Company consists of 20,000,000 shares with a $0.001 par value.

 

Series A Preferred Stock

 

On August 10, 2022, the Company designated 10 shares of its preferred stock as Series A Preferred Stock (“Series A”). Each share of Series A entitles the holder to ten million (10,000,000) votes on all matters submitted to a vote of the stockholders of the Corporation. When and as any dividend or distribution is declared or paid by the Company on the common stock, the Series A holders are entitled to participate in such dividend or distribution. Each Series A share is convertible, at the option of the holder, into one share of fully paid and non-assessable common stock. Upon any liquidation, dissolution, or winding-up of the Company, the Series A holders are entitled to receive out the assets of the Company, for each share of Series A, an amount equal to par value before any distribution or payment shall be made to the holder of any junior securities (including common stock and all other equity or equity equivalent securities of the Company).

 

As of June 30, 2023, and September 30, 2022, there were 9 and 9 shares of Series A preferred stock issued and outstanding, respectively. The preferred stock was issued on August 16, 2022, as follows: Bradley White (former Chief Executive Officer and Director), 3 shares; Dr. Clayton Yates (Chief Scientific Officer and Chairman), 3 shares; and Dr. Jesse Jaynes (Chief Research Officer and Director), 3 shares. See Note 7.

 

Series B Preferred Stock

 

On October 19, 2022, the Company filed a Certificate of Designation with the State of Nevada to designate its Series B Preferred Stock (“Series B”). The designation authorized 2,500,000 shares of Series B. Each share of Series B shall have 10 votes on all matters submitted to a vote of the stockholders of the Company. Each share of Series B is convertible into 10 shares of common stock of the Company.

 

F-9

 

 

On October 19, 2022, the following shareholders converted shares of common stock of the Company into shares of Series B to modify the common shares outstanding to reduce the outstanding common stock issued by the Company, as follows:

 

Name 

Common
Shares

Exchanged

  

Series B

Issued

 
Jaynes Investment LLC   2,000,000    200,000 
ACT Holdings LLC   7,312,612    731,262 
LASB Family Trust   3,800,112    380,012 
Jesse Michael Jaynes   4,767,611    476,762 
Bradley White (a)   1,225,000    122,500 
PJ Advisory Group   1,500,000    150,000 
Total   20,605,334    2,060,536 

 

(a)   Related party

 

The conversion of the common stock into the Series B was valued at par, respectively, offset to additional paid-in capital. The Series B is convertible into common stock into the original amount of common stock converted therefore there is no change in the amount of common stock outstanding on a fully diluted basis.

 

As of June 30, 2023, and September 30, 2022, there were 2,060,536 and 0 shares of Series B preferred stock issued and outstanding, respectively.

 

Common Stock

 

The authorized common stock of the Company consists of 300,000,000 shares with a $0.001 par value. All common stock shares are non-assessable and have one vote per share.

 

In connection with the Merger (see Note 1), the founding shareholders of the Company cancelled 18,144,112 shares of common stock, retaining 5%, or 1,855,888 shares of common stock, as of June 30, 2022. The cancellation is presented in the accompanying statements of changes in stockholders’ deficit within the line item “Retroactive application of recapitalization.”

 

Stock Issued for Cash

 

On November 17, 2022, the Company issued 300,000 shares of common stock to an investor for $150,000.

 

On May 3, 2023, the Company issued 100,000 shares of common stock to an investor for $50,000.

 

On May 12, 2023, the Company issued 15,000 shares of common stock to an investor for $15,000.

 

On May 29, 2023, the Company issued 10,000 shares of common stock to an investor for $10,000.

 

Other Stock Issuances

 

On June 14, 2023, the Company issued 25,000 shares of common stock related to the conversion of a note payable for $12,500.

 

NOTE 5 – FEDERAL INCOME TAX

 

As of June 30, 2023, and September 30, 2022, the Company has net operating loss carry forwards of $2,696,890 and $2,572,885, respectively, which may be available to reduce future years’ taxable income through 2043. The Company’s net operating loss carry forwards may be subject to annual limitations, which could reduce or defer the utilization of the losses as a result of an ownership change as defined in Section 382 of the Internal Revenue Code.

 

F-10

 

 

The Company’s tax expense differs from the “expected” tax expense for Federal income tax purposes (computed by applying the United States Federal tax rate of 21% to loss before taxes for fiscal year 2023 and 2022), as follows:

 

   June 30,   September 30, 
   2023   2022 
Tax benefit at the statutory rate  $(110,344)  $(204,559)
State income taxes, net of federal income tax benefit   (13,662)   (25,326)
Change in valuation allowance   124,006    229,885 
Total  $-   $- 

 

The tax effects of the temporary differences between reportable financial statement income and taxable income are recognized as deferred tax assets and liabilities.

 

The tax years 2023 and 2022 remain open for examination by federal agencies and other jurisdictions in which it operates.

 

The tax effect of significant components of the Company’s deferred tax assets and liabilities at June 30, 2023, and September 30, 2022, are as follows:

 

   June 30,   September 30, 
   2023   2022 
Net operating loss carryforward  $2,696,890   $2,572,885 
Total gross deferred tax assets   2,696,890    2,572,885 
Less: Deferred tax asset valuation allowance   (2,696,890)   (2,572,885)
Total net deferred taxes  $-   $- 

 

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment.

 

Because of the historical earnings history of the Company, the net deferred tax assets for 2022 and 2021 were fully offset by a 100% valuation allowance. The valuation allowance for the remaining net deferred tax assets was $2,696,890 and $2,572,885 as of June 30, 2023, and September 30, 2022, respectively.

 

NOTE 6 – COMMITMENTS AND CONTINGENCIES

 

From time to time, the Company may be involved in litigation in the ordinary course of business. The Company is not currently involved in any litigation that we believe could have a material adverse effect on its financial condition or results of operations.

 

Subscription Agreement and Cash Held in Escrow

 

On February 20, 2019, the Company entered into a subscription escrow agreement (the “Trust Agreement”) with Branch Banking and Trust Company (“BB&T”). This Trust Agreement was established for the subscription agreement proceeds raised and escrowed pursuant to the Company’s prior Rule 419 S-1 offering. The balance held in trust at June 30, 2023 and September 30, 2022, totaled $19,705.

 

Upon completion of the Merger (see Notes 1 and 8), the Company issued 975,000 common stock shares to the investors in that prior S-1 offering during July 2022 and were released to the Company.

 

Consulting Agreements

 

During the nine months ended June 30, 2023, the Company paid the Company’s former CEO, Bradley White, $32,500 pursuant to a consulting agreement carried over from related party NBFL. The agreement provides for an annual salary of $150,000 which increases based on certain capital raise thresholds. On June 20, 2023, Mr. White was terminated as an officer of the Company. At June 30, 2023 and September 30, 2022, accrued payroll owed to the former CEO totaled $228,213 and $188,484, respectively, as presented in the accompanying consolidated balance sheets.

 

On July 24, 2020, the Company entered into a consulting agreement for business development activities, networking, negotiations, and strategic planning. The compensation pursuant to the agreement was $20,000 monthly.

 

F-11

 

 

Office Lease

 

The Company entered into a sublease agreement with the above consultant (providing business development assistance from 2019-2020) effective August 1, 2019, subject to the terms and conditions of the office lease held by the consultant at 15540 Quorum Drive #2624, Addison, Texas. On January 1, 2019, the Company adopted ASC 842 requiring this lease to be recorded as an asset and corresponding liability on its balance sheet. The Company records rent expense associated with this lease on the straight-line basis in conjunction with the terms of the underlying lease. A discount rate was not used in the determination of the right of use asset and liability since its effect would not be significant. The lease moved to a month-to-month basis beginning in September 2021 at $2,810 per month in addition to common area maintenance charges. During the nine months ended June 30, 2023, and 2022, we incurred $10,187 and $20,607, respectively, in office rental expense.

 

Research and Development Agreement

 

During September 2020, the Company assumed a Cooperative Research And Development Agreement (CRADA) with the United States Department of Agriculture (USDA), Agricultural Research Service (ARS). Under this agreement, the Company committed to funding the remaining amount due. As of June 30, 2023, and September 30, 2022, $246,400 and $246,400, respectively, remained outstanding and is presented in the accompanying consolidated balance sheets as USDA CRADA liability.

 

NOTE 7 – RELATED PARTY TRANSACTIONS

 

Share Issuances to the Board of Directors

 

The Company issued Series A preferred stock on August 16, 2022, as follows: Bradley White (former Chief Executive Officer), 3 shares; Dr. Clayton Yates (Chief Scientific Officer and Chairman), 3 shares; and Dr. Jesse Jaynes (Chief Research Officer and Director), 3 shares. See Note 4.

 

NOTE 8 – SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events from the balance sheet through the date of this filing and determined there were no events to disclose except the following.

 

On July 12, 2023, the Company sold 25,000 shares of common stock for $10,000 to an investor at a value of $0.40 per share.

 

On July 13, 2023, the Company sold 20,000 shares of common stock for $10,000 to an investor at a value of $0.50 per share.

 

On July 14, 2023, the Company sold 50,000 shares of common stock for $25,000 to an investor at a value of $0.50 per share.

 

On August 4, 2023, the Company executed into a promissory note with Jason Adams for $15,000.

 

On or about August 4, 2023, the Company’s former Chief Executive Officer, Bradley White, and LASB Family Trust presented conversion notices to the Company’s transfer agent to convert their shares of the Company’s Series B Preferred Stock into shares of Company common stock, and the Company objected to those conversions. Shares held by LASB Family Trust may be deemed to be beneficially owned by Mr. White.

 

F-12

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Rule 175 of the Securities Act of 1933, as amended, and Rule 3b-6 of the Securities Act of 1934, as amended, that involve substantial risks and uncertainties. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about our industry, our beliefs and our assumptions. Words such as “anticipate,” “expects,” “intends,” “plans,” “believes,” “seeks” and “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this Form 10-Q. Investors should carefully consider all of such risks before making an investment decision with respect to the Company’s stock. The following discussion and analysis should be read in conjunction with our financial statements and summary of selected financial data for Genvor Incorporated. Such discussion represents only the best present assessment from our Management.

 

Company Overview

 

Genvor Incorporated (the “Company”) was incorporated in Florida on September 26, 2018, as Allure Worldwide, Inc., and as of November 18, 2019, redomiciled to Nevada. On June 24, 2022, the Company changed its name to from Allure Worldwide, Inc. to Genvor Incorporated.

 

The Company was originally formed with the intention of seeking to acquire the assets or shares of an entity actively engaged in business which generates revenues, in exchange for its securities. On January 11, 2021, the Company entered into an Exchange Agreement (the “Purchase Agreement”) with Genvor Inc., a Delaware corporation (“Genvor”) to acquire (the “Acquisition”) Genvor. On March 2, 2022, the Company and Genvor entered into a merger agreement (the “Merger Agreement”) to consummate the Acquisition, and pursuant to which a wholly-owned subsidiary of the Company, Genvor Acquisition Corp., a Delaware corporation, would merge (the “Merger”) with and into Genvor, with each share of Genvor common stock issued immediately prior to the time of the merger automatically converted into the right to receive one share of common stock of the Company.

 

On May 27, 2022, the Acquisition closed, Merger Subsidiary merged with and into Genvor, each share of Genvor was exchanged for the right to receive one share of Company common stock, 35,261,871 shares of Company common stock were issued to Genvor’s pre-merger shareholders (the “Merger Shares”), constituting a change of control of the Company, and Genvor became a wholly owned subsidiary of the Company. As a result of these transactions, the Company had 55,261,871 issued and outstanding common shares upon the closing of the share exchange with Genvor, and subsequently the Company’s original founding shareholders cancelled 18,144,112 shares of Company common stock in connection with the Acquisition.

 

As a result of the Acquisition, the Company’s business plan is that of Genvor, and the Company is developing plant-based defense technology designed to help farmers achieve global food security.

 

The Company’s technology was developed by two university scientists, Dr. Clayton Yates and Dr. Jesse Jaynes, who shared a mission to develop crop protection technology designed to defend against crop diseases effecting both animals and humans alike. The Company’s technology is currently being advanced by the USDA in corn seed varieties and with U.S. Sugar in citrus trees.

 

The Company’s headquarters is located at 13155 Noel Road, Suite 900, Dallas, Texas, 75240.

 

The following Management Discussion and Analysis should be read in conjunction with the financial statements and accompanying notes included in this Form 10-Q.

 

Plan of Operation

 

The United States Food and Agriculture Organization reports that annual global crop losses due to plant pathogens and viruses are now estimated to exceed $100 billion. Alarming to the FDA are the fungi “Aspergillus Flavus,” which produce Aflatoxins, a toxic and carcinogenic compound known to cause liver cancer in humans and animals. Aspergillus Flavus is also the second leading cause of “aspergillosis” in humans. Patients infected with Aspergillus flavus often have reduced or compromised immune systems.

 

4

 

 

The U.S. Food and Drug Administration estimates the annual cost of Aflatoxin contamination in the United States at approximately $500 million through two categories of loss: market rejection and animal health impacts. As a result, the United States Department of Agriculture (USDA) has imposed strict guidelines for crop inspection and discovery of diseased crops caused by Aflatoxins. Both planted fields and harvested crops that are found to be contaminated beyond permitted testing levels must be destroyed. As a result, farmers and growers can be exposed to catastrophic economic losses. This Aflatoxin problem has created a significant opportunity for agricultural companies who can develop the technology needed to defend against Aflatoxins.

 

The Company’s Solution

 

The Company’s technology is the only known solution that it is aware of, which it believes provides broad spectrum effectiveness against Aspergillus Flavus and Aflatoxins. This technology is deliverable by both bioengineered seed trait, as well as through biopesticide application.

 

Dr. Jaynes, one of Genvor’s founders, has been on a 30+ year quest to find a global crop solution for defense against Aflatoxins. As a result of successful testing and collaboration between Dr. Jaynes and the United States Department of Agriculture, Agriculture Research Service (USDA-ARS), the USDA-ARS awarded Genvor with a Cooperative Research & Development Agreement in August of 2018. The stated goal of this agreement is to develop and commercialize disease resistant and nutritionally enhanced corn seed varieties using Genvor’s seed trait technology.

 

Seed Traits

 

In the United States, the adoption of crop seeds with enhanced traits has been staggering. Currently, over 90 percent of U.S. corn, cotton and soybeans are produced using seeds with enhanced traits. Trait fees for these three crops alone represent over $2 billion annually based on an average trait fee of $13 per acre on approximately 170 million acres. U.S. corn crops alone account for roughly $1.2 billion of the estimated $2 billion.

 

Biopesticides

 

Biopesticides are one of the fastest-growing crop protection market sectors, increasing at twice the compound annual growth rate of the crop protection market as a whole. Primary drivers of this growth include a rising global demand for organic foods, the trend in the reduction of chemical residues, stricter import and supermarket standards, shorter pre-harvest intervals, a push for sustainability, and the demand for additional modes of action for managing resistance. The biopesticide market in north America alone is currently estimated to be over $4.8 billion annually.

 

Genvor’s technology is effective with corn seed and is believed by Genvor to be effective with many known crop types, and the technology may be delivered as a topical spray in the form of a biopesticide.

 

Reports to Security Holders

 

The Company is required to file reports pursuant to Section 15(d) of the Securities Exchange Act of 1934 and is required to furnish its stockholders with annual reports containing consolidated financial statements audited by its independent registered public accounting firm and to make available quarterly reports containing unaudited consolidated financial statements for each of the first three quarters of each fiscal year ending September 30th. The Company files Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K and Current Reports on Form 8-K with the Securities and Exchange Commission. The Company may also file additional documents with the Commission if those documents become necessary in the course of its operations.

 

Available Information

 

All reports of the Company filed with the SEC are available free of charge through the SEC’s website at www.sec.gov. In addition, the public may read and copy materials filed by the Company at the SEC’s Public Reference Room located at 100 F Street, N.E., Washington, D.C. 20549. The public may also obtain additional information on the operation of the Public Reference Room by calling the Commission at 1-800-SEC-0330.

 

5

 

 

Results of Operations

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and notes thereto for the three and nine months ended June 30, 2023, and 2022, and related management discussion herein.

 

Our financial statements are stated in U.S. Dollars and are prepared in accordance with generally accepted accounting principles of the United States (“GAAP”).

 

Going Concern Qualification

 

Several conditions and events cast substantial doubt about the Company’s ability to continue as a going concern. The Company has incurred cumulative net losses of $16,904,197 from its inception to June 30, 2023, and requires capital for its contemplated operational and marketing activities to take place. The Company’s ability to raise additional capital through debt or future issuances of capital stock is unknown. The obtainment of additional financing, the successful development of the Company’s contemplated plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability to successfully resolve these factors raises substantial doubt about the Company’s ability to continue as a going concern.

 

For the Three Months Ended June 30, 2023, and 2022

 

Revenues

 

We did not earn any revenues during the three months ending June 30, 2023, and 2022.

 

Operating Loss

 

During the three months ending June 30, 2023, and 2022, the Company had an operating loss of $149,072 and $645,503, respectively. For the three months June 30, 2022, the primary expenses were stock-based compensation of $502,875. The decrease in operating loss was primarily due to decreases in stock-based compensation and other general administrative expenses during the three months ending June 30, 2023, as compared to the three months ending June 30, 2022.

 

Net Loss

 

The Company incurred a net loss of $215,029 and $687,743, respectively, during the three months ended June 30, 2023, and 2022, as a result of the decreasing operating loss described operating loss described previously.

 

For the Nine Months Ended June 30, 2023, and 2022

 

Revenues

 

We did not earn any revenues during the nine months ending June 30, 2023, and 2022.

 

Operating Loss

 

During the nine months ending June 30, 2023, and 2022, the Company had an operating loss of $417,935 and $4,300,762, respectively. For the nine months June 30, 2022, the primary expenses were stock-based compensation of $3,712,500. The decrease in operating loss was primarily due to decreases in payroll, stock-based compensation, and other general administrative expenses during the nine months ended June 30 2022.

 

Net Loss

 

The Company incurred a net loss of $615,780 and $4,469,004, respectively, during the nine months ended June 30, 2023, and 2022, as a result of the decreasing operating loss described previously.

 

6

 

 

Liquidity and Capital Resources

 

Based upon our current financial condition, we do not have sufficient cash to operate our business at the current level for the next twelve months. We intend to fund operations through debt and/or equity financing arrangements, which may be insufficient to fund expenditures or other cash requirements. We plan to seek additional financing in a private equity offering to secure funding for operations. There can be no assurance that we will be successful in raising additional funding. If we are not able to secure additional funding, the implementation of our business plan will be impaired. There can be no assurance that such additional financing will be available to us on acceptable terms or at all.

 

Working Capital

 

Cash Flow

 

We fund our operations with cash received from advances from officers and related parties and issuances of equity or notes payable.

 

Cash Flows from Operating Activities

 

For the nine months ended June 30, 2023, as compared to the nine months ended March 31, 2022, cash used in operating expenses increased due to payments of contract payroll and accounts payable, as well as due to an increase in professional fees and research and development expenses.

 

Cash Flows from Investing Activities

 

For the nine months ended June 30, 2023, no cashflows were provided by or used in investing activities.

 

Cash Flows from Financing Activities

 

For the nine months ended June 30, 2023, cash was raised through the sale of common stock and proceeds from notes payable.

 

Off-Balance Sheet Arrangements

 

The Company does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

Not Applicable.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Disclosure Controls and Procedures

 

The Securities and Exchange Commission defines the term “disclosure controls and procedures” to mean the company’s controls and other procedures of an issuer that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company maintains such a simple system of controls and procedures in an effort to ensure that all information which it is required to disclose in the reports it files under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified under the SEC’s rules and forms and that information required to be disclosed is accumulated and communicated to principal executive and principal financial officers to allow timely decisions regarding disclosure.

 

7

 

 

As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were not effective to provide reasonable assurance of achieving the objectives of timely alerting them to material information required to be included in our periodic SEC reports and of ensuring that such information is recorded, processed, summarized, and reported with the time periods specified. Our chief executive officer and chief financial officer also concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this report to provide reasonable assurance of the achievement of these objectives.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in the Company’s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or 15d-15 of the Exchange Act that occurred during the quarter ended June 30, 2023, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

The Company is not a party to any significant pending legal proceedings other than as disclosed below, and no other such proceedings are known to be contemplated. No director, officer or affiliate of the Company, and no owner of record or beneficial owner of more than 5.0% of the securities of the Company, or any associate of any such director, officer or security holder is a party adverse to the Company or has a material interest adverse to the Company in reference to pending litigation.

 

ITEM 1A. RISK FACTORS.

 

Not applicable.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

On May 3, 2023, the Company issued 100,000 shares of common stock to an investor for $50,000.

 

On May 12, 2023, the Company issued 15,000 shares of common stock to an investor for $15,000.

 

On May 29, 2023, the Company issued 10,000 shares of common stock to an investor for $10,000.

 

On June 14, 2023, the Company issued 25,000 shares of common stock related to the conversion of a note payable for $12,500.

 

The forgoing shares were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder, as there was no general solicitation and the transactions did not involve a public offering.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

None.

 

ITEM 5. OTHER INFORMATION.

 

None.

 

8

 

 

ITEM 6. EXHIBITS.

 

Exhibit   Description
     
3.1   Florida Articles of Incorporation (incorporated by reference to Exhibit 3.A to our Registration Statement on Form S-1, filed on May 4, 2020)
     
3.2   Nevada Articles of Incorporation (incorporated by reference to Exhibit 3.2 to our Quarterly Report on Form 10-Q, filed on July 20, 2021)
     
3.3   Certificate of Correction to Nevada Articles of Incorporation (incorporated by reference to Exhibit 3.3 to our Quarterly Report on Form 10-Q, filed on July 20, 2021)
     
3.4   Bylaws (incorporated by reference to Exhibit 3.B to our Registration Statement on Form S-1, filed on May 4, 2020)
     
10.1*   Exchange Agreement, by and between the Company and Genvor Inc. (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on February 1, 2021)
     
10.2*   Agreement and Plan of Merger, by and between the Company, Genvor Inc., and Genvor Acquisition Corp. (incorporated by reference to Exhibit 10.2 to our Annual Report on Form 10-K filed on March 21, 2022)
     
31.1**   Certification of CEO required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
31.2**   Certification of CFO required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32.1**   Certification of CEO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C. 63
     
32.2**   Certification of CFO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C. 63
     
101.INS***   Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
     
101.SCH***   Inline XBRL Taxonomy Extension Schema Document.
     
101.CAL***   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
     
101.DEF***   Inline XBRL Taxonomy Extension Definition Linkbase Document.
     
101.LAB***   Inline XBRL Taxonomy Extension Labels Linkbase Document.
     
101.PRE***   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
     
104   Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

 

* Certain schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. A copy of any omitted schedule or exhibit will be furnished supplementally to the Securities and Exchange Commission upon request; provided, however that the Company may request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended, for any schedule or Exhibit so furnished.

** Filed herewith.

*** XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

 

9

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  GENVOR INCORPORATED
     
Date: August 9, 2023 By: /s/ Judith S. Miller
    Judith S. Miller
   

Interim Chief Executive Officer,

Interim Chief Financial Officer

 

10

 

 EX-31.1 2 ex31-1.htm

 

EXHIBITS 31.1 & 31.2

 

CERTIFICATION

 

I, Judith S. Miller, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Genvor Incorporated;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 9, 2023 By: /s/ Judith S. Miller
    Judith S. Miller
    Interim Chief Executive Officer and Interim Chief Financial Officer

 

 

 

 EX-32.1 3 ex32-1.htm

 

EXHIBITS 32.1 & 32.2

 

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Judith S. Miller, Interim Chief Executive Officer and Interim Chief Financial Officer of Genvor Incorporated (the “Company”), certify, pursuant to 18 U.S.C. Section 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) the Quarterly Report on Form 10-Q of the Company for the period ended June 30, 2023 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

 

  (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: August 9, 2023 By: /s/ Judith S. Miller
    Judith S. Miller
    Interim Chief Executive Officer and Interim Chief Financial Officer

 

 

 

 EX-101.SCH 4 gnvr-20230630.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flow (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - BORROWINGS link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - STOCKHOLDERS’ DEFICIT link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - FEDERAL INCOME TAX link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - BORROWINGS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - STOCKHOLDERS’ DEFICIT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - FEDERAL INCOME TAX (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - SCHEDULE OF CONVERTIBLE NOTES PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - SCHEDULE OF CONVERTIBLE NOTES PAYABLE (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - BORROWINGS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - SCHEDULE OF CONVERTED SHARES OF COMMON STOCK (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - STOCKHOLDERS’ DEFICIT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - SCHEDULE OF LOSS BEFORE TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - FEDERAL INCOME TAX (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 5 gnvr-20230630_cal.xml XBRL CALCULATION FILE EX-101.DEF 6 gnvr-20230630_def.xml XBRL DEFINITION FILE EX-101.LAB 7 gnvr-20230630_lab.xml XBRL LABEL FILE Class of Stock [Axis] Series A Preferred Stock [Member] Series B Preferred Stock [Member] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Debt Instrument [Axis] Paycheck Protection Program [Member] Noteholder B [Member] Note Holder A [Member] Noteholder C [Member] Noteholder D [Member] Noteholder E [Member] Noteholder F [Member] Noteholder H [Member] Noteholder I [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Title of Individual [Axis] Bradley White [Member] Dr. Clayton Yates [Member] Dr. Jesse Jaynes [Member] Shareholder [Member] Stock Issued For Cash [Member] Related Party, Type [Axis] Jaynes Investment LLC [Member] ACT Holdings LLC [Member] LASB Family Trust [Member] Jesse Michael Jaynes [Member] PJ Advisory Group [Member] Investor [Member] Plan Name [Axis] Consulting Agreements [Member] Chief Executive Officer [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Related Party Transaction [Axis] Consultant [Member] Category of Item Purchased [Axis] Research and Development Arrangement [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Jason Adams [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement [Table] Statement [Line Items] ASSETS Current assets: Cash Other current assets Total current assets Fixed assets, net Total assets LIABILITIES AND STOCKHOLDERS’ DEFICIT Current liabilities: Convertible notes payable Accounts payable and accrued expenses Due to related party SBA loan USDA CRADA liability Total current liabilities Non-current liabilities: Convertible notes payable, net of discounts Total non-current liabilities Total liabilities Commitments and contingencies (Note 6) Stockholders’ deficit: Preferred stock value Common stock, $0.001 par value, 300,000,000 shares authorized, 18,572,821 and 38,678,155 shares issued, issuable and outstanding as of June 30, 2023 and September 30, 2022, respectively Additional paid-in capital Accumulated deficit Total stockholders’ deficit Total liabilities and stockholders’ deficit Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue Operating expenses Professional fees Payroll related expenses Research and development Stock-based compensation Depreciation expense Other general and administrative expenses Total operating expenses Operating loss Other income (expense) Interest expense Loss on debt settlement Penalties Amortization of debt discount Total other income (expense) Net loss Net loss per common share - basic Net loss per common share - diluted Weighted average common shares outstanding - basic Weighted average common shares outstanding - diluted Beginning balance, value Beginning balance, shares Recapilitalization / RTO impact Adjusted balance, beginning of period Adjusted balance beginning of period, shares Common stock issued for services Common stock issued for services, shares Exercise of options Exercise of options, shares Common stock issued for cash Common stock issued for cash, shares Net loss Issuance of common stock for services Conversion of note payable into common stock Conversion of note payable into common stock, shares Payment for reverse capitalization 419 fund raising services 419 fund raising services, shares Founder shares issued Founder shares issued, shares Common stock issued for settlement Common stock issued for settlement, shares Common stock issued to prior S-1 investors Common stock issued to prior S-1 investors, shares Stock issued for debt conversion Stock issued for debt conversion, shares Conversion of common stock into Series B preferred stock Conversion of common stock into Series B preferred stock, shares Sale of common stock Sale of common stock, shares Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net loss to net cash used in operating activities: Late fee capitalized into notes payable Loss on debt settlement Common stock issued for interest expense Amortization of debt discount Changes in assets and liabilities: Prepaid expenses Other current assets Accounts payable and accrued expenses USDA CRADA liability Net cash used in operating activities Cash flows from financing activities: Proceeds from notes payable Repayments of related party payable Proceeds from sale of common stock Net cash provided by financing activities Net increase in cash Cash at beginning of period Cash at end of period Cash paid for interest Cash paid for taxes Non-cash investing and financing activities: Conversion of note payable into common stock Principal and interest settled through common stock issuance Accrued payroll settled through common stock issuance Right of use, lease asset and liability Prepaid costs for reverse capitalization recognized in additional paid-in capital Accounting Policies [Abstract] ORGANIZATION AND BASIS OF PRESENTATION SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Broker-Dealer [Abstract] BORROWINGS Equity [Abstract] STOCKHOLDERS’ DEFICIT Income Tax Disclosure [Abstract] FEDERAL INCOME TAX Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Subsequent Events [Abstract] SUBSEQUENT EVENTS Use of Estimates Cash Flow Reporting Cash and Cash Equivalents Fixed Assets Stock-Based Compensation Fair Value of Financial Instruments Financial Instruments Long-lived Assets Research and Development Patents Income Taxes Loss Per Share of Common Stock Recent Accounting Pronouncements SCHEDULE OF CONVERTIBLE NOTES PAYABLE SCHEDULE OF CONVERTED SHARES OF COMMON STOCK SCHEDULE OF LOSS BEFORE TAXES SCHEDULE OF DEFERRED TAX ASSETS Accumulated deficit Net loss Net cash used in operating activities Cash equivalents Cash uninsured amount Fixed assets, estimated useful lives Research and development expenses Additional dilutive securities outstanding Schedule of Short-Term Debt [Table] Short-Term Debt [Line Items] Origination Maturity date Interest rate Loan Balance Number of shares the notesis convertible into shares Debt discount Total loan Notes payable converted Shares issued during conversion Principal amont Interest rate [custom:DebtDefaultPenaltyAmount] Interest expense Late fees Schedule of Stock by Class [Table] Class of Stock [Line Items] Common Shares Exchanged Series B Issued Preferred stock, shares par value Designation authorized shares Number of votes Conversion share description Common stock, shares par value Number of common stock cancel Number of common stock retaining Shares issued Shares issued, value Issuance of common stock Conversion of common stock Tax benefit at the statutory rate State income taxes, net of federal income tax benefit Change in valuation allowance Total Net operating loss carryforward Total gross deferred tax assets Less: Deferred tax asset valuation allowance Total net deferred taxes Net operating loss carry forwards Federal tax statutory rate Valuation allowance for net deferred tax assets Long-Term Purchase Commitment [Table] Long-Term Purchase Commitment [Line Items] Assets held in trust Number of shares issued Related party payable Annual salary Accrued payroll Salary and Wage, Excluding Cost of Good and Service Sold Rent expense Fund Amount Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table] Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] Subsequent Event [Table] Subsequent Event [Line Items] Common stock sold Common stock value Issue price Promissory note Due to related party. Cash Flow Reporting [Policy Text Block] Patents [Policy Text Block] Dilutive securities outstanding. Paycheck Protection Program [Member] Origination Note Holder A [Member] Noteholder B [Member] Noteholder C [Member] Noteholder D [Member] Noteholder E [Member] Noteholder F [Member] Noteholder H [Member] Noteholder I [Member] Debt default penalty amount. Penalties. Late fees. Designation authorized shares. Bradley White [Member] Dr. Clayton Yates [Member] Dr. Jesse Jaynes [Member] Jaynes Investment LLC [Member] ACT Holdings LLC [Member] LASB Family Trust [Member] Jesse Michael Jaynes [Member] PJ Advisory Group [Member] Number of common stock retaining. Shareholder [Member] Stock Issued For Cash [Member] Recapitalization rto impact. Stockholders equity adjusted balance. Shares outstanding adjusted balance. Payment for reverses capitalization. Fund raising services amount. Fund raising services shares. Consulting Agreements [Member] Consultant [Member] Fund amount. Stock issued for debt conversion. Stock issued for debt conversion shares. Related party payable Late fee capitalized into notes payable. Common stock issued for interest expense. Accrued payroll settled through common stock issuance. Right of use asset lease asset and liability. Prepaid costs for reverse capitalization recognized in additional paid in capital. Lawrence J Minogue [Member] Ryan Hart [Member] John Lusk [Member] Issuance of common stock for services. Founder shares issued share. Founder shares issued amount. Common stock issued to prior investors. Common stock issued to prior investors, shares. Conversion of note payable into common stock. Assets, Current Assets Liabilities, Current Liabilities, Noncurrent Liabilities Equity, Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Interest Expense Amortization Nonoperating Income (Expense) Shares, Outstanding Increase (Decrease) in Prepaid Expense Increase (Decrease) in Other Current Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Other Operating Liabilities Net Cash Provided by (Used in) Operating Activities Repayments of Related Party Debt Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations ConversionOfNotePayableIntoCommonStock Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Debt Instrument, Unamortized Discount Debt Instrument, Interest Rate, Stated Percentage Income Tax Expense (Benefit) Deferred Tax Assets, Net of Valuation Allowance EX-101.PRE 8 gnvr-20230630_pre.xml XBRL PRESENTATION FILE XML 9 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover - shares
 9 Months Ended
Jun. 30, 2023
Aug. 11, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2023  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --09-30  
Entity File Number 333-234815  
Entity Registrant Name GENVOR INCORPORATED  
Entity Central Index Key 0001792941  
Entity Tax Identification Number 83-2054746  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 201 S. Elliott Road  
Entity Address, Address Line Two Suite 538  
Entity Address, City or Town Chapel Hill  
Entity Address, State or Province NC  
Entity Address, Postal Zip Code 27514  
City Area Code (984)  
Local Phone Number 261-7338  
Entity Current Reporting Status No  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period true  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   18,667,821
XML 10 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2023
Sep. 30, 2022
Current assets:    
Cash $ 100 $ 296,386
Other current assets 1,500 2,000
Total current assets 1,600 298,386
Fixed assets, net 16,192 17,565
Total assets 17,792 315,951
Current liabilities:    
Convertible notes payable 1,179,500 1,052,000
Accounts payable and accrued expenses 133,958 516,658
Due to related party 236,333 3,846
SBA loan 48,750 48,750
USDA CRADA liability 246,400 246,400
Total current liabilities 1,844,941 1,867,654
Non-current liabilities:    
Convertible notes payable, net of discounts 179,555 89,221
Total non-current liabilities 179,555 89,221
Total liabilities 2,024,496 1,956,875
Commitments and contingencies (Note 6)
Stockholders’ deficit:    
Common stock, $0.001 par value, 300,000,000 shares authorized, 18,572,821 and 38,678,155 shares issued, issuable and outstanding as of June 30, 2023 and September 30, 2022, respectively 18,573 38,678
Additional paid-in capital 14,876,859 14,608,815
Accumulated deficit (16,904,197) (16,288,417)
Total stockholders’ deficit (2,006,704) (1,640,924)
Total liabilities and stockholders’ deficit 17,792 315,951
Series A Preferred Stock [Member]    
Stockholders’ deficit:    
Preferred stock value
Series B Preferred Stock [Member]    
Stockholders’ deficit:    
Preferred stock value $ 2,061
XML 11 R3.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares
Jun. 30, 2023
Sep. 30, 2022
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 20,000,000 20,000,000
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 300,000,000 300,000,000
Common stock, shares issued 18,572,821 38,678,155
Common stock, shares outstanding 18,572,821 38,678,155
Series A Preferred Stock [Member]    
Preferred stock, shares authorized 10 10
Preferred stock, shares issued 9 9
Preferred stock, shares outstanding 9 9
Series B Preferred Stock [Member]    
Preferred stock, shares authorized 2,500,000 2,500,000
Preferred stock, shares issued 2,060,536 0
Preferred stock, shares outstanding 2,060,536 0
XML 12 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Revenue
Operating expenses        
Professional fees 59,762 45,170 125,424 132,928
Payroll related expenses 37,500 37,500 112,500 180,725
Research and development 109,248
Stock-based compensation 502,875 3,712,500
Depreciation expense 458 458 1,374 1,374
Other general and administrative expenses 51,352 59,500 178,637 163,987
Total operating expenses 149,072 645,503 417,935 4,300,762
Operating loss (149,072) (645,503) (417,935) (4,300,762)
Other income (expense)        
Interest expense (5,846) (12,240) (17,511) (73,242)
Loss on debt settlement (5,000)
Penalties (30,000) (30,000) (90,000) (90,000)
Amortization of debt discount (30,111) (90,334)
Total other income (expense) (65,956) (42,240) (197,844) (168,242)
Net loss $ (215,029) $ (687,743) $ (615,780) $ (4,469,004)
Net loss per common share - basic $ (0.01) $ (0.02) $ (0.03) $ (0.15)
Net loss per common share - diluted $ (0.01) $ (0.02) $ (0.03) $ (0.15)
Weighted average common shares outstanding - basic 18,502,546 36,439,887 19,800,317 30,506,420
Weighted average common shares outstanding - diluted 18,502,546 36,439,887 19,800,317 30,506,420
XML 13 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Sep. 30, 2021 $ 2,000 $ (64,540) $ (62,540)
Beginning balance, shares at Sep. 30, 2021 20,000,000      
Recapilitalization / RTO impact $ 18,000 8,546,798 (10,947,544) (2,382,746)
Adjusted balance, beginning of period $ 20,000 8,546,798 (11,012,084) (2,445,286)
Adjusted balance beginning of period, shares     20,000,000      
Common stock issued for services $ 2,650 197,350 200,000
Common stock issued for services, shares     2,650,000      
Exercise of options $ 1,400   1,400
Exercise of options, shares     1,400,000      
Common stock issued for cash $ 1,475 736,035   737,510
Common stock issued for cash, shares     1,475,020      
Net loss (515,716) (515,716)
Ending balance, value at Dec. 31, 2021 $ 25,525 9,480,183 (11,527,800) (2,022,092)
Ending balance, shares at Dec. 31, 2021 25,525,020      
Beginning balance, value at Sep. 30, 2021 $ 2,000 (64,540) (62,540)
Beginning balance, shares at Sep. 30, 2021 20,000,000      
Net loss           (4,469,004)
Ending balance, value at Jun. 30, 2022 $ 37,284 14,328,585 (15,481,088) (1,115,219)
Ending balance, shares at Jun. 30, 2022   37,283,555      
Beginning balance, value at Dec. 31, 2021 $ 25,525 9,480,183 (11,527,800) (2,022,092)
Beginning balance, shares at Dec. 31, 2021 25,525,020      
Common stock issued for services $ 6,020 3,003,980 3,010,000
Common stock issued for services, shares     6,020,000      
Common stock issued for cash $ 280 139,720 140,000
Common stock issued for cash, shares     280,000      
Net loss (3,265,545) (3,265,545)
Issuance of common stock for services
Conversion of note payable into common stock $ 689 336,884 337,573
Conversion of note payable into common stock, shares     688,675      
Payment for reverse capitalization (150,000) (150,000)
419 fund raising services $ 170 (170)
419 fund raising services, shares     170,000      
Ending balance, value at Mar. 31, 2022 $ 32,684 12,810,597 (14,793,345) (1,950,064)
Ending balance, shares at Mar. 31, 2022 32,683,695      
Common stock issued for services     $ 505 501,995   502,500
Common stock issued for services, shares     505,000      
Common stock issued for cash     $ 25 24,975   25,000
Common stock issued for cash, shares     25,000      
Net loss (687,743) (687,743)
Founder shares issued     $ 1,856 (1,856)  
Founder shares issued, shares     1,855,888      
Common stock issued for settlement     $ 100 (100)  
Common stock issued for settlement, shares     99,600      
Common stock issued to prior S-1 investors     $ 180 $ 48,750   $ 48,930
Common stock issued to prior S-1 investors, shares     180,400      
Stock issued for debt conversion     1,934 944,224   946,158
Stock issued for debt conversion, shares     1,933,972      
Ending balance, value at Jun. 30, 2022 $ 37,284 $ 14,328,585 (15,481,088) $ (1,115,219)
Ending balance, shares at Jun. 30, 2022   37,283,555      
Beginning balance, value at Sep. 30, 2022 $ 38,678 14,608,815 (16,288,417) (1,640,924)
Beginning balance, shares at Sep. 30, 2022 38,678,155      
Net loss (179,539) (179,539)
Conversion of common stock into Series B preferred stock $ 2,061 $ (20,605) 18,544
Conversion of common stock into Series B preferred stock, shares   2,060,536 (20,605,334)      
Sale of common stock $ 300 149,700 150,000
Sale of common stock, shares     300,000      
Ending balance, value at Dec. 31, 2022 $ 2,061 $ 18,373 14,777,059 (16,467,956) (1,670,463)
Ending balance, shares at Dec. 31, 2022 2,060,536 18,372,821      
Beginning balance, value at Sep. 30, 2022 $ 38,678 14,608,815 (16,288,417) (1,640,924)
Beginning balance, shares at Sep. 30, 2022 38,678,155      
Net loss           (615,780)
Ending balance, value at Jun. 30, 2023 $ 2,061 $ 18,573 14,876,859 (16,904,197) (2,006,704)
Ending balance, shares at Jun. 30, 2023 2,060,536 18,572,821      
Beginning balance, value at Dec. 31, 2022 $ 2,061 $ 18,373 14,777,059 (16,467,956) (1,670,463)
Beginning balance, shares at Dec. 31, 2022 2,060,536 18,372,821      
Net loss (221,212) (221,212)
Sale of common stock $ 50 12,450 12,500
Sale of common stock, shares     50,000      
Ending balance, value at Mar. 31, 2023 $ 2,061 $ 18,423 14,789,509 (16,689,168) (1,879,175)
Ending balance, shares at Mar. 31, 2023 2,060,536 18,422,821      
Net loss (215,029) (215,029)
Conversion of note payable into common stock     $ 25 12,475 12,500
Conversion of note payable into common stock, shares     25,000      
Sale of common stock $ 125 74,875 75,000
Sale of common stock, shares     125,000      
Ending balance, value at Jun. 30, 2023 $ 2,061 $ 18,573 $ 14,876,859 $ (16,904,197) $ (2,006,704)
Ending balance, shares at Jun. 30, 2023 2,060,536 18,572,821      
XML 14 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)
 9 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net loss $ (615,780) $ (4,469,004)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 1,374 1,374
Stock-based compensation 3,712,500
Late fee capitalized into notes payable 90,000 90,000
Loss on debt settlement 5,000
Common stock issued for interest expense 2,500
Amortization of debt discount 90,334 10,911
Changes in assets and liabilities:    
Prepaid expenses 3,393
Other current assets 500
Accounts payable and accrued expenses (150,214) (27,076)
USDA CRADA liability 2,800
Net cash used in operating activities (583,786) (667,602)
Cash flows from financing activities:    
Proceeds from notes payable 50,000 300,000
Repayments of related party payable (4,330)
Proceeds from sale of common stock 237,500 735,005
Net cash provided by financing activities 287,500 1,030,675
Net increase in cash (296,286) 363,073
Cash at beginning of period 296,386 72,315
Cash at end of period 100 435,388
Cash paid for interest
Cash paid for taxes
Non-cash investing and financing activities:    
Conversion of note payable into common stock 12,500
Principal and interest settled through common stock issuance 1,135,946
Accrued payroll settled through common stock issuance 125,750
Right of use, lease asset and liability 13,480
Prepaid costs for reverse capitalization recognized in additional paid-in capital $ 150,000
XML 15 R7.htm IDEA: XBRL DOCUMENT v3.23.2
ORGANIZATION AND BASIS OF PRESENTATION
 9 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
ORGANIZATION AND BASIS OF PRESENTATION

NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION

 

On May 27, 2022, Genvor Incorporated, formerly known as Allure Worldwide, Inc. (the “Company” or “Genvor” or “we”), a Nevada corporation, Genvor Acquisition, Corp., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”), and Genvor Inc., a Delaware corporation (“Old Genvor”), completed their previously announced merger transaction pursuant to which the Company acquired Old Genvor (the “Acquisition”), and Old Genvor became a wholly-owned subsidiary of the Company. The Acquisition was completed pursuant to an Exchange Agreement, dated as of January 11, 2021 (the “Acquisition Agreement”), pursuant to which Old Genvor was to be acquired by the Company as its wholly owned subsidiary and each share of Old Genvor common stock would be exchanged for a share of the Company’s common stock, and a merger agreement, dated March 2, 2022 (the “Merger Agreement”), pursuant to which Merger Sub merged with and into Old Genvor, with Old Genvor continuing as a wholly owned subsidiary of the Company and the surviving corporation of the merger, and each share of Old Genvor being converted into the right to receive a share of the Company (the “Merger”). After closing of the Merger, the Company was renamed “Genvor Incorporated”. Genvor develops plant-based defense technology designed to help farmers achieve global food security.

 

During May 2019, Old Genvor acquired Nexion Biosciences LLC (“NBLLC”) from a founder for nominal consideration as a wholly owned subsidiary. NBLLC was formed in the state of Delaware on December 28, 2018 (“inception”). The consolidated financial statements of the Company include the accounts of Genvor Incorporated, Old Genvor, and its wholly owned subsidiary NBLLC. Intercompany accounts and transactions have been eliminated upon consolidation.

 

Nature of Operations

 

The Company’s business plan is developing plant-based defense technology designed to help farmers achieve global food security. The Company’s technology was developed by two university scientists, Dr. Clayton Yates and Dr. Jesse Jaynes, who shared a mission to develop crop protection technology designed to defend against crop diseases effecting both animals and humans alike.

 

Basis of Presentation

 

The accompanying unaudited financial information as of and for the nine months ended June 30, 2023, and 2022 has been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, such financial information includes all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of our financial position at such date and the operating results and cash flows for such periods. Operating results for the nine months ended June 30, 2023, are not necessarily indicative of the results that may be expected for the entire year or for any other subsequent interim period.

 

Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been omitted pursuant to the rules of the U.S. Securities and Exchange Commission, or the SEC. These unaudited financial statements and related notes should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended September 30, 2022, as filed with the SEC.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany balances and transactions have been eliminated in the consolidation. The consolidated financial statements included herein, presented in accordance with United States generally accepted accounting principles (“GAAP”) and stated in United States dollars, have been prepared by the Company, pursuant to the rules and regulations of the Securities and Exchange Commission.

 

 

Liquidity and Going Concern

 

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. At June 30, 2023, the Company had an accumulated deficit of $16,904,197. For the nine months ended June 30, 2023, the Company recognized a net loss of $615,780 and had net cash used in operating activities of $583,786, with no revenues earned, and a lack of operational history. These matters, among others, raise substantial doubt about the Company’s ability to continue as a going concern.

 

While the Company is attempting to generate revenues, the Company’s cash position may not be significant enough to support the Company’s daily operations. Management intends to raise additional funds by way of additional public and/or private offerings of its stock. Management believes that the actions presently being taken to further implement its business plan and generate revenues provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to generate revenues and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate revenues. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 
XML 16 R8.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 9 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Cash Flow Reporting

 

The Company follows Accounting Standards Codification (“ASC 230”), Statement of Cash Flows, for cash flow reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“indirect method”) as defined by ASC 230, Statement of Cash Flows, to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid debt instruments and other short-term investments with a maturity of three months or less, when purchased, to be cash equivalents. There were no cash equivalents as of June 30, 2023, and September 30, 2022.

 

The Company maintains its cash balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. At June 30, 2023, and September 30, 2022, $0 and $46,386, respectively, the Company’s cash balances were in excess of federally insured limits.

 

Fixed Assets

 

Furniture and equipment are stated at cost. Depreciation is provided by the straight-line method over the useful lives of the related assets, approximately seven years. Expenditures for minor enhancements and maintenance are expensed as incurred.

 

Stock-Based Compensation

 

The Company accounts for stock-based instruments issued to employees in accordance with ASC Topic 718, Compensation – Stock Compensation, and Certain Redeemable Financial Instruments. ASC Topic 718 requires companies to recognize in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees. The value of the portion of an award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line attribution method.

 

 

Fair Value of Financial Instruments

 

The book values of cash, accounts receivable, and accounts payable approximate their respective fair values due to the short-term nature of these instruments. The fair value hierarchy under GAAP distinguishes between assumptions based on market data (observable inputs) and an entity’s own assumptions (unobservable inputs).

 

The hierarchy consists of three levels

 

  ● Level one — Quoted market prices in active markets for identical assets or liabilities;
  ● Level two — Inputs other than level one inputs that are either directly or indirectly observable; and
  ● Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.

 

Determining which category an asset or liability falls within the hierarchy requires significant judgment. We evaluate our hierarchy disclosures each quarter.

 

Financial Instruments

 

The Company’s financial instruments include cash and cash equivalents, payables, and accrued interest and short-term and long-term notes payable and are accounted for under the provisions of ASC 825, Financial Instruments. The carrying amount of these financial instruments, as reflected in the accompanying consolidated balance sheet, approximates fair value.

 

Long-lived Assets

 

The Company’s long-lived assets and other assets (consisting of furniture, equipment and a patent) are reviewed for impairment in accordance with the guidance of the ASC 360, Property, Plant, and Equipment, and ASC 205, Presentation of Financial Statements. The Company tests for impairment losses on long-lived assets used in operations whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Recoverability of an asset to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. Impairment evaluations involve management’s estimates on asset useful lives and future cash flows. Actual useful lives and cash flows could be different from those estimated by management, which could have a material effect on our reporting results and financial positions. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals, as considered necessary. During the nine months ended June 30, 2023, and 2022, the Company had not experienced impairment losses on its long-lived assets.

 

Research and Development

 

The Company expenses the cost of research and development as incurred. Research and development expenses consist primarily of professional service costs associated with the development of the plant-based defense technology products. For the nine months ended June 30, 2023, and 2022, the Company had $0 and $109,248 in research and development expenses, respectively.

 

Patents

 

Any patent costs for internally developed patents will be expensed as incurred. Costs to maintain and defend patents are recorded as administrative expenses in the statement of operations.

 

Purchased patents are recorded at cost and reviewed for impairment in accordance with the guidance of the ASC 360, Property, Plant, and Equipment, and ASC 205, Presentation of Financial Statements.

 

Income Taxes

 

The Company accounts for income taxes in accordance with FASB ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and loss carryforwards and their respective tax bases.

 

 

Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income (loss) in the years in which those temporary differences are expected to be recovered or settled.

 

The effect of a change in tax rules on deferred tax assets and liabilities is recognized in operations in the year of change. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized.

 

Tax benefits of uncertain tax positions are recognized only if it is more likely than not that the Company will be able to sustain a position taken on an income tax return. The Company has no liability for uncertain tax positions as of June 30, 2023. Interest and penalties in any, related to unrecognized tax benefits would be recognized as interest expense. The Company does not have any accrued interest or penalties associated with unrecognized tax benefits, nor was any significant interest expense recognized during the nine months ended June 30, 2023.

 

Loss Per Share of Common Stock

 

Basic net loss per common share is computed using the weighted average number of common shares outstanding. Diluted earnings per share (“EPS”) include additional dilution from common stock equivalents, such as stock issuable pursuant to the exercise of stock options, warrants and convertible notes. Common stock equivalents are not included in the computation of diluted earnings per share when the Company reports a loss because to do so would be anti-dilutive for periods presented. The Company had total potential additional dilutive securities outstanding at June 30, 2023, and September 30, 2022, of 22,065,343 and 1,460,009, respectively.

 

Recent Accounting Pronouncements

 

In August 2020, the FASB issued ASU 2020-06, Debt with Conversion and Other Options, which simplifies accounting for convertible instruments. The new guidance eliminates two of the three models in ASC 470-20 that require separating embedded conversion features from convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation. The guidance is effective for fiscal years beginning after December 15, 2021. The Company is currently utilizing the guidance as applicable. There have been no material impacts on the Company’s financials.

 

Recently Issued Accounting Standards: Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

 
XML 17 R9.htm IDEA: XBRL DOCUMENT v3.23.2
BORROWINGS
 9 Months Ended
Jun. 30, 2023
Broker-Dealer [Abstract]  
BORROWINGS

NOTE 3 – BORROWINGS

 

Commercial Loan

 

On April 9, 2020, the Company received a loan from the Small Business Administration pursuant to the Paycheck Protection Program (PPP) in the principal amount of $48,750. The note bears interest at a variable rate of approximately 1% and matured in April 2022; and it is currently in default. Forgiveness for the loan was applied for and is pending. The principal amount of the loan was based on the consulting agreement salary between Nexion Biosciences, Inc., organized in the state of Florida (NBFL) (a related party) and the CEO.

 

 

Notes Payable

 

From time to time, the Company’s subsidiary, Genvor Inc., enters into unsecured notes payable with individual investors. Only Noteholder E (below) has security in the form of a personal guarantee by the CEO and prior consultant (Note 6). The terms of these notes are listed below. Several of the notes are convertible into shares of the Company’s common stock as detailed in the following schedule.

 

                 Balance 
                 Convertible 
         Interest   Loan   into 
Noteholder  Origination  Maturity  Rate   Balance   Shares (c) 
Noteholder A (a)  2019  12/31/2021   0%  $217,000    N/A 
Noteholder B (a)  3/19/2019  4/29/2019   0%   540,000    N/A 
Noteholder C (a)  3/1/2019  2/29/2020   18%   32,500    N/A 
Noteholder D (d)  4/29/2019  unspecified   0%   300,000    30,000 
Noteholder E (a)  8/1/2019  8/31/2019   0%   37,500     N/A  
Noteholder F (a)(b)  2/27/2020  4/30/2020   0%   2,500    5,000 
Noteholder H  6/27/2022  6/27/2024   5%   300,000    1,000,000 
Noteholder I (c)  10/26/2022  12/31/2023   3%   50,000    400,000 
               1,479,500    1,435,000 
(d) Debt discount              (120,445)     
              $1,359,055      

 

(a) Past due at June 30, 2023
(b) Note is payable in a combination of $2,500 to $6,000 in cash and 5,000 to 15,000 share of common stock
(c) Convertible into common stock of the subsidiary, Genvor Inc.

 

The notes do not have default provisions except Noteholder B receives a default penalty of $10,000 each month the note goes unpaid.

 

Interest expense totaled $17,511 and $73,242, respectively, for the nine months ended June 30, 2023, and 2022, including default penalties. Late fees totaled $90,000 and $90,000, respectively, for the nine months ended June 30, 2023, and 2022.

 
XML 18 R10.htm IDEA: XBRL DOCUMENT v3.23.2
STOCKHOLDERS’ DEFICIT
 9 Months Ended
Jun. 30, 2023
Equity [Abstract]  
STOCKHOLDERS’ DEFICIT

NOTE 4 – STOCKHOLDERS’ DEFICIT

 

Preferred Stock

 

The authorized preferred stock of the Company consists of 20,000,000 shares with a $0.001 par value.

 

Series A Preferred Stock

 

On August 10, 2022, the Company designated 10 shares of its preferred stock as Series A Preferred Stock (“Series A”). Each share of Series A entitles the holder to ten million (10,000,000) votes on all matters submitted to a vote of the stockholders of the Corporation. When and as any dividend or distribution is declared or paid by the Company on the common stock, the Series A holders are entitled to participate in such dividend or distribution. Each Series A share is convertible, at the option of the holder, into one share of fully paid and non-assessable common stock. Upon any liquidation, dissolution, or winding-up of the Company, the Series A holders are entitled to receive out the assets of the Company, for each share of Series A, an amount equal to par value before any distribution or payment shall be made to the holder of any junior securities (including common stock and all other equity or equity equivalent securities of the Company).

 

As of June 30, 2023, and September 30, 2022, there were 9 and 9 shares of Series A preferred stock issued and outstanding, respectively. The preferred stock was issued on August 16, 2022, as follows: Bradley White (former Chief Executive Officer and Director), 3 shares; Dr. Clayton Yates (Chief Scientific Officer and Chairman), 3 shares; and Dr. Jesse Jaynes (Chief Research Officer and Director), 3 shares. See Note 7.

 

Series B Preferred Stock

 

On October 19, 2022, the Company filed a Certificate of Designation with the State of Nevada to designate its Series B Preferred Stock (“Series B”). The designation authorized 2,500,000 shares of Series B. Each share of Series B shall have 10 votes on all matters submitted to a vote of the stockholders of the Company. Each share of Series B is convertible into 10 shares of common stock of the Company.

 

 

On October 19, 2022, the following shareholders converted shares of common stock of the Company into shares of Series B to modify the common shares outstanding to reduce the outstanding common stock issued by the Company, as follows:

 

Name 

Common
Shares

Exchanged

  

Series B

Issued

 
Jaynes Investment LLC   2,000,000    200,000 
ACT Holdings LLC   7,312,612    731,262 
LASB Family Trust   3,800,112    380,012 
Jesse Michael Jaynes   4,767,611    476,762 
Bradley White (a)   1,225,000    122,500 
PJ Advisory Group   1,500,000    150,000 
Total   20,605,334    2,060,536 

 

(a)   Related party

 

The conversion of the common stock into the Series B was valued at par, respectively, offset to additional paid-in capital. The Series B is convertible into common stock into the original amount of common stock converted therefore there is no change in the amount of common stock outstanding on a fully diluted basis.

 

As of June 30, 2023, and September 30, 2022, there were 2,060,536 and 0 shares of Series B preferred stock issued and outstanding, respectively.

 

Common Stock

 

The authorized common stock of the Company consists of 300,000,000 shares with a $0.001 par value. All common stock shares are non-assessable and have one vote per share.

 

In connection with the Merger (see Note 1), the founding shareholders of the Company cancelled 18,144,112 shares of common stock, retaining 5%, or 1,855,888 shares of common stock, as of June 30, 2022. The cancellation is presented in the accompanying statements of changes in stockholders’ deficit within the line item “Retroactive application of recapitalization.”

 

Stock Issued for Cash

 

On November 17, 2022, the Company issued 300,000 shares of common stock to an investor for $150,000.

 

On May 3, 2023, the Company issued 100,000 shares of common stock to an investor for $50,000.

 

On May 12, 2023, the Company issued 15,000 shares of common stock to an investor for $15,000.

 

On May 29, 2023, the Company issued 10,000 shares of common stock to an investor for $10,000.

 

Other Stock Issuances

 

On June 14, 2023, the Company issued 25,000 shares of common stock related to the conversion of a note payable for $12,500.

 
XML 19 R11.htm IDEA: XBRL DOCUMENT v3.23.2
FEDERAL INCOME TAX
 9 Months Ended
Jun. 30, 2023
Income Tax Disclosure [Abstract]  
FEDERAL INCOME TAX

NOTE 5 – FEDERAL INCOME TAX

 

As of June 30, 2023, and September 30, 2022, the Company has net operating loss carry forwards of $2,696,890 and $2,572,885, respectively, which may be available to reduce future years’ taxable income through 2043. The Company’s net operating loss carry forwards may be subject to annual limitations, which could reduce or defer the utilization of the losses as a result of an ownership change as defined in Section 382 of the Internal Revenue Code.

 

 

The Company’s tax expense differs from the “expected” tax expense for Federal income tax purposes (computed by applying the United States Federal tax rate of 21% to loss before taxes for fiscal year 2023 and 2022), as follows:

 

   June 30,   September 30, 
   2023   2022 
Tax benefit at the statutory rate  $(110,344)  $(204,559)
State income taxes, net of federal income tax benefit   (13,662)   (25,326)
Change in valuation allowance   124,006    229,885 
Total  $-   $- 

 

The tax effects of the temporary differences between reportable financial statement income and taxable income are recognized as deferred tax assets and liabilities.

 

The tax years 2023 and 2022 remain open for examination by federal agencies and other jurisdictions in which it operates.

 

The tax effect of significant components of the Company’s deferred tax assets and liabilities at June 30, 2023, and September 30, 2022, are as follows:

 

   June 30,   September 30, 
   2023   2022 
Net operating loss carryforward  $2,696,890   $2,572,885 
Total gross deferred tax assets   2,696,890    2,572,885 
Less: Deferred tax asset valuation allowance   (2,696,890)   (2,572,885)
Total net deferred taxes  $-   $- 

 

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment.

 

Because of the historical earnings history of the Company, the net deferred tax assets for 2022 and 2021 were fully offset by a 100% valuation allowance. The valuation allowance for the remaining net deferred tax assets was $2,696,890 and $2,572,885 as of June 30, 2023, and September 30, 2022, respectively.

 
XML 20 R12.htm IDEA: XBRL DOCUMENT v3.23.2
COMMITMENTS AND CONTINGENCIES
 9 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 6 – COMMITMENTS AND CONTINGENCIES

 

From time to time, the Company may be involved in litigation in the ordinary course of business. The Company is not currently involved in any litigation that we believe could have a material adverse effect on its financial condition or results of operations.

 

Subscription Agreement and Cash Held in Escrow

 

On February 20, 2019, the Company entered into a subscription escrow agreement (the “Trust Agreement”) with Branch Banking and Trust Company (“BB&T”). This Trust Agreement was established for the subscription agreement proceeds raised and escrowed pursuant to the Company’s prior Rule 419 S-1 offering. The balance held in trust at June 30, 2023 and September 30, 2022, totaled $19,705.

 

Upon completion of the Merger (see Notes 1 and 8), the Company issued 975,000 common stock shares to the investors in that prior S-1 offering during July 2022 and were released to the Company.

 

Consulting Agreements

 

During the nine months ended June 30, 2023, the Company paid the Company’s former CEO, Bradley White, $32,500 pursuant to a consulting agreement carried over from related party NBFL. The agreement provides for an annual salary of $150,000 which increases based on certain capital raise thresholds. On June 20, 2023, Mr. White was terminated as an officer of the Company. At June 30, 2023 and September 30, 2022, accrued payroll owed to the former CEO totaled $228,213 and $188,484, respectively, as presented in the accompanying consolidated balance sheets.

 

On July 24, 2020, the Company entered into a consulting agreement for business development activities, networking, negotiations, and strategic planning. The compensation pursuant to the agreement was $20,000 monthly.

 

 

Office Lease

 

The Company entered into a sublease agreement with the above consultant (providing business development assistance from 2019-2020) effective August 1, 2019, subject to the terms and conditions of the office lease held by the consultant at 15540 Quorum Drive #2624, Addison, Texas. On January 1, 2019, the Company adopted ASC 842 requiring this lease to be recorded as an asset and corresponding liability on its balance sheet. The Company records rent expense associated with this lease on the straight-line basis in conjunction with the terms of the underlying lease. A discount rate was not used in the determination of the right of use asset and liability since its effect would not be significant. The lease moved to a month-to-month basis beginning in September 2021 at $2,810 per month in addition to common area maintenance charges. During the nine months ended June 30, 2023, and 2022, we incurred $10,187 and $20,607, respectively, in office rental expense.

 

Research and Development Agreement

 

During September 2020, the Company assumed a Cooperative Research And Development Agreement (CRADA) with the United States Department of Agriculture (USDA), Agricultural Research Service (ARS). Under this agreement, the Company committed to funding the remaining amount due. As of June 30, 2023, and September 30, 2022, $246,400 and $246,400, respectively, remained outstanding and is presented in the accompanying consolidated balance sheets as USDA CRADA liability.

 
XML 21 R13.htm IDEA: XBRL DOCUMENT v3.23.2
RELATED PARTY TRANSACTIONS
 9 Months Ended
Jun. 30, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 7 – RELATED PARTY TRANSACTIONS

 

Share Issuances to the Board of Directors

 

The Company issued Series A preferred stock on August 16, 2022, as follows: Bradley White (former Chief Executive Officer), 3 shares; Dr. Clayton Yates (Chief Scientific Officer and Chairman), 3 shares; and Dr. Jesse Jaynes (Chief Research Officer and Director), 3 shares. See Note 4.

 
XML 22 R14.htm IDEA: XBRL DOCUMENT v3.23.2
SUBSEQUENT EVENTS
 9 Months Ended
Jun. 30, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 8 – SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events from the balance sheet through the date of this filing and determined there were no events to disclose except the following.

 

On July 12, 2023, the Company sold 25,000 shares of common stock for $10,000 to an investor at a value of $0.40 per share.

 

On July 13, 2023, the Company sold 20,000 shares of common stock for $10,000 to an investor at a value of $0.50 per share.

 

On July 14, 2023, the Company sold 50,000 shares of common stock for $25,000 to an investor at a value of $0.50 per share.

 

On August 4, 2023, the Company executed into a promissory note with Jason Adams for $15,000.

 

On or about August 4, 2023, the Company’s former Chief Executive Officer, Bradley White, and LASB Family Trust presented conversion notices to the Company’s transfer agent to convert their shares of the Company’s Series B Preferred Stock into shares of Company common stock, and the Company objected to those conversions. Shares held by LASB Family Trust may be deemed to be beneficially owned by Mr. White.
XML 23 R15.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 9 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 
Cash Flow Reporting

Cash Flow Reporting

 

The Company follows Accounting Standards Codification (“ASC 230”), Statement of Cash Flows, for cash flow reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“indirect method”) as defined by ASC 230, Statement of Cash Flows, to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.

 
Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers all highly liquid debt instruments and other short-term investments with a maturity of three months or less, when purchased, to be cash equivalents. There were no cash equivalents as of June 30, 2023, and September 30, 2022.

 

The Company maintains its cash balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. At June 30, 2023, and September 30, 2022, $0 and $46,386, respectively, the Company’s cash balances were in excess of federally insured limits.

 
Fixed Assets

Fixed Assets

 

Furniture and equipment are stated at cost. Depreciation is provided by the straight-line method over the useful lives of the related assets, approximately seven years. Expenditures for minor enhancements and maintenance are expensed as incurred.

 
Stock-Based Compensation

Stock-Based Compensation

 

The Company accounts for stock-based instruments issued to employees in accordance with ASC Topic 718, Compensation – Stock Compensation, and Certain Redeemable Financial Instruments. ASC Topic 718 requires companies to recognize in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees. The value of the portion of an award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line attribution method.

 

 
Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

The book values of cash, accounts receivable, and accounts payable approximate their respective fair values due to the short-term nature of these instruments. The fair value hierarchy under GAAP distinguishes between assumptions based on market data (observable inputs) and an entity’s own assumptions (unobservable inputs).

 

The hierarchy consists of three levels

 

  ● Level one — Quoted market prices in active markets for identical assets or liabilities;
  ● Level two — Inputs other than level one inputs that are either directly or indirectly observable; and
  ● Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.

 

Determining which category an asset or liability falls within the hierarchy requires significant judgment. We evaluate our hierarchy disclosures each quarter.

 
Financial Instruments

Financial Instruments

 

The Company’s financial instruments include cash and cash equivalents, payables, and accrued interest and short-term and long-term notes payable and are accounted for under the provisions of ASC 825, Financial Instruments. The carrying amount of these financial instruments, as reflected in the accompanying consolidated balance sheet, approximates fair value.

 
Long-lived Assets

Long-lived Assets

 

The Company’s long-lived assets and other assets (consisting of furniture, equipment and a patent) are reviewed for impairment in accordance with the guidance of the ASC 360, Property, Plant, and Equipment, and ASC 205, Presentation of Financial Statements. The Company tests for impairment losses on long-lived assets used in operations whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Recoverability of an asset to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. Impairment evaluations involve management’s estimates on asset useful lives and future cash flows. Actual useful lives and cash flows could be different from those estimated by management, which could have a material effect on our reporting results and financial positions. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals, as considered necessary. During the nine months ended June 30, 2023, and 2022, the Company had not experienced impairment losses on its long-lived assets.

 
Research and Development

Research and Development

 

The Company expenses the cost of research and development as incurred. Research and development expenses consist primarily of professional service costs associated with the development of the plant-based defense technology products. For the nine months ended June 30, 2023, and 2022, the Company had $0 and $109,248 in research and development expenses, respectively.

 
Patents

Patents

 

Any patent costs for internally developed patents will be expensed as incurred. Costs to maintain and defend patents are recorded as administrative expenses in the statement of operations.

 

Purchased patents are recorded at cost and reviewed for impairment in accordance with the guidance of the ASC 360, Property, Plant, and Equipment, and ASC 205, Presentation of Financial Statements.

 
Income Taxes

Income Taxes

 

The Company accounts for income taxes in accordance with FASB ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and loss carryforwards and their respective tax bases.

 

 

Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income (loss) in the years in which those temporary differences are expected to be recovered or settled.

 

The effect of a change in tax rules on deferred tax assets and liabilities is recognized in operations in the year of change. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized.

 

Tax benefits of uncertain tax positions are recognized only if it is more likely than not that the Company will be able to sustain a position taken on an income tax return. The Company has no liability for uncertain tax positions as of June 30, 2023. Interest and penalties in any, related to unrecognized tax benefits would be recognized as interest expense. The Company does not have any accrued interest or penalties associated with unrecognized tax benefits, nor was any significant interest expense recognized during the nine months ended June 30, 2023.

 
Loss Per Share of Common Stock

Loss Per Share of Common Stock

 

Basic net loss per common share is computed using the weighted average number of common shares outstanding. Diluted earnings per share (“EPS”) include additional dilution from common stock equivalents, such as stock issuable pursuant to the exercise of stock options, warrants and convertible notes. Common stock equivalents are not included in the computation of diluted earnings per share when the Company reports a loss because to do so would be anti-dilutive for periods presented. The Company had total potential additional dilutive securities outstanding at June 30, 2023, and September 30, 2022, of 22,065,343 and 1,460,009, respectively.

 
Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

In August 2020, the FASB issued ASU 2020-06, Debt with Conversion and Other Options, which simplifies accounting for convertible instruments. The new guidance eliminates two of the three models in ASC 470-20 that require separating embedded conversion features from convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation. The guidance is effective for fiscal years beginning after December 15, 2021. The Company is currently utilizing the guidance as applicable. There have been no material impacts on the Company’s financials.

 

Recently Issued Accounting Standards: Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.
XML 24 R16.htm IDEA: XBRL DOCUMENT v3.23.2
BORROWINGS (Tables)
 9 Months Ended
Jun. 30, 2023
Broker-Dealer [Abstract]  
SCHEDULE OF CONVERTIBLE NOTES PAYABLE

 

                 Balance 
                 Convertible 
         Interest   Loan   into 
Noteholder  Origination  Maturity  Rate   Balance   Shares (c) 
Noteholder A (a)  2019  12/31/2021   0%  $217,000    N/A 
Noteholder B (a)  3/19/2019  4/29/2019   0%   540,000    N/A 
Noteholder C (a)  3/1/2019  2/29/2020   18%   32,500    N/A 
Noteholder D (d)  4/29/2019  unspecified   0%   300,000    30,000 
Noteholder E (a)  8/1/2019  8/31/2019   0%   37,500     N/A  
Noteholder F (a)(b)  2/27/2020  4/30/2020   0%   2,500    5,000 
Noteholder H  6/27/2022  6/27/2024   5%   300,000    1,000,000 
Noteholder I (c)  10/26/2022  12/31/2023   3%   50,000    400,000 
               1,479,500    1,435,000 
(d) Debt discount              (120,445)     
              $1,359,055      

 

(a) Past due at June 30, 2023
(b) Note is payable in a combination of $2,500 to $6,000 in cash and 5,000 to 15,000 share of common stock
(c) Convertible into common stock of the subsidiary, Genvor Inc.
XML 25 R17.htm IDEA: XBRL DOCUMENT v3.23.2
STOCKHOLDERS’ DEFICIT (Tables)
 9 Months Ended
Jun. 30, 2023
Equity [Abstract]  
SCHEDULE OF CONVERTED SHARES OF COMMON STOCK

On October 19, 2022, the following shareholders converted shares of common stock of the Company into shares of Series B to modify the common shares outstanding to reduce the outstanding common stock issued by the Company, as follows:

 

Name 

Common
Shares

Exchanged

  

Series B

Issued

 
Jaynes Investment LLC   2,000,000    200,000 
ACT Holdings LLC   7,312,612    731,262 
LASB Family Trust   3,800,112    380,012 
Jesse Michael Jaynes   4,767,611    476,762 
Bradley White (a)   1,225,000    122,500 
PJ Advisory Group   1,500,000    150,000 
Total   20,605,334    2,060,536 

 

(a)   Related party
XML 26 R18.htm IDEA: XBRL DOCUMENT v3.23.2
FEDERAL INCOME TAX (Tables)
 9 Months Ended
Jun. 30, 2023
Income Tax Disclosure [Abstract]  
SCHEDULE OF LOSS BEFORE TAXES

 

   June 30,   September 30, 
   2023   2022 
Tax benefit at the statutory rate  $(110,344)  $(204,559)
State income taxes, net of federal income tax benefit   (13,662)   (25,326)
Change in valuation allowance   124,006    229,885 
Total  $-   $- 
SCHEDULE OF DEFERRED TAX ASSETS

The tax effect of significant components of the Company’s deferred tax assets and liabilities at June 30, 2023, and September 30, 2022, are as follows:

 

   June 30,   September 30, 
   2023   2022 
Net operating loss carryforward  $2,696,890   $2,572,885 
Total gross deferred tax assets   2,696,890    2,572,885 
Less: Deferred tax asset valuation allowance   (2,696,890)   (2,572,885)
Total net deferred taxes  $-   $- 
XML 27 R19.htm IDEA: XBRL DOCUMENT v3.23.2
ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) - USD ($)
 9 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Sep. 30, 2022
Accounting Policies [Abstract]      
Accumulated deficit $ 16,904,197   $ 16,288,417
Net loss 615,780    
Net cash used in operating activities $ 583,786 $ 667,602  
XML 28 R20.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Sep. 30, 2022
Accounting Policies [Abstract]          
Cash equivalents $ 0   $ 0   $ 0
Cash uninsured amount $ 0   $ 0   $ 46,386
Fixed assets, estimated useful lives 7 years   7 years    
Research and development expenses $ 109,248  
Additional dilutive securities outstanding 22,065,343   22,065,343   1,460,009
XML 29 R21.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF CONVERTIBLE NOTES PAYABLE (Details)
 9 Months Ended
Jun. 30, 2023
USD ($)
shares
Short-Term Debt [Line Items]  
Loan Balance $ 1,479,500
Number of shares the notesis convertible into shares | shares 1,435,000
Debt discount $ (120,445)
Total loan $ 1,359,055
Note Holder A [Member]  
Short-Term Debt [Line Items]  
Origination 2019 [1]
Maturity date Dec. 31, 2021 [1]
Interest rate 0.00% [1]
Loan Balance $ 217,000 [1]
Noteholder B [Member]  
Short-Term Debt [Line Items]  
Origination 3/19/2019 [1]
Maturity date Apr. 29, 2019 [1]
Interest rate 0.00% [1]
Loan Balance $ 540,000 [1]
Noteholder C [Member]  
Short-Term Debt [Line Items]  
Origination 3/1/2019 [1]
Maturity date Feb. 29, 2020 [1]
Interest rate 18.00% [1]
Loan Balance $ 32,500 [1]
Noteholder D [Member]  
Short-Term Debt [Line Items]  
Origination 4/29/2019
Interest rate 0.00%
Loan Balance $ 300,000
Number of shares the notesis convertible into shares | shares 30,000
Noteholder E [Member]  
Short-Term Debt [Line Items]  
Origination 8/1/2019 [1]
Maturity date Aug. 31, 2019 [1]
Interest rate 0.00% [1]
Loan Balance $ 37,500 [1]
Noteholder F [Member]  
Short-Term Debt [Line Items]  
Origination 2/27/2020 [1],[2]
Maturity date Apr. 30, 2020 [1],[2]
Interest rate 0.00% [1],[2]
Loan Balance $ 2,500 [1],[2]
Number of shares the notesis convertible into shares | shares 5,000 [1],[2]
Noteholder H [Member]  
Short-Term Debt [Line Items]  
Origination 6/27/2022
Maturity date Jun. 27, 2024
Interest rate 5.00%
Loan Balance $ 300,000
Number of shares the notesis convertible into shares | shares 1,000,000
Noteholder I [Member]  
Short-Term Debt [Line Items]  
Origination 10/26/2022 [3]
Maturity date Dec. 31, 2023 [3]
Interest rate 3.00% [3]
Loan Balance $ 50,000 [3]
Number of shares the notesis convertible into shares | shares 400,000 [3]
[1] Past due at June 30, 2023
[2] Note is payable in a combination of $2,500 to $6,000 in cash and 5,000 to 15,000 share of common stock
[3] Convertible into common stock of the subsidiary, Genvor Inc.
XML 30 R22.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF CONVERTIBLE NOTES PAYABLE (Details) (Parenthetical)
 9 Months Ended
Jun. 30, 2023
USD ($)
shares
Short-Term Debt [Line Items]  
Shares issued during conversion 1,435,000
Noteholder F [Member]  
Short-Term Debt [Line Items]  
Shares issued during conversion 5,000 [1],[2]
Noteholder F [Member] | Minimum [Member]  
Short-Term Debt [Line Items]  
Notes payable converted | $ $ 2,500
Shares issued during conversion 5,000
Noteholder F [Member] | Maximum [Member]  
Short-Term Debt [Line Items]  
Notes payable converted | $ $ 6,000
Shares issued during conversion 15,000
[1] Note is payable in a combination of $2,500 to $6,000 in cash and 5,000 to 15,000 share of common stock
[2] Past due at June 30, 2023
XML 31 R23.htm IDEA: XBRL DOCUMENT v3.23.2
BORROWINGS (Details Narrative) - USD ($)
 9 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Apr. 09, 2020
Short-Term Debt [Line Items]      
Principal amont $ 1,479,500    
Interest expense 17,511 $ 73,242  
Late fees 90,000 $ 90,000  
Paycheck Protection Program [Member]      
Short-Term Debt [Line Items]      
Principal amont     $ 48,750
Interest rate     1.00%
Noteholder B [Member]      
Short-Term Debt [Line Items]      
Principal amont [1] 540,000    
[custom:DebtDefaultPenaltyAmount] $ 10,000    
[1] Past due at June 30, 2023
XML 32 R24.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF CONVERTED SHARES OF COMMON STOCK (Details) - Series B Preferred Stock [Member]
Oct. 19, 2022
shares
Class of Stock [Line Items]  
Common Shares Exchanged 20,605,334
Series B Issued 2,060,536
Jaynes Investment LLC [Member]  
Class of Stock [Line Items]  
Common Shares Exchanged 2,000,000
Series B Issued 200,000
ACT Holdings LLC [Member]  
Class of Stock [Line Items]  
Common Shares Exchanged 7,312,612
Series B Issued 731,262
LASB Family Trust [Member]  
Class of Stock [Line Items]  
Common Shares Exchanged 3,800,112
Series B Issued 380,012
Jesse Michael Jaynes [Member]  
Class of Stock [Line Items]  
Common Shares Exchanged 4,767,611
Series B Issued 476,762
Bradley White [Member]  
Class of Stock [Line Items]  
Common Shares Exchanged 1,225,000 [1]
Series B Issued 122,500 [1]
PJ Advisory Group [Member]  
Class of Stock [Line Items]  
Common Shares Exchanged 1,500,000
Series B Issued 150,000
[1] Related party
XML 33 R25.htm IDEA: XBRL DOCUMENT v3.23.2
STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)
 3 Months Ended
Jun. 14, 2023
May 29, 2023
May 12, 2023
May 03, 2023
Nov. 17, 2022
Oct. 19, 2022
Aug. 10, 2022
Apr. 21, 2022
Jun. 30, 2023
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2022
Aug. 16, 2022
Class of Stock [Line Items]                            
Preferred stock, shares authorized                 20,000,000       20,000,000  
Preferred stock, shares par value                 $ 0.001       $ 0.001  
Common stock, shares authorized                 300,000,000       300,000,000  
Common stock, shares par value                 $ 0.001       $ 0.001  
Number of common stock cancel               18,144,112            
Number of common stock retaining                   1,855,888        
Shares issued, value                   $ 25,000 $ 140,000 $ 737,510    
Issuance of common stock 25,000                          
Conversion of common stock $ 12,500               $ 12,500   $ 337,573      
Bradley White [Member]                            
Class of Stock [Line Items]                            
Preferred stock, shares issued                           3
Dr. Clayton Yates [Member]                            
Class of Stock [Line Items]                            
Preferred stock, shares issued                           3
Dr. Jesse Jaynes [Member]                            
Class of Stock [Line Items]                            
Preferred stock, shares issued                           3
Series A Preferred Stock [Member]                            
Class of Stock [Line Items]                            
Preferred stock, shares authorized                 10       10  
Designation authorized shares             10              
Number of votes             Each share of Series A entitles the holder to ten million (10,000,000) votes on all matters submitted to a vote of the stockholders of the Corporation.              
Conversion share description             Each Series A share is convertible, at the option of the holder, into one share of fully paid and non-assessable common stock.              
Preferred stock, shares issued                 9       9  
Preferred stock, shares outstanding                 9       9  
Series B Preferred Stock [Member]                            
Class of Stock [Line Items]                            
Preferred stock, shares authorized                 2,500,000       2,500,000  
Designation authorized shares           2,500,000                
Number of votes           Each share of Series B shall have 10 votes on all matters submitted to a vote of the stockholders of the Company.                
Conversion share description           Each share of Series B is convertible into 10 shares of common stock of the Company.                
Preferred stock, shares issued                 2,060,536       0  
Preferred stock, shares outstanding                 2,060,536       0  
Stock Issued For Cash [Member] | Shareholder [Member]                            
Class of Stock [Line Items]                            
Shares issued   10,000 15,000 100,000 300,000                  
Shares issued, value   $ 10,000 $ 15,000 $ 50,000 $ 150,000                  
XML 34 R26.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF LOSS BEFORE TAXES (Details) - USD ($)
 9 Months Ended 12 Months Ended
Jun. 30, 2023
Sep. 30, 2022
Income Tax Disclosure [Abstract]    
Tax benefit at the statutory rate $ (110,344) $ (204,559)
State income taxes, net of federal income tax benefit (13,662) (25,326)
Change in valuation allowance 124,006 229,885
Total
XML 35 R27.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)
Jun. 30, 2023
Sep. 30, 2022
Income Tax Disclosure [Abstract]    
Net operating loss carryforward $ 2,696,890 $ 2,572,885
Total gross deferred tax assets 2,696,890 2,572,885
Less: Deferred tax asset valuation allowance (2,696,890) (2,572,885)
Total net deferred taxes
XML 36 R28.htm IDEA: XBRL DOCUMENT v3.23.2
FEDERAL INCOME TAX (Details Narrative) - USD ($)
 9 Months Ended 12 Months Ended
Jun. 30, 2023
Sep. 30, 2022
Income Tax Disclosure [Abstract]    
Net operating loss carry forwards $ 2,696,890 $ 2,572,885
Federal tax statutory rate 21.00% 21.00%
Valuation allowance for net deferred tax assets $ 2,696,890 $ 2,572,885
XML 37 R29.htm IDEA: XBRL DOCUMENT v3.23.2
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
 1 Months Ended 9 Months Ended
Jul. 24, 2020
Sep. 30, 2021
Jun. 30, 2023
Jun. 30, 2022
Sep. 30, 2022
Long-Term Purchase Commitment [Line Items]          
Assets held in trust     $ 19,705   $ 19,705
Rent expense   $ 2,810 10,187 $ 20,607  
Research and Development Arrangement [Member]          
Long-Term Purchase Commitment [Line Items]          
Fund Amount     246,400   246,400
Chief Executive Officer [Member] | Consulting Agreements [Member]          
Long-Term Purchase Commitment [Line Items]          
Annual salary     150,000    
Accrued payroll     228,213   $ 188,484
Consulting Agreements [Member] | Consultant [Member]          
Long-Term Purchase Commitment [Line Items]          
Salary and Wage, Excluding Cost of Good and Service Sold $ 20,000        
Consulting Agreements [Member] | Chief Executive Officer [Member]          
Long-Term Purchase Commitment [Line Items]          
Related party payable     $ 32,500    
Investor [Member]          
Long-Term Purchase Commitment [Line Items]          
Number of shares issued     975,000    
XML 38 R30.htm IDEA: XBRL DOCUMENT v3.23.2
RELATED PARTY TRANSACTIONS (Details Narrative)
Aug. 16, 2022
shares
Bradley White [Member]  
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]  
Preferred stock, shares issued 3
Dr. Clayton Yates [Member]  
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]  
Preferred stock, shares issued 3
Dr. Jesse Jaynes [Member]  
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]  
Preferred stock, shares issued 3
XML 39 R31.htm IDEA: XBRL DOCUMENT v3.23.2
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
 3 Months Ended
Jul. 14, 2023
Jul. 13, 2023
Jul. 12, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Aug. 04, 2023
Subsequent Event [Line Items]              
Common stock value       $ 75,000 $ 12,500 $ 150,000  
Investor [Member] | Subsequent Event [Member]              
Subsequent Event [Line Items]              
Common stock sold 50,000 20,000 25,000        
Common stock value $ 25,000 $ 10,000 $ 10,000        
Issue price $ 0.50 $ 0.50 $ 0.40        
Jason Adams [Member] | Subsequent Event [Member]              
Subsequent Event [Line Items]              
Promissory note             $ 15,000
XML 40 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001792941 2022-10-01 2023-06-30 0001792941 2023-08-11 0001792941 2023-06-30 0001792941 2022-09-30 0001792941 us-gaap:SeriesAPreferredStockMember 2023-06-30 0001792941 us-gaap:SeriesAPreferredStockMember 2022-09-30 0001792941 us-gaap:SeriesBPreferredStockMember 2023-06-30 0001792941 us-gaap:SeriesBPreferredStockMember 2022-09-30 0001792941 2023-04-01 2023-06-30 0001792941 2022-04-01 2022-06-30 0001792941 2021-10-01 2022-06-30 0001792941 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-09-30 0001792941 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-09-30 0001792941 us-gaap:CommonStockMember 2021-09-30 0001792941 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001792941 us-gaap:RetainedEarningsMember 2021-09-30 0001792941 2021-09-30 0001792941 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001792941 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001792941 us-gaap:CommonStockMember 2021-12-31 0001792941 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001792941 us-gaap:RetainedEarningsMember 2021-12-31 0001792941 2021-12-31 0001792941 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001792941 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001792941 us-gaap:CommonStockMember 2022-03-31 0001792941 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001792941 us-gaap:RetainedEarningsMember 2022-03-31 0001792941 2022-03-31 0001792941 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-09-30 0001792941 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-09-30 0001792941 us-gaap:CommonStockMember 2022-09-30 0001792941 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001792941 us-gaap:RetainedEarningsMember 2022-09-30 0001792941 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001792941 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001792941 us-gaap:CommonStockMember 2022-12-31 0001792941 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001792941 us-gaap:RetainedEarningsMember 2022-12-31 0001792941 2022-12-31 0001792941 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001792941 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001792941 us-gaap:CommonStockMember 2023-03-31 0001792941 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001792941 us-gaap:RetainedEarningsMember 2023-03-31 0001792941 2023-03-31 0001792941 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-10-01 2021-12-31 0001792941 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-10-01 2021-12-31 0001792941 us-gaap:CommonStockMember 2021-10-01 2021-12-31 0001792941 us-gaap:AdditionalPaidInCapitalMember 2021-10-01 2021-12-31 0001792941 us-gaap:RetainedEarningsMember 2021-10-01 2021-12-31 0001792941 2021-10-01 2021-12-31 0001792941 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001792941 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001792941 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001792941 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001792941 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001792941 2022-01-01 2022-03-31 0001792941 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001792941 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001792941 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001792941 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001792941 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001792941 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-10-01 2022-12-31 0001792941 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-10-01 2022-12-31 0001792941 us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001792941 us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001792941 us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001792941 2022-10-01 2022-12-31 0001792941 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001792941 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001792941 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001792941 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001792941 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001792941 2023-01-01 2023-03-31 0001792941 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001792941 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001792941 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001792941 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001792941 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001792941 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-06-30 0001792941 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-06-30 0001792941 us-gaap:CommonStockMember 2022-06-30 0001792941 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001792941 us-gaap:RetainedEarningsMember 2022-06-30 0001792941 2022-06-30 0001792941 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001792941 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001792941 us-gaap:CommonStockMember 2023-06-30 0001792941 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001792941 us-gaap:RetainedEarningsMember 2023-06-30 0001792941 GNVR:PaycheckProtectionProgramMember 2020-04-09 0001792941 GNVR:NoteholderBMember 2022-10-01 2023-06-30 0001792941 GNVR:NoteholderAMember 2022-10-01 2023-06-30 0001792941 GNVR:NoteholderAMember 2023-06-30 0001792941 GNVR:NoteholderBMember 2023-06-30 0001792941 GNVR:NoteholderCMember 2022-10-01 2023-06-30 0001792941 GNVR:NoteholderCMember 2023-06-30 0001792941 GNVR:NoteholderDMember 2022-10-01 2023-06-30 0001792941 GNVR:NoteholderDMember 2023-06-30 0001792941 GNVR:NoteholderEMember 2022-10-01 2023-06-30 0001792941 GNVR:NoteholderEMember 2023-06-30 0001792941 GNVR:NoteholderFMember 2022-10-01 2023-06-30 0001792941 GNVR:NoteholderFMember 2023-06-30 0001792941 GNVR:NoteholderHMember 2022-10-01 2023-06-30 0001792941 GNVR:NoteholderHMember 2023-06-30 0001792941 GNVR:NoteholderIMember 2022-10-01 2023-06-30 0001792941 GNVR:NoteholderIMember 2023-06-30 0001792941 srt:MinimumMember GNVR:NoteholderFMember 2022-10-01 2023-06-30 0001792941 srt:MaximumMember GNVR:NoteholderFMember 2022-10-01 2023-06-30 0001792941 us-gaap:SeriesAPreferredStockMember 2022-08-10 0001792941 us-gaap:SeriesAPreferredStockMember 2022-08-02 2022-08-10 0001792941 GNVR:BradleyWhiteMember 2022-08-16 0001792941 GNVR:ClaytonYatesMember 2022-08-16 0001792941 GNVR:JesseJaynesMember 2022-08-16 0001792941 us-gaap:SeriesBPreferredStockMember 2022-10-19 0001792941 us-gaap:SeriesBPreferredStockMember 2022-10-19 2022-10-19 0001792941 2022-04-21 2022-04-21 0001792941 GNVR:ShareholderMember GNVR:StockIssuedForCashMember 2022-11-17 2022-11-17 0001792941 GNVR:ShareholderMember GNVR:StockIssuedForCashMember 2023-05-03 2023-05-03 0001792941 GNVR:ShareholderMember GNVR:StockIssuedForCashMember 2023-05-12 2023-05-12 0001792941 GNVR:ShareholderMember GNVR:StockIssuedForCashMember 2023-05-29 2023-05-29 0001792941 2023-06-14 2023-06-14 0001792941 GNVR:JaynesInvestmentLLCMember us-gaap:SeriesBPreferredStockMember 2022-10-19 2022-10-19 0001792941 GNVR:ACTHoldingsLLCMember us-gaap:SeriesBPreferredStockMember 2022-10-19 2022-10-19 0001792941 GNVR:LASBFamilyTrustMember us-gaap:SeriesBPreferredStockMember 2022-10-19 2022-10-19 0001792941 GNVR:JesseMichaelJaynesMember us-gaap:SeriesBPreferredStockMember 2022-10-19 2022-10-19 0001792941 GNVR:BradleyWhiteMember us-gaap:SeriesBPreferredStockMember 2022-10-19 2022-10-19 0001792941 GNVR:PJAdvisoryGroupMember us-gaap:SeriesBPreferredStockMember 2022-10-19 2022-10-19 0001792941 2021-10-01 2022-09-30 0001792941 us-gaap:InvestorMember 2022-10-01 2023-06-30 0001792941 GNVR:ConsultingAgreementsMember srt:ChiefExecutiveOfficerMember 2022-10-01 2023-06-30 0001792941 srt:ChiefExecutiveOfficerMember GNVR:ConsultingAgreementsMember 2022-10-01 2023-06-30 0001792941 srt:ChiefExecutiveOfficerMember GNVR:ConsultingAgreementsMember 2023-06-30 0001792941 srt:ChiefExecutiveOfficerMember GNVR:ConsultingAgreementsMember 2022-09-30 0001792941 GNVR:ConsultingAgreementsMember GNVR:ConsultantMember 2020-07-24 2020-07-24 0001792941 2021-09-01 2021-09-30 0001792941 us-gaap:ResearchAndDevelopmentArrangementMember 2023-06-30 0001792941 us-gaap:ResearchAndDevelopmentArrangementMember 2022-09-30 0001792941 us-gaap:InvestorMember us-gaap:SubsequentEventMember 2023-07-12 2023-07-12 0001792941 us-gaap:InvestorMember us-gaap:SubsequentEventMember 2023-07-12 0001792941 us-gaap:InvestorMember us-gaap:SubsequentEventMember 2023-07-13 2023-07-13 0001792941 us-gaap:InvestorMember us-gaap:SubsequentEventMember 2023-07-13 0001792941 us-gaap:InvestorMember us-gaap:SubsequentEventMember 2023-07-14 2023-07-14 0001792941 us-gaap:InvestorMember us-gaap:SubsequentEventMember 2023-07-14 0001792941 GNVR:JasonAdamsMember us-gaap:SubsequentEventMember 2023-08-04 iso4217:USD shares iso4217:USD shares pure 0001792941 false Q3 --09-30 10-Q true 2023-06-30 2023 false 333-234815 GENVOR INCORPORATED NV 83-2054746 201 S. Elliott Road Suite 538 Chapel Hill NC 27514 (984) 261-7338 No Yes Non-accelerated Filer true true true false 18667821 100 296386 1500 2000 1600 298386 16192 17565 17792 315951 1179500 1052000 133958 516658 236333 3846 48750 48750 246400 246400 1844941 1867654 179555 89221 179555 89221 2024496 1956875 0.001 0.001 20000000 20000000 10 10 9 9 9 9 2500000 2500000 2060536 2060536 0 0 2061 0.001 0.001 300000000 300000000 18572821 18572821 38678155 38678155 18573 38678 14876859 14608815 -16904197 -16288417 -2006704 -1640924 17792 315951 59762 45170 125424 132928 37500 37500 112500 180725 109248 502875 3712500 458 458 1374 1374 51352 59500 178637 163987 149072 645503 417935 4300762 -149072 -645503 -417935 -4300762 5846 12240 17511 73242 -5000 -30000 -30000 -90000 -90000 30111 90334 -65956 -42240 -197844 -168242 -215029 -687743 -615780 -4469004 -0.01 -0.01 -0.02 -0.02 -0.03 -0.03 -0.15 -0.15 18502546 18502546 36439887 36439887 19800317 19800317 30506420 30506420 20000000 2000 -64540 -62540 18000 8546798 -10947544 -2382746 20000000 20000 8546798 -11012084 -2445286 2650000 2650 197350 200000 1400000 1400 1400 1475020 1475 736035 737510 -515716 -515716 25525020 25525 9480183 -11527800 -2022092 6020000 6020 3003980 3010000 280000 280 139720 140000 688675 689 336884 337573 -150000 -150000 170000 170 -170 -3265545 -3265545 32683695 32684 12810597 -14793345 -1950064 1855888 1856 -1856 505000 505 501995 502500 25000 25 24975 25000 99600 100 -100 180400 180 48750 48930 1933972 1934 944224 946158 -687743 -687743 37283555 37284 14328585 -15481088 -1115219 38678155 38678 14608815 -16288417 -1640924 2060536 2061 -20605334 -20605 18544 300000 300 149700 150000 -179539 -179539 2060536 2061 18372821 18373 14777059 -16467956 -1670463 50000 50 12450 12500 -221212 -221212 2060536 2061 18422821 18423 14789509 -16689168 -1879175 125000 125 74875 75000 25000 25 12475 12500 -215029 -215029 2060536 2061 18572821 18573 14876859 -16904197 -2006704 -615780 -4469004 1374 1374 3712500 90000 90000 -5000 2500 90334 10911 -3393 -500 -150214 -27076 2800 -583786 -667602 50000 300000 4330 237500 735005 287500 1030675 -296286 363073 296386 72315 100 435388 12500 1135946 125750 13480 150000 <p id="xdx_806_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_z0YhDeLrMOTf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_824_zNLJqllkeFqc">ORGANIZATION AND BASIS OF PRESENTATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 27, 2022, Genvor Incorporated, formerly known as Allure Worldwide, Inc. (the “Company” or “Genvor” or “we”), a Nevada corporation, Genvor Acquisition, Corp., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”), and Genvor Inc., a Delaware corporation (“Old Genvor”), completed their previously announced merger transaction pursuant to which the Company acquired Old Genvor (the “Acquisition”), and Old Genvor became a wholly-owned subsidiary of the Company. The Acquisition was completed pursuant to an Exchange Agreement, dated as of January 11, 2021 (the “Acquisition Agreement”), pursuant to which Old Genvor was to be acquired by the Company as its wholly owned subsidiary and each share of Old Genvor common stock would be exchanged for a share of the Company’s common stock, and a merger agreement, dated March 2, 2022 (the “Merger Agreement”), pursuant to which Merger Sub merged with and into Old Genvor, with Old Genvor continuing as a wholly owned subsidiary of the Company and the surviving corporation of the merger, and each share of Old Genvor being converted into the right to receive a share of the Company (the “Merger”). After closing of the Merger, the Company was renamed “Genvor Incorporated”. Genvor develops plant-based defense technology designed to help farmers achieve global food security.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During May 2019, Old Genvor acquired Nexion Biosciences LLC (“NBLLC”) from a founder for nominal consideration as a wholly owned subsidiary. NBLLC was formed in the state of Delaware on December 28, 2018 (“inception”). The consolidated financial statements of the Company include the accounts of Genvor Incorporated, Old Genvor, and its wholly owned subsidiary NBLLC. Intercompany accounts and transactions have been eliminated upon consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature of Operations</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s business plan is developing plant-based defense technology designed to help farmers achieve global food security. The Company’s technology was developed by two university scientists, Dr. Clayton Yates and Dr. Jesse Jaynes, who shared a mission to develop crop protection technology designed to defend against crop diseases effecting both animals and humans alike.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis of Presentation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited financial information as of and for the nine months ended June 30, 2023, and 2022 has been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, such financial information includes all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of our financial position at such date and the operating results and cash flows for such periods. Operating results for the nine months ended June 30, 2023, are not necessarily indicative of the results that may be expected for the entire year or for any other subsequent interim period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been omitted pursuant to the rules of the U.S. Securities and Exchange Commission, or the SEC. These unaudited financial statements and related notes should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended September 30, 2022, as filed with the SEC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principles of Consolidation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany balances and transactions have been eliminated in the consolidation. The consolidated financial statements included herein, presented in accordance with United States generally accepted accounting principles (“GAAP”) and stated in United States dollars, have been prepared by the Company, pursuant to the rules and regulations of the Securities and Exchange Commission.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity and Going Concern</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. At June 30, 2023, the Company had an accumulated deficit of $<span id="xdx_90E_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20230630_zUdvb7A9tHQ2" title="Accumulated deficit">16,904,197</span>. For the nine months ended June 30, 2023, the Company recognized a net loss of $<span id="xdx_90D_eus-gaap--ProfitLoss_c20221001__20230630_zbSvFVRlbC98" title="Net loss">615,780</span> and had net cash used in operating activities of $<span id="xdx_902_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20221001__20230630_zowkcJKLZABl" title="Net cash used in operating activities">583,786</span>, with no revenues earned, and a lack of operational history. These matters, among others, raise substantial doubt about the Company’s ability to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While the Company is attempting to generate revenues, the Company’s cash position may not be significant enough to support the Company’s daily operations. Management intends to raise additional funds by way of additional public and/or private offerings of its stock. Management believes that the actions presently being taken to further implement its business plan and generate revenues provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to generate revenues and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate revenues. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> -16904197 615780 -583786 <p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zxUpwAhGCDy6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – <span id="xdx_82C_zKG5VozyEIMj">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--UseOfEstimates_zjARIpBtMKW" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_z4lDw6rqS2Tl">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_ecustom--CashFlowReportingPolicyTextBlock_zvjTXZEzpthf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_z7jrIlriANsi">Cash Flow Reporting</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows Accounting Standards Codification (“ASC 230”), <i>Statement of Cash Flows</i>, for cash flow reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“indirect method”) as defined by ASC 230, Statement of Cash Flows, to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z8aCqJV2UJ2d" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zk6qG8upthZ5">Cash and Cash Equivalents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid debt instruments and other short-term investments with a maturity of three months or less, when purchased, to be cash equivalents. There were <span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20230630_z2WWWcMssuSg" title="Cash equivalents"><span id="xdx_904_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20220930_zULABt0IEjU3" title="Cash equivalents">no</span></span> cash equivalents as of June 30, 2023, and September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. At June 30, 2023, and September 30, 2022, $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_c20230630_ziKaXqiS4Ah5" title="Cash uninsured amount">0</span> and $<span id="xdx_900_eus-gaap--CashFDICInsuredAmount_iI_c20220930_zeQk30yoBgSc" title="Cash uninsured amount">46,386</span>, respectively, the Company’s cash balances were in excess of federally insured limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_znidJ8nOoOR9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zhe0AyHwP6N7">Fixed Assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and equipment are stated at cost. Depreciation is provided by the straight-line method over the useful lives of the related assets, approximately <span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20230630_zHAMNGl7DMe9" title="Fixed assets, estimated useful lives">seven years</span>. Expenditures for minor enhancements and maintenance are expensed as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zoN6TPkkZuX5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zGcuCnNXRjmi">Stock-Based Compensation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock-based instruments issued to employees in accordance with ASC Topic 718, <i>Compensation – Stock Compensation, and Certain Redeemable Financial Instruments</i>. ASC Topic 718 requires companies to recognize in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees. The value of the portion of an award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line attribution method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z10t5l8kBLkf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zRGvjMfEbJOh">Fair Value of Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The book values of cash, accounts receivable, and accounts payable approximate their respective fair values due to the short-term nature of these instruments. The fair value hierarchy under GAAP distinguishes between assumptions based on market data (observable inputs) and an entity’s own assumptions (unobservable inputs).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The hierarchy consists of three levels</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level one — Quoted market prices in active markets for identical assets or liabilities;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level two — Inputs other than level one inputs that are either directly or indirectly observable; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determining which category an asset or liability falls within the hierarchy requires significant judgment. We evaluate our hierarchy disclosures each quarter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zTv6VrSr3ZAf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zGGttxVfmv3k">Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s financial instruments include cash and cash equivalents, payables, and accrued interest and short-term and long-term notes payable and are accounted for under the provisions of ASC 825, <i>Financial Instruments</i>. The carrying amount of these financial instruments, as reflected in the accompanying consolidated balance sheet, approximates fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zqFfrhjKBs9i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zak01UcV5h6h">Long-lived Assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s long-lived assets and other assets (consisting of furniture, equipment and a patent) are reviewed for impairment in accordance with the guidance of the ASC 360, <i>Property, Plant, and Equipment</i>, and ASC 205, <i>Presentation of Financial Statements</i>. The Company tests for impairment losses on long-lived assets used in operations whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Recoverability of an asset to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. Impairment evaluations involve management’s estimates on asset useful lives and future cash flows. Actual useful lives and cash flows could be different from those estimated by management, which could have a material effect on our reporting results and financial positions. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals, as considered necessary. During the nine months ended June 30, 2023, and 2022, the Company had not experienced impairment losses on its long-lived assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_znjxsUSnB8Mj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_z1OqjlXS4Zs4">Research and Development</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company expenses the cost of research and development as incurred. Research and development expenses consist primarily of professional service costs associated with the development of the plant-based defense technology products. For the nine months ended June 30, 2023, and 2022, the Company had $<span id="xdx_900_eus-gaap--ResearchAndDevelopmentExpense_dxL_c20221001__20230630_zc8Ue4FnutD1" title="Research and development expenses::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0763">0</span></span> and $<span id="xdx_906_eus-gaap--ResearchAndDevelopmentExpense_c20211001__20220630_za8qx8bp8WL5" title="Research and development expenses">109,248</span> in research and development expenses, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--PatentsPolicyTextBlock_zvPJIghsqF0h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_z6y1spon4PZa">Patents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any patent costs for internally developed patents will be expensed as incurred. Costs to maintain and defend patents are recorded as administrative expenses in the statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchased patents are recorded at cost and reviewed for impairment in accordance with the guidance of the ASC 360, <i>Property, Plant, and Equipment</i>, and ASC 205, <i>Presentation of Financial Statements</i>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--IncomeTaxPolicyTextBlock_z3zR2yjzc6L9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_z2Ea5D9zCSH5">Income Taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for income taxes in accordance with FASB ASC 740, <i>Income Taxes</i>. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and loss carryforwards and their respective tax bases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income (loss) in the years in which those temporary differences are expected to be recovered or settled.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The effect of a change in tax rules on deferred tax assets and liabilities is recognized in operations in the year of change. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax benefits of uncertain tax positions are recognized only if it is more likely than not that the Company will be able to sustain a position taken on an income tax return. The Company has no liability for uncertain tax positions as of June 30, 2023. Interest and penalties in any, related to unrecognized tax benefits would be recognized as interest expense. The Company does not have any accrued interest or penalties associated with unrecognized tax benefits, nor was any significant interest expense recognized during the nine months ended June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_zjGd2t14x9Md" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_z65npBRCZA14">Loss Per Share of Common Stock</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic net loss per common share is computed using the weighted average number of common shares outstanding. Diluted earnings per share (“EPS”) include additional dilution from common stock equivalents, such as stock issuable pursuant to the exercise of stock options, warrants and convertible notes. Common stock equivalents are not included in the computation of diluted earnings per share when the Company reports a loss because to do so would be anti-dilutive for periods presented. The Company had total potential additional dilutive securities outstanding at June 30, 2023, and September 30, 2022, of <span id="xdx_90E_ecustom--DilutiveSecuritiesOutstanding_iI_c20230630_zIJBOJuSVWg6" title="Additional dilutive securities outstanding">22,065,343</span> and <span id="xdx_900_ecustom--DilutiveSecuritiesOutstanding_iI_c20220930_zrG6r9T1WO07" title="Additional dilutive securities outstanding">1,460,009</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zbj2M3PeKBV8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zbSltx5LxsD5">Recent Accounting Pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the FASB issued ASU 2020-06, <i>Debt with Conversion and Other Options</i>, which simplifies accounting for convertible instruments. The new guidance eliminates two of the three models in ASC 470-20 that require separating embedded conversion features from convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation. The guidance is effective for fiscal years beginning after December 15, 2021. The Company is currently utilizing the guidance as applicable. There have been no material impacts on the Company’s financials.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recently Issued Accounting Standards: Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.</span></p> <p id="xdx_854_zZnyyfoCyj86" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--UseOfEstimates_zjARIpBtMKW" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_z4lDw6rqS2Tl">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_ecustom--CashFlowReportingPolicyTextBlock_zvjTXZEzpthf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_z7jrIlriANsi">Cash Flow Reporting</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows Accounting Standards Codification (“ASC 230”), <i>Statement of Cash Flows</i>, for cash flow reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“indirect method”) as defined by ASC 230, Statement of Cash Flows, to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z8aCqJV2UJ2d" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zk6qG8upthZ5">Cash and Cash Equivalents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid debt instruments and other short-term investments with a maturity of three months or less, when purchased, to be cash equivalents. There were <span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20230630_z2WWWcMssuSg" title="Cash equivalents"><span id="xdx_904_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20220930_zULABt0IEjU3" title="Cash equivalents">no</span></span> cash equivalents as of June 30, 2023, and September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. At June 30, 2023, and September 30, 2022, $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_c20230630_ziKaXqiS4Ah5" title="Cash uninsured amount">0</span> and $<span id="xdx_900_eus-gaap--CashFDICInsuredAmount_iI_c20220930_zeQk30yoBgSc" title="Cash uninsured amount">46,386</span>, respectively, the Company’s cash balances were in excess of federally insured limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 0 46386 <p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_znidJ8nOoOR9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zhe0AyHwP6N7">Fixed Assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and equipment are stated at cost. Depreciation is provided by the straight-line method over the useful lives of the related assets, approximately <span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20230630_zHAMNGl7DMe9" title="Fixed assets, estimated useful lives">seven years</span>. Expenditures for minor enhancements and maintenance are expensed as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P7Y <p id="xdx_84C_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zoN6TPkkZuX5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zGcuCnNXRjmi">Stock-Based Compensation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock-based instruments issued to employees in accordance with ASC Topic 718, <i>Compensation – Stock Compensation, and Certain Redeemable Financial Instruments</i>. ASC Topic 718 requires companies to recognize in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees. The value of the portion of an award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line attribution method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z10t5l8kBLkf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zRGvjMfEbJOh">Fair Value of Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The book values of cash, accounts receivable, and accounts payable approximate their respective fair values due to the short-term nature of these instruments. The fair value hierarchy under GAAP distinguishes between assumptions based on market data (observable inputs) and an entity’s own assumptions (unobservable inputs).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The hierarchy consists of three levels</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level one — Quoted market prices in active markets for identical assets or liabilities;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level two — Inputs other than level one inputs that are either directly or indirectly observable; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determining which category an asset or liability falls within the hierarchy requires significant judgment. We evaluate our hierarchy disclosures each quarter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zTv6VrSr3ZAf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zGGttxVfmv3k">Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s financial instruments include cash and cash equivalents, payables, and accrued interest and short-term and long-term notes payable and are accounted for under the provisions of ASC 825, <i>Financial Instruments</i>. The carrying amount of these financial instruments, as reflected in the accompanying consolidated balance sheet, approximates fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zqFfrhjKBs9i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zak01UcV5h6h">Long-lived Assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s long-lived assets and other assets (consisting of furniture, equipment and a patent) are reviewed for impairment in accordance with the guidance of the ASC 360, <i>Property, Plant, and Equipment</i>, and ASC 205, <i>Presentation of Financial Statements</i>. The Company tests for impairment losses on long-lived assets used in operations whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Recoverability of an asset to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. Impairment evaluations involve management’s estimates on asset useful lives and future cash flows. Actual useful lives and cash flows could be different from those estimated by management, which could have a material effect on our reporting results and financial positions. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals, as considered necessary. During the nine months ended June 30, 2023, and 2022, the Company had not experienced impairment losses on its long-lived assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_znjxsUSnB8Mj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_z1OqjlXS4Zs4">Research and Development</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company expenses the cost of research and development as incurred. Research and development expenses consist primarily of professional service costs associated with the development of the plant-based defense technology products. For the nine months ended June 30, 2023, and 2022, the Company had $<span id="xdx_900_eus-gaap--ResearchAndDevelopmentExpense_dxL_c20221001__20230630_zc8Ue4FnutD1" title="Research and development expenses::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0763">0</span></span> and $<span id="xdx_906_eus-gaap--ResearchAndDevelopmentExpense_c20211001__20220630_za8qx8bp8WL5" title="Research and development expenses">109,248</span> in research and development expenses, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 109248 <p id="xdx_844_ecustom--PatentsPolicyTextBlock_zvPJIghsqF0h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_z6y1spon4PZa">Patents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any patent costs for internally developed patents will be expensed as incurred. Costs to maintain and defend patents are recorded as administrative expenses in the statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchased patents are recorded at cost and reviewed for impairment in accordance with the guidance of the ASC 360, <i>Property, Plant, and Equipment</i>, and ASC 205, <i>Presentation of Financial Statements</i>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--IncomeTaxPolicyTextBlock_z3zR2yjzc6L9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_z2Ea5D9zCSH5">Income Taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for income taxes in accordance with FASB ASC 740, <i>Income Taxes</i>. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and loss carryforwards and their respective tax bases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income (loss) in the years in which those temporary differences are expected to be recovered or settled.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The effect of a change in tax rules on deferred tax assets and liabilities is recognized in operations in the year of change. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax benefits of uncertain tax positions are recognized only if it is more likely than not that the Company will be able to sustain a position taken on an income tax return. The Company has no liability for uncertain tax positions as of June 30, 2023. Interest and penalties in any, related to unrecognized tax benefits would be recognized as interest expense. The Company does not have any accrued interest or penalties associated with unrecognized tax benefits, nor was any significant interest expense recognized during the nine months ended June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_zjGd2t14x9Md" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_z65npBRCZA14">Loss Per Share of Common Stock</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic net loss per common share is computed using the weighted average number of common shares outstanding. Diluted earnings per share (“EPS”) include additional dilution from common stock equivalents, such as stock issuable pursuant to the exercise of stock options, warrants and convertible notes. Common stock equivalents are not included in the computation of diluted earnings per share when the Company reports a loss because to do so would be anti-dilutive for periods presented. The Company had total potential additional dilutive securities outstanding at June 30, 2023, and September 30, 2022, of <span id="xdx_90E_ecustom--DilutiveSecuritiesOutstanding_iI_c20230630_zIJBOJuSVWg6" title="Additional dilutive securities outstanding">22,065,343</span> and <span id="xdx_900_ecustom--DilutiveSecuritiesOutstanding_iI_c20220930_zrG6r9T1WO07" title="Additional dilutive securities outstanding">1,460,009</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 22065343 1460009 <p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zbj2M3PeKBV8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zbSltx5LxsD5">Recent Accounting Pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the FASB issued ASU 2020-06, <i>Debt with Conversion and Other Options</i>, which simplifies accounting for convertible instruments. The new guidance eliminates two of the three models in ASC 470-20 that require separating embedded conversion features from convertible instruments. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation. The guidance is effective for fiscal years beginning after December 15, 2021. The Company is currently utilizing the guidance as applicable. There have been no material impacts on the Company’s financials.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recently Issued Accounting Standards: Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.</span></p> <p id="xdx_80E_eus-gaap--SubordinatedBorrowingsDisclosureTextBlock_zVQAoUeV6wA4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – <span id="xdx_824_zGDMhOKQFi8f">BORROWINGS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commercial Loan</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 9, 2020, the Company received a loan from the Small Business Administration pursuant to the Paycheck Protection Program (PPP) in the principal amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20200409__us-gaap--DebtInstrumentAxis__custom--PaycheckProtectionProgramMember_zLYfNjCZiEVk" title="Principal amont">48,750</span>. The note bears interest at a variable rate of approximately <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20200409__us-gaap--DebtInstrumentAxis__custom--PaycheckProtectionProgramMember_z7tfq7NMsI7d" title="Interest rate">1</span>% and matured in April 2022; and it is currently in default. Forgiveness for the loan was applied for and is pending. The principal amount of the loan was based on the consulting agreement salary between Nexion Biosciences, Inc., organized in the state of Florida (NBFL) (a related party) and the CEO.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes Payable</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, the Company’s subsidiary, Genvor Inc., enters into unsecured notes payable with individual investors. Only Noteholder E (below) has security in the form of a personal guarantee by the CEO and prior consultant (Note 6). The terms of these notes are listed below. Several of the notes are convertible into shares of the Company’s common stock as detailed in the following schedule.</span></p> <p id="xdx_89E_eus-gaap--ConvertibleDebtTableTextBlock_zHGgnbHKQeFc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zivgPpFW4HC" style="display: none">SCHEDULE OF CONVERTIBLE NOTES PAYABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Balance</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Convertible</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Interest</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Loan</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">into</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Noteholder</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Origination</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Maturity</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Rate</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares (c)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 24%; text-align: left">Noteholder A (a)</td><td style="width: 2%"> </td> <td style="width: 12%; text-align: center"><span id="xdx_90C_ecustom--Origination_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderAMember_fKGEp_z2yrNvHNlkB7" title="Origination">2019</span></td><td style="width: 2%"> </td> <td style="width: 12%; text-align: center"><span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderAMember_fKGEp_zmgLVugAb71g" title="Maturity date">12/31/2021</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_901_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderAMember_fKGEp_zaAk7MhTkjLe" title="Interest rate">0</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--DebtInstrumentFaceAmount_iI_c20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderAMember_fKGEp_z10X9e9jw3r4" style="width: 12%; text-align: right" title="Loan Balance">217,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Noteholder B (a)</td><td> </td> <td style="text-align: center"><span id="xdx_905_ecustom--Origination_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderBMember_fKGEp_zCJjrm7NFQaj" title="Origination">3/19/2019</span></td><td> </td> <td style="text-align: center"><span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderBMember_fKGEp_zOP7STCpsZjc" title="Maturity date">4/29/2019</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderBMember_fKGEp_zRpRabDVzvbj" title="Interest rate">0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--DebtInstrumentFaceAmount_iI_c20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderBMember_fKGEp_z3ptQtQK0mih" style="text-align: right" title="Loan Balance">540,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Noteholder C (a)</td><td> </td> <td style="text-align: center"><span id="xdx_90B_ecustom--Origination_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderCMember_fKGEp_za0BDYQXzBVd" title="Origination">3/1/2019</span></td><td> </td> <td style="text-align: center"><span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderCMember_fKGEp_zP4dxS0NzMr9" title="Maturity date">2/29/2020</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderCMember_fKGEp_zC8FzIlYZ8pj" title="Interest rate">18</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--DebtInstrumentFaceAmount_iI_c20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderCMember_fKGEp_zcphDQTD2A0a" style="text-align: right" title="Loan Balance">32,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Noteholder D (d)</td><td> </td> <td style="text-align: center"><span id="xdx_905_ecustom--Origination_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderDMember_fKGQp_zysc6PeRKY23" title="Origination">4/29/2019</span></td><td> </td> <td style="text-align: center">unspecified</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderDMember_fKGQp_zpxXgye2dGWk" title="Interest rate">0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DebtInstrumentFaceAmount_iI_c20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderDMember_fKGQp_zP50v3t1aNr7" style="text-align: right" title="Loan Balance">300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderDMember_fKGQp_zagpzz99OfF" style="text-align: right" title="Number of shares the notesis convertible into shares">30,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Noteholder E (a)</td><td> </td> <td style="text-align: center"><span id="xdx_904_ecustom--Origination_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderEMember_fKGEp_z99JiIPziZr4" title="Origination">8/1/2019</span></td><td> </td> <td style="text-align: center"><span id="xdx_905_eus-gaap--DebtInstrumentMaturityDate_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderEMember_fKGEp_z26vdKbbVn9a" title="Maturity date">8/31/2019</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderEMember_fKGEp_zTPGTgoHgMzf" title="Interest rate">0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DebtInstrumentFaceAmount_iI_c20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderEMember_fKGEp_zkt6geOtqiE5" style="text-align: right" title="Loan Balance">37,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> N/A </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Noteholder F (a)(b)</td><td> </td> <td style="text-align: center"><span id="xdx_906_ecustom--Origination_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderFMember_fKGEpKGIp_zJ9kKr3Pcq08" title="Origination">2/27/2020</span></td><td> </td> <td style="text-align: center"><span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderFMember_fKGEpKGIp_zSjezDJ01Dfj" title="Maturity date">4/30/2020</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderFMember_fKGEpKGIp_zorMcuDDtuuh" title="Interest rate">0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--DebtInstrumentFaceAmount_iI_c20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderFMember_fKGEpKGIp_znm0Z7oZ7r88" style="text-align: right" title="Loan Balance">2,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderFMember_fKGEpKGIp_z5csRGYWYLfj" style="text-align: right" title="Number of shares the notesis convertible into shares">5,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Noteholder H</td><td> </td> <td style="text-align: center"><span id="xdx_90D_ecustom--Origination_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderHMember_zrXTkDr3UBrc" title="Origination">6/27/2022</span></td><td> </td> <td style="text-align: center"><span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderHMember_zRCCxGfpKrhf" title="Maturity date">6/27/2024</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderHMember_zC6EHpaJ1TL9" title="Interest rate">5</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--DebtInstrumentFaceAmount_iI_c20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderHMember_zHdkFytpk854" style="text-align: right" title="Loan Balance">300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderHMember_zSLjBWNfpOu1" style="text-align: right" title="Number of shares the notesis convertible into shares">1,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Noteholder I (c)</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_901_ecustom--Origination_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderIMember_fKGMp_zBWUQvkfzUOl" title="Origination">10/26/2022</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderIMember_fKGMp_zFV9IyatgxR1" title="Maturity date">12/31/2023</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderIMember_fKGMp_zAZiH9Z9FVKl" title="Interest rate">3</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--DebtInstrumentFaceAmount_iI_c20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderIMember_fKGMp_zrm6o1CkMmid" style="border-bottom: Black 1.5pt solid; text-align: right" title="Loan Balance">50,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderIMember_fKGMp_zcmzGbWga3w2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares the notesis convertible into shares">400,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--DebtInstrumentFaceAmount_iI_c20230630_z3klcI5CUJLl" style="text-align: right" title="Loan Balance">1,479,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20221001__20230630_zPHyf2O5NQCc" style="text-align: right" title="Number of shares the notesis convertible into shares">1,435,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">(d) Debt discount</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_c20230630_zfgI6MEWGksk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Debt discount">(120,445</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--LongTermDebt_iI_c20230630_zdLaGwtbyINg" style="border-bottom: Black 2.5pt double; text-align: right" title="Total loan">1,359,055</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span id="xdx_F09_z4zLGTLBtkUf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: bottom"><span id="xdx_F1C_zzW6B7gXJsj3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Past due at June 30, 2023</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span id="xdx_F06_zp4N8y877PXl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span id="xdx_F16_zHlrCfVHpGy6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note is payable in a combination of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--DebtConversionOriginalDebtAmount1_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderFMember__srt--RangeAxis__srt--MinimumMember_z8XDeTEuPjfi" title="Notes payable converted">2,500</span> to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--DebtConversionOriginalDebtAmount1_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderFMember__srt--RangeAxis__srt--MaximumMember_zdDm7YTcuO4a" title="Notes payable converted">6,000</span> in cash and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderFMember__srt--RangeAxis__srt--MinimumMember_zTcRAigZJssc" title="Shares issued during conversion">5,000</span> to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderFMember__srt--RangeAxis__srt--MaximumMember_z7OhvnWvnMJj" title="Shares issued during conversion">15,000</span> share of common stock</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span id="xdx_F03_zPyEX5oOdoN" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: bottom"><span id="xdx_F1C_zkUEx78Kobof" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible into common stock of the subsidiary, Genvor Inc.</span></td></tr> </table> <p id="xdx_8A5_zutyjXBxnWOj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The notes do not have default provisions except Noteholder B receives a default penalty of $<span id="xdx_902_ecustom--DebtDefaultPenaltyAmount_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderBMember_zLgzMxIrEhfd">10,000</span> each month the note goes unpaid.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest expense totaled $<span id="xdx_90D_eus-gaap--InterestExpenseDebt_c20221001__20230630_zlSBLpvmWlXj" title="Interest expense">17,511</span> and $<span id="xdx_900_eus-gaap--InterestExpenseDebt_c20211001__20220630_zw7tAkwvbPLl" title="Interest expense">73,242</span>, respectively, for the nine months ended June 30, 2023, and 2022, including default penalties. Late fees totaled $<span id="xdx_90F_ecustom--LateFees_c20221001__20230630_zNraWUu8tpY" title="Late fees">90,000</span> and $<span id="xdx_905_ecustom--LateFees_c20211001__20220630_zgNe4DBM4L39" title="Late fees">90,000</span>, respectively, for the nine months ended June 30, 2023, and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 48750 0.01 <p id="xdx_89E_eus-gaap--ConvertibleDebtTableTextBlock_zHGgnbHKQeFc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zivgPpFW4HC" style="display: none">SCHEDULE OF CONVERTIBLE NOTES PAYABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Balance</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Convertible</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Interest</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Loan</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">into</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Noteholder</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Origination</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Maturity</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Rate</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares (c)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 24%; text-align: left">Noteholder A (a)</td><td style="width: 2%"> </td> <td style="width: 12%; text-align: center"><span id="xdx_90C_ecustom--Origination_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderAMember_fKGEp_z2yrNvHNlkB7" title="Origination">2019</span></td><td style="width: 2%"> </td> <td style="width: 12%; text-align: center"><span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderAMember_fKGEp_zmgLVugAb71g" title="Maturity date">12/31/2021</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_901_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderAMember_fKGEp_zaAk7MhTkjLe" title="Interest rate">0</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--DebtInstrumentFaceAmount_iI_c20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderAMember_fKGEp_z10X9e9jw3r4" style="width: 12%; text-align: right" title="Loan Balance">217,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Noteholder B (a)</td><td> </td> <td style="text-align: center"><span id="xdx_905_ecustom--Origination_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderBMember_fKGEp_zCJjrm7NFQaj" title="Origination">3/19/2019</span></td><td> </td> <td style="text-align: center"><span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderBMember_fKGEp_zOP7STCpsZjc" title="Maturity date">4/29/2019</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderBMember_fKGEp_zRpRabDVzvbj" title="Interest rate">0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--DebtInstrumentFaceAmount_iI_c20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderBMember_fKGEp_z3ptQtQK0mih" style="text-align: right" title="Loan Balance">540,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Noteholder C (a)</td><td> </td> <td style="text-align: center"><span id="xdx_90B_ecustom--Origination_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderCMember_fKGEp_za0BDYQXzBVd" title="Origination">3/1/2019</span></td><td> </td> <td style="text-align: center"><span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderCMember_fKGEp_zP4dxS0NzMr9" title="Maturity date">2/29/2020</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderCMember_fKGEp_zC8FzIlYZ8pj" title="Interest rate">18</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--DebtInstrumentFaceAmount_iI_c20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderCMember_fKGEp_zcphDQTD2A0a" style="text-align: right" title="Loan Balance">32,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Noteholder D (d)</td><td> </td> <td style="text-align: center"><span id="xdx_905_ecustom--Origination_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderDMember_fKGQp_zysc6PeRKY23" title="Origination">4/29/2019</span></td><td> </td> <td style="text-align: center">unspecified</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderDMember_fKGQp_zpxXgye2dGWk" title="Interest rate">0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DebtInstrumentFaceAmount_iI_c20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderDMember_fKGQp_zP50v3t1aNr7" style="text-align: right" title="Loan Balance">300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderDMember_fKGQp_zagpzz99OfF" style="text-align: right" title="Number of shares the notesis convertible into shares">30,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Noteholder E (a)</td><td> </td> <td style="text-align: center"><span id="xdx_904_ecustom--Origination_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderEMember_fKGEp_z99JiIPziZr4" title="Origination">8/1/2019</span></td><td> </td> <td style="text-align: center"><span id="xdx_905_eus-gaap--DebtInstrumentMaturityDate_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderEMember_fKGEp_z26vdKbbVn9a" title="Maturity date">8/31/2019</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderEMember_fKGEp_zTPGTgoHgMzf" title="Interest rate">0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DebtInstrumentFaceAmount_iI_c20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderEMember_fKGEp_zkt6geOtqiE5" style="text-align: right" title="Loan Balance">37,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> N/A </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Noteholder F (a)(b)</td><td> </td> <td style="text-align: center"><span id="xdx_906_ecustom--Origination_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderFMember_fKGEpKGIp_zJ9kKr3Pcq08" title="Origination">2/27/2020</span></td><td> </td> <td style="text-align: center"><span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderFMember_fKGEpKGIp_zSjezDJ01Dfj" title="Maturity date">4/30/2020</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderFMember_fKGEpKGIp_zorMcuDDtuuh" title="Interest rate">0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--DebtInstrumentFaceAmount_iI_c20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderFMember_fKGEpKGIp_znm0Z7oZ7r88" style="text-align: right" title="Loan Balance">2,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderFMember_fKGEpKGIp_z5csRGYWYLfj" style="text-align: right" title="Number of shares the notesis convertible into shares">5,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Noteholder H</td><td> </td> <td style="text-align: center"><span id="xdx_90D_ecustom--Origination_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderHMember_zrXTkDr3UBrc" title="Origination">6/27/2022</span></td><td> </td> <td style="text-align: center"><span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderHMember_zRCCxGfpKrhf" title="Maturity date">6/27/2024</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderHMember_zC6EHpaJ1TL9" title="Interest rate">5</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--DebtInstrumentFaceAmount_iI_c20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderHMember_zHdkFytpk854" style="text-align: right" title="Loan Balance">300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderHMember_zSLjBWNfpOu1" style="text-align: right" title="Number of shares the notesis convertible into shares">1,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Noteholder I (c)</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_901_ecustom--Origination_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderIMember_fKGMp_zBWUQvkfzUOl" title="Origination">10/26/2022</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderIMember_fKGMp_zFV9IyatgxR1" title="Maturity date">12/31/2023</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_uPure_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderIMember_fKGMp_zAZiH9Z9FVKl" title="Interest rate">3</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--DebtInstrumentFaceAmount_iI_c20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderIMember_fKGMp_zrm6o1CkMmid" style="border-bottom: Black 1.5pt solid; text-align: right" title="Loan Balance">50,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderIMember_fKGMp_zcmzGbWga3w2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares the notesis convertible into shares">400,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--DebtInstrumentFaceAmount_iI_c20230630_z3klcI5CUJLl" style="text-align: right" title="Loan Balance">1,479,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20221001__20230630_zPHyf2O5NQCc" style="text-align: right" title="Number of shares the notesis convertible into shares">1,435,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">(d) Debt discount</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_c20230630_zfgI6MEWGksk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Debt discount">(120,445</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--LongTermDebt_iI_c20230630_zdLaGwtbyINg" style="border-bottom: Black 2.5pt double; text-align: right" title="Total loan">1,359,055</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><span id="xdx_F09_z4zLGTLBtkUf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: bottom"><span id="xdx_F1C_zzW6B7gXJsj3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Past due at June 30, 2023</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span id="xdx_F06_zp4N8y877PXl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span id="xdx_F16_zHlrCfVHpGy6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note is payable in a combination of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--DebtConversionOriginalDebtAmount1_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderFMember__srt--RangeAxis__srt--MinimumMember_z8XDeTEuPjfi" title="Notes payable converted">2,500</span> to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--DebtConversionOriginalDebtAmount1_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderFMember__srt--RangeAxis__srt--MaximumMember_zdDm7YTcuO4a" title="Notes payable converted">6,000</span> in cash and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderFMember__srt--RangeAxis__srt--MinimumMember_zTcRAigZJssc" title="Shares issued during conversion">5,000</span> to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20221001__20230630__us-gaap--DebtInstrumentAxis__custom--NoteholderFMember__srt--RangeAxis__srt--MaximumMember_z7OhvnWvnMJj" title="Shares issued during conversion">15,000</span> share of common stock</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span id="xdx_F03_zPyEX5oOdoN" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; white-space: nowrap; vertical-align: bottom"><span id="xdx_F1C_zkUEx78Kobof" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible into common stock of the subsidiary, Genvor Inc.</span></td></tr> </table> 2019 2021-12-31 0 217000 3/19/2019 2019-04-29 0 540000 3/1/2019 2020-02-29 0.18 32500 4/29/2019 0 300000 30000 8/1/2019 2019-08-31 0 37500 2/27/2020 2020-04-30 0 2500 5000 6/27/2022 2024-06-27 0.05 300000 1000000 10/26/2022 2023-12-31 0.03 50000 400000 1479500 1435000 120445 1359055 2500 6000 5000 15000 10000 17511 73242 90000 90000 <p id="xdx_80B_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zMOxFPb7fUEe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – <span id="xdx_824_zwZ8ro4EMLYg">STOCKHOLDERS’ DEFICIT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Preferred Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The authorized preferred stock of the Company consists of <span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_pp0d_c20230630_zvViOZBCvGr5" title="Preferred stock, shares authorized">20,000,000</span> shares with a $<span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20230630_zTbs62RxsCok" title="Preferred stock, shares par value">0.001</span> par value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series A Preferred Stock</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 10, 2022, the Company designated <span id="xdx_90A_ecustom--DesignationAuthorizedShares_iI_pp0d_c20220810__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zPouD8Cmq7ak" title="Designation authorized shares">10</span> shares of its preferred stock as Series A Preferred Stock (“Series A”). <span id="xdx_90D_eus-gaap--PreferredStockVotingRights_c20220802__20220810__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zTod0MUvyxW3" title="Number of votes">Each share of Series A entitles the holder to ten million (10,000,000) votes on all matters submitted to a vote of the stockholders of the Corporation.</span> When and as any dividend or distribution is declared or paid by the Company on the common stock, the Series A holders are entitled to participate in such dividend or distribution. <span id="xdx_90A_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20220802__20220810__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z5lOrGDww9d6" title="Conversion share description">Each Series A share is convertible, at the option of the holder, into one share of fully paid and non-assessable common stock.</span> Upon any liquidation, dissolution, or winding-up of the Company, the Series A holders are entitled to receive out the assets of the Company, for each share of Series A, an amount equal to par value before any distribution or payment shall be made to the holder of any junior securities (including common stock and all other equity or equity equivalent securities of the Company).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, and September 30, 2022, there were <span id="xdx_902_eus-gaap--PreferredStockSharesIssued_iI_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zlo1xOQK8NIi" title="Preferred stock, shares issued"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zqFVRpEiGbii" title="Preferred stock, shares outstanding">9</span></span> and <span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z0bNhiJK03dh" title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zb0mIzGbb0xg" title="Preferred stock, shares outstanding">9</span></span> shares of Series A preferred stock issued and outstanding, respectively. The preferred stock was issued on August 16, 2022, as follows: Bradley White (former Chief Executive Officer and Director), <span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_pp0d_c20220816__srt--TitleOfIndividualAxis__custom--BradleyWhiteMember_z1lS7fuDf943" title="Preferred stock, shares issued">3</span> shares; Dr. Clayton Yates (Chief Scientific Officer and Chairman), <span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_pp0d_c20220816__srt--TitleOfIndividualAxis__custom--ClaytonYatesMember_zcs0YcTE9Si7" title="Preferred stock, shares issued">3</span> shares; and Dr. Jesse Jaynes (Chief Research Officer and Director), <span id="xdx_90B_eus-gaap--PreferredStockSharesIssued_iI_pp0d_c20220816__srt--TitleOfIndividualAxis__custom--JesseJaynesMember_zyfJaurnUbB" title="Preferred stock, shares issued">3</span> shares. See Note 7.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series B Preferred Stock</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 19, 2022, the Company filed a Certificate of Designation with the State of Nevada to designate its Series B Preferred Stock (“Series B”). The designation authorized <span id="xdx_908_ecustom--DesignationAuthorizedShares_c20221019__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_pp0d" title="Designation authorized shares">2,500,000</span> shares of Series B. <span id="xdx_904_eus-gaap--PreferredStockVotingRights_c20221019__20221019__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zY64bAEB67za" title="Number of votes">Each share of Series B shall have 10 votes on all matters submitted to a vote of the stockholders of the Company.</span> <span id="xdx_90D_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20221019__20221019__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zKq2r6iOUl34" title="Conversion share description">Each share of Series B is convertible into 10 shares of common stock of the Company.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfConversionsOfStockTextBlock_zBBhkqrD8xZ7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 19, 2022, the following shareholders converted shares of common stock of the Company into shares of Series B to modify the common shares outstanding to reduce the outstanding common stock issued by the Company, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_zso2nZxlJXu7" style="display: none">SCHEDULE OF CONVERTED SHARES OF COMMON STOCK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Name</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common <br/> Shares</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exchanged</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series B</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issued</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Jaynes Investment LLC</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ConversionOfStockSharesConverted1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JaynesInvestmentLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_znRRpOKb2zbh" style="width: 16%; text-align: right" title="Common Shares Exchanged">2,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ConversionOfStockSharesIssued1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JaynesInvestmentLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zRWY0t5AkXd3" style="width: 16%; text-align: right" title="Series B Issued">200,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">ACT Holdings LLC</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ConversionOfStockSharesConverted1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ACTHoldingsLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zfTwx7dWurj8" style="text-align: right" title="Common Shares Exchanged">7,312,612</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ConversionOfStockSharesIssued1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ACTHoldingsLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zs3pzEbkmrFe" style="text-align: right" title="Series B Issued">731,262</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">LASB Family Trust</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ConversionOfStockSharesConverted1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LASBFamilyTrustMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zNh2WnOKbXM8" style="text-align: right" title="Common Shares Exchanged">3,800,112</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConversionOfStockSharesIssued1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LASBFamilyTrustMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z9RLh7JmrVWj" style="text-align: right" title="Series B Issued">380,012</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Jesse Michael Jaynes</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ConversionOfStockSharesConverted1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JesseMichaelJaynesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z1oHD4J7NQc6" style="text-align: right" title="Common Shares Exchanged">4,767,611</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ConversionOfStockSharesIssued1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JesseMichaelJaynesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zbpml1ec8j1b" style="text-align: right" title="Series B Issued">476,762</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Bradley White (a)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConversionOfStockSharesConverted1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BradleyWhiteMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_fKGEp_zTdPQQQYvQdk" style="text-align: right" title="Common Shares Exchanged">1,225,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ConversionOfStockSharesIssued1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BradleyWhiteMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_fKGEp_zzEojiCmlWs6" style="text-align: right" title="Series B Issued">122,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">PJ Advisory Group</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ConversionOfStockSharesConverted1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PJAdvisoryGroupMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zNFiawtxHepe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Common Shares Exchanged">1,500,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConversionOfStockSharesIssued1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PJAdvisoryGroupMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zKCMN8v5tPse" style="border-bottom: Black 1.5pt solid; text-align: right" title="Series B Issued">150,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConversionOfStockSharesConverted1_pp0d_c20221019__20221019__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zR32sfj7d4ig" style="border-bottom: Black 2.5pt double; text-align: right" title="Common Shares Exchanged">20,605,334</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ConversionOfStockSharesIssued1_pp0d_c20221019__20221019__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z9lSGIdvJT97" style="border-bottom: Black 2.5pt double; text-align: right" title="Series B Issued">2,060,536</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.2in; text-align: right"><span id="xdx_F01_zEPJIgZwI7H2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zpuGUKeMXoD4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related party</span></td></tr> </table> <p id="xdx_8AE_zSb7pJH0wFNl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The conversion of the common stock into the Series B was valued at par, respectively, offset to additional paid-in capital. The Series B is convertible into common stock into the original amount of common stock converted therefore there is no change in the amount of common stock outstanding on a fully diluted basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, and September 30, 2022, there were <span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_iI_pp0d_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zFUNBw6xnPFh" title="Preferred stock, shares issued"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_pp0d_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z1Yn4ZsHIxj" title="Preferred stock, shares outstanding">2,060,536</span></span> and <span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_iI_pp0d_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zVtokaZuZNB2" title="Preferred stock, shares issued"><span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_pp0d_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zEpYgP3lOPc2" title="Preferred stock, shares outstanding">0</span></span> shares of Series B preferred stock issued and outstanding, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The authorized common stock of the Company consists of <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_pp0d_c20230630_zIdDwybIiiza" title="Common stock, shares authorized">300,000,000</span> shares with a $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230630_zER7wLesnRT5" title="Common stock, shares par value">0.001</span> par value. All common stock shares are non-assessable and have one vote per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the Merger (see Note 1), the founding shareholders of the Company cancelled <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20220421__20220421_zABJw7oedE07" title="Number of common stock cancel">18,144,112</span> shares of common stock, retaining 5%, or <span id="xdx_90A_ecustom--CommonStockRetainingShareValue_iI_pp0d_c20220630_zJ6Chihwzz2h" title="Number of common stock retaining">1,855,888</span> shares of common stock, as of June 30, 2022. The cancellation is presented in the accompanying statements of changes in stockholders’ deficit within the line item “Retroactive application of recapitalization.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock Issued for Cash</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 17, 2022, the Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221117__20221117__srt--TitleOfIndividualAxis__custom--ShareholderMember__us-gaap--StatementClassOfStockAxis__custom--StockIssuedForCashMember_zWg4hmNjbPV1" title="Shares issued">300,000</span> shares of common stock to an investor for $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20221117__20221117__srt--TitleOfIndividualAxis__custom--ShareholderMember__us-gaap--StatementClassOfStockAxis__custom--StockIssuedForCashMember_zxF9zwL7ZSzi" title="Shares issued, value">150,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 3, 2023, the Company issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230503__20230503__srt--TitleOfIndividualAxis__custom--ShareholderMember__us-gaap--StatementClassOfStockAxis__custom--StockIssuedForCashMember_z6qoCJ3MD9Vg" title="Shares issued">100,000</span> shares of common stock to an investor for $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230503__20230503__srt--TitleOfIndividualAxis__custom--ShareholderMember__us-gaap--StatementClassOfStockAxis__custom--StockIssuedForCashMember_z2isT3HjTAJf" title="Shares issued, value">50,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 12, 2023, the Company issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230512__20230512__srt--TitleOfIndividualAxis__custom--ShareholderMember__us-gaap--StatementClassOfStockAxis__custom--StockIssuedForCashMember_z85OinWmO0Wd" title="Shares issued">15,000</span> shares of common stock to an investor for $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230512__20230512__srt--TitleOfIndividualAxis__custom--ShareholderMember__us-gaap--StatementClassOfStockAxis__custom--StockIssuedForCashMember_z9DkM6womGV4" title="Shares issued, value">15,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 29, 2023, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230529__20230529__srt--TitleOfIndividualAxis__custom--ShareholderMember__us-gaap--StatementClassOfStockAxis__custom--StockIssuedForCashMember_zvOabSu2ONB5" title="Shares issued">10,000</span> shares of common stock to an investor for $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230529__20230529__srt--TitleOfIndividualAxis__custom--ShareholderMember__us-gaap--StatementClassOfStockAxis__custom--StockIssuedForCashMember_zMf8hrm8KLRi" title="Shares issued, value">10,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other Stock Issuances</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 14, 2023, the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20230614__20230614_zlIXgSuAgd8g" title="Issuance of common stock">25,000</span> shares of common stock related to the conversion of a note payable for $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20230614__20230614_zvUtpdsqn83j" title="Conversion of common stock">12,500</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 20000000 0.001 10 Each share of Series A entitles the holder to ten million (10,000,000) votes on all matters submitted to a vote of the stockholders of the Corporation. Each Series A share is convertible, at the option of the holder, into one share of fully paid and non-assessable common stock. 9 9 9 9 3 3 3 2500000 Each share of Series B shall have 10 votes on all matters submitted to a vote of the stockholders of the Company. Each share of Series B is convertible into 10 shares of common stock of the Company. <p id="xdx_896_eus-gaap--ScheduleOfConversionsOfStockTextBlock_zBBhkqrD8xZ7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 19, 2022, the following shareholders converted shares of common stock of the Company into shares of Series B to modify the common shares outstanding to reduce the outstanding common stock issued by the Company, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_zso2nZxlJXu7" style="display: none">SCHEDULE OF CONVERTED SHARES OF COMMON STOCK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Name</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common <br/> Shares</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exchanged</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series B</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issued</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Jaynes Investment LLC</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ConversionOfStockSharesConverted1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JaynesInvestmentLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_znRRpOKb2zbh" style="width: 16%; text-align: right" title="Common Shares Exchanged">2,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ConversionOfStockSharesIssued1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JaynesInvestmentLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zRWY0t5AkXd3" style="width: 16%; text-align: right" title="Series B Issued">200,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">ACT Holdings LLC</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ConversionOfStockSharesConverted1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ACTHoldingsLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zfTwx7dWurj8" style="text-align: right" title="Common Shares Exchanged">7,312,612</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ConversionOfStockSharesIssued1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ACTHoldingsLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zs3pzEbkmrFe" style="text-align: right" title="Series B Issued">731,262</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">LASB Family Trust</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ConversionOfStockSharesConverted1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LASBFamilyTrustMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zNh2WnOKbXM8" style="text-align: right" title="Common Shares Exchanged">3,800,112</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConversionOfStockSharesIssued1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LASBFamilyTrustMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z9RLh7JmrVWj" style="text-align: right" title="Series B Issued">380,012</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Jesse Michael Jaynes</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ConversionOfStockSharesConverted1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JesseMichaelJaynesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z1oHD4J7NQc6" style="text-align: right" title="Common Shares Exchanged">4,767,611</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ConversionOfStockSharesIssued1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JesseMichaelJaynesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zbpml1ec8j1b" style="text-align: right" title="Series B Issued">476,762</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Bradley White (a)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConversionOfStockSharesConverted1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BradleyWhiteMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_fKGEp_zTdPQQQYvQdk" style="text-align: right" title="Common Shares Exchanged">1,225,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ConversionOfStockSharesIssued1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BradleyWhiteMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_fKGEp_zzEojiCmlWs6" style="text-align: right" title="Series B Issued">122,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">PJ Advisory Group</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ConversionOfStockSharesConverted1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PJAdvisoryGroupMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zNFiawtxHepe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Common Shares Exchanged">1,500,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConversionOfStockSharesIssued1_pp0d_c20221019__20221019__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PJAdvisoryGroupMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zKCMN8v5tPse" style="border-bottom: Black 1.5pt solid; text-align: right" title="Series B Issued">150,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConversionOfStockSharesConverted1_pp0d_c20221019__20221019__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zR32sfj7d4ig" style="border-bottom: Black 2.5pt double; text-align: right" title="Common Shares Exchanged">20,605,334</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ConversionOfStockSharesIssued1_pp0d_c20221019__20221019__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z9lSGIdvJT97" style="border-bottom: Black 2.5pt double; text-align: right" title="Series B Issued">2,060,536</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.2in; text-align: right"><span id="xdx_F01_zEPJIgZwI7H2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zpuGUKeMXoD4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related party</span></td></tr> </table> 2000000 200000 7312612 731262 3800112 380012 4767611 476762 1225000 122500 1500000 150000 20605334 2060536 2060536 2060536 0 0 300000000 0.001 18144112 1855888 300000 150000 100000 50000 15000 15000 10000 10000 25000 12500 <p id="xdx_800_eus-gaap--IncomeTaxDisclosureTextBlock_zxH51FdYW048" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 – <span id="xdx_82B_zrCqKphUpLk1">FEDERAL INCOME TAX</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, and September 30, 2022, the Company has net operating loss carry forwards of $<span id="xdx_903_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20230630_z0PmjjQorzf8" title="Net operating loss carry forwards">2,696,890</span> and $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20220930_zbOQylAfk201" title="Net operating loss carry forwards">2,572,885</span>, respectively, which may be available to reduce future years’ taxable income through 2043. The Company’s net operating loss carry forwards may be subject to annual limitations, which could reduce or defer the utilization of the losses as a result of an ownership change as defined in Section 382 of the Internal Revenue Code.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s tax expense differs from the “expected” tax expense for Federal income tax purposes (computed by applying the United States Federal tax rate of <span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20211001__20220930_zHgvRWDvVaJ2" title="Federal tax statutory rate"><span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20221001__20230630_zW31HrSC39p5" title="Federal tax statutory rate">21</span></span>% to loss before taxes for fiscal year 2023 and 2022), as follows:</span></p> <p id="xdx_899_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zIvIVSEIueOc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zazLWbfq1Jzk" style="display: none">SCHEDULE OF LOSS BEFORE TAXES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_494_20221001__20230630_zAmZgnRalh2c" style="text-align: center">June 30,</td><td> </td><td> </td> <td colspan="2" id="xdx_49E_20211001__20220930_zsKJwp4vTed" style="text-align: center">September 30,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzKgE_zqkdKoXBycD8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Tax benefit at the statutory rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(110,344</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(204,559</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maITEBzKgE_zeLtWooRK84b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">State income taxes, net of federal income tax benefit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(13,662</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(25,326</td><td style="text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzKgE_zxoATmhc1WTj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Change in valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">124,006</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">229,885</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzKgE_zLNC4efF1bh5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1005">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1006">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zodI3ndCFMPh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The tax effects of the temporary differences between reportable financial statement income and taxable income are recognized as deferred tax assets and liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The tax years 2023 and 2022 remain open for examination by federal agencies and other jurisdictions in which it operates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zOL5rXV9BRt5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The tax effect of significant components of the Company’s deferred tax assets and liabilities at June 30, 2023, and September 30, 2022, are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_z8s7ZKq63vac" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_491_20230630_zqsuYE2ZiEQ1" style="text-align: center">June 30,</td><td> </td><td> </td> <td colspan="2" id="xdx_495_20220930_znjJM2k7m653" style="text-align: center">September 30,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_ztv6b7gLoPri" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1.5pt">Net operating loss carryforward</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">2,696,890</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">2,572,885</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsGross_iI_maDTANzQs7_zU1rq6dEzdtf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total gross deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,696,890</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,572,885</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzQs7_zcdMlzoDBk84" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less: Deferred tax asset valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,696,890</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,572,885</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzQs7_zhm2uz6qTXlg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total net deferred taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1019">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1020">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zc4AbiWMDoSh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because of the historical earnings history of the Company, the net deferred tax assets for 2022 and 2021 were fully offset by a 100% valuation allowance. The valuation allowance for the remaining net deferred tax assets was $<span id="xdx_90C_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20230630_zvmimWTQN7Hl" title="Valuation allowance for net deferred tax assets">2,696,890</span> and $<span id="xdx_906_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20220930_zyDtHQfG8cXi" title="Valuation allowance for net deferred tax assets">2,572,885</span> as of June 30, 2023, and September 30, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2696890 2572885 0.21 0.21 <p id="xdx_899_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zIvIVSEIueOc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zazLWbfq1Jzk" style="display: none">SCHEDULE OF LOSS BEFORE TAXES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_494_20221001__20230630_zAmZgnRalh2c" style="text-align: center">June 30,</td><td> </td><td> </td> <td colspan="2" id="xdx_49E_20211001__20220930_zsKJwp4vTed" style="text-align: center">September 30,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzKgE_zqkdKoXBycD8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Tax benefit at the statutory rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(110,344</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(204,559</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maITEBzKgE_zeLtWooRK84b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">State income taxes, net of federal income tax benefit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(13,662</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(25,326</td><td style="text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzKgE_zxoATmhc1WTj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Change in valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">124,006</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">229,885</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzKgE_zLNC4efF1bh5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1005">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1006">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> -110344 -204559 -13662 -25326 124006 229885 <p id="xdx_89B_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zOL5rXV9BRt5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The tax effect of significant components of the Company’s deferred tax assets and liabilities at June 30, 2023, and September 30, 2022, are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_z8s7ZKq63vac" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_491_20230630_zqsuYE2ZiEQ1" style="text-align: center">June 30,</td><td> </td><td> </td> <td colspan="2" id="xdx_495_20220930_znjJM2k7m653" style="text-align: center">September 30,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_ztv6b7gLoPri" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1.5pt">Net operating loss carryforward</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">2,696,890</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">2,572,885</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsGross_iI_maDTANzQs7_zU1rq6dEzdtf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total gross deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,696,890</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,572,885</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzQs7_zcdMlzoDBk84" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less: Deferred tax asset valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,696,890</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,572,885</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzQs7_zhm2uz6qTXlg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total net deferred taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1019">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1020">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2696890 2572885 2696890 2572885 2696890 2572885 2696890 2572885 <p id="xdx_809_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zNpmFb1blyk1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 – <span id="xdx_825_z4YqhEP02aPk">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, the Company may be involved in litigation in the ordinary course of business. The Company is not currently involved in any litigation that we believe could have a material adverse effect on its financial condition or results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription Agreement and Cash Held in Escrow</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 20, 2019, the Company entered into a subscription escrow agreement (the “Trust Agreement”) with Branch Banking and Trust Company (“BB&amp;T”). This Trust Agreement was established for the subscription agreement proceeds raised and escrowed pursuant to the Company’s prior Rule 419 S-1 offering. The balance held in trust at June 30, 2023 and September 30, 2022, totaled $<span id="xdx_909_eus-gaap--AssetsHeldInTrust_iI_pp0p0_c20230630_zQKK64AROnR7" title="Assets held in trust"><span id="xdx_904_eus-gaap--AssetsHeldInTrust_iI_pp0p0_c20220930_zgYWVy9lAL17" title="Assets held in trust">19,705</span></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon completion of the Merger (see Notes 1 and 8), the Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pp0d_c20221001__20230630__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zsgDovWPueP4" title="Number of shares issued">975,000</span> common stock shares to the investors in that prior S-1 offering during July 2022 and were released to the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consulting Agreements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the nine months ended June 30, 2023, the Company paid the Company’s former CEO, Bradley White, $<span id="xdx_900_ecustom--RelatedPartyPayable_c20221001__20230630__us-gaap--PlanNameAxis__custom--ConsultingAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zFMFWvwQUe17" title="Related party payable">32,500</span> pursuant to a consulting agreement carried over from related party NBFL. The agreement provides for an annual salary of $<span id="xdx_903_eus-gaap--SalariesAndWages_pp0p0_c20221001__20230630__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zKa88wqqYd0b" title="Annual salary">150,000</span> which increases based on certain capital raise thresholds. On June 20, 2023, Mr. White was terminated as an officer of the Company. At June 30, 2023 and September 30, 2022, accrued payroll owed to the former CEO totaled $<span id="xdx_90C_eus-gaap--AccruedPayrollTaxesCurrent_iI_pp0p0_c20230630__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zjwLm4kAhBg6" title="Accrued payroll">228,213</span> and $<span id="xdx_90D_eus-gaap--AccruedPayrollTaxesCurrent_iI_pp0p0_c20220930__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zKGf9g43sCF" title="Accrued payroll">188,484</span>, respectively, as presented in the accompanying consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 24, 2020, the Company entered into a consulting agreement for business development activities, networking, negotiations, and strategic planning. The compensation pursuant to the agreement was $<span id="xdx_903_eus-gaap--SalariesWagesAndOfficersCompensation_pp0p0_c20200724__20200724__us-gaap--PlanNameAxis__custom--ConsultingAgreementsMember__us-gaap--RelatedPartyTransactionAxis__custom--ConsultantMember_z3uzuKOwvNz7">20,000</span> monthly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Office Lease</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company entered into a sublease agreement with the above consultant (providing business development assistance from 2019-2020) effective August 1, 2019, subject to the terms and conditions of the office lease held by the consultant at 15540 Quorum Drive #2624, Addison, Texas. On January 1, 2019, the Company adopted ASC 842 requiring this lease to be recorded as an asset and corresponding liability on its balance sheet. The Company records rent expense associated with this lease on the straight-line basis in conjunction with the terms of the underlying lease. A discount rate was not used in the determination of the right of use asset and liability since its effect would not be significant. The lease moved to a month-to-month basis beginning in September 2021 at $<span id="xdx_904_eus-gaap--PaymentsForRent_pp0p0_c20210901__20210930_zxD1hSRUg5n2" title="Rent expense">2,810</span> per month in addition to common area maintenance charges. During the nine months ended June 30, 2023, and 2022, we incurred $<span id="xdx_900_eus-gaap--PaymentsForRent_pp0p0_c20221001__20230630_znmowSwaGSGg" title="Rent expense">10,187</span> and $<span id="xdx_90B_eus-gaap--PaymentsForRent_pp0p0_c20211001__20220630_zlK2MiN1VKdb" title="Rent expense">20,607</span>, respectively, in office rental expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Research and Development Agreement</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During September 2020, the Company assumed a Cooperative Research And Development Agreement (CRADA) with the United States Department of Agriculture (USDA), Agricultural Research Service (ARS). Under this agreement, the Company committed to funding the remaining amount due. As of June 30, 2023, and September 30, 2022, $<span id="xdx_900_ecustom--FundAmount_iI_pp0p0_c20230630__us-gaap--LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis__us-gaap--ResearchAndDevelopmentArrangementMember_zPgd5t5TIWHa" title="Fund Amount">246,400</span> and $<span id="xdx_907_ecustom--FundAmount_iI_pp0p0_c20220930__us-gaap--LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis__us-gaap--ResearchAndDevelopmentArrangementMember_zv6sNVnceXFd" title="Fund Amount">246,400</span>, respectively, remained outstanding and is presented in the accompanying consolidated balance sheets as USDA CRADA liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 19705 19705 975000 32500 150000 228213 188484 20000 2810 10187 20607 246400 246400 <p id="xdx_807_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zcdewMuTSxh3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 – <span id="xdx_820_zsJFkRGY7yQ2">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share Issuances to the Board of Directors</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued Series A preferred stock on August 16, 2022, as follows: Bradley White (former Chief Executive Officer), <span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_pp0d_c20220816__srt--TitleOfIndividualAxis__custom--BradleyWhiteMember_zBCiCBsFOWy2" title="Preferred stock, shares issued">3</span> shares; Dr. Clayton Yates (Chief Scientific Officer and Chairman), <span id="xdx_903_eus-gaap--PreferredStockSharesIssued_iI_pp0d_c20220816__srt--TitleOfIndividualAxis__custom--ClaytonYatesMember_zbyLzWNinu1h" title="Preferred stock, shares issued">3</span> shares; and Dr. Jesse Jaynes (Chief Research Officer and Director), <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pp0d_c20220816__srt--TitleOfIndividualAxis__custom--JesseJaynesMember_zr0G3TP4T8xh" title="Preferred stock, shares issued">3</span> shares. See Note 4.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 3 3 3 <p id="xdx_80A_eus-gaap--SubsequentEventsTextBlock_zBOF0tXhfXDc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 – <span id="xdx_82E_zs4j61TNQ6jg">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has evaluated subsequent events from the balance sheet through the date of this filing and determined there were no events to disclose except the following.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 12, 2023, the Company sold <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pp0d_c20230712__20230712__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zCPV6EDuamk3" title="Common stock sold">25,000</span> shares of common stock for $<span id="xdx_90A_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0d_c20230712__20230712__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zmCCBe9Acvlh" title="Common stock value">10,000</span> to an investor at a value of $<span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230712__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zeZEM3vNJYU" title="Issue price">0.40</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 13, 2023, the Company sold <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pp0d_c20230713__20230713__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zDJiaCwQMyaf" title="Common stock sold">20,000</span> shares of common stock for $<span id="xdx_906_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0d_c20230713__20230713__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zDVAMmxt3iTc" title="Common stock value">10,000</span> to an investor at a value of $<span id="xdx_905_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230713__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zcgquSuzkte1" title="Issue price">0.50</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 14, 2023, the Company sold <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pp0d_c20230714__20230714__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zFPrQVVViXM3" title="Common stock sold">50,000</span> shares of common stock for $<span id="xdx_909_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0d_c20230714__20230714__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zB3toVQLNPta" title="Common stock value">25,000</span> to an investor at a value of $<span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230714__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zoX6scZGJdIa" title="Issue price">0.50</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 4, 2023, the Company executed into a promissory note with Jason Adams for $<span id="xdx_909_eus-gaap--NotesPayable_iI_c20230804__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JasonAdamsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z7wAciGXzyj4" title="Promissory note">15,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">On or about August 4, 2023, the Company’s former Chief Executive Officer, Bradley White, and LASB Family Trust presented conversion notices to the Company’s transfer agent to convert their shares of the Company’s Series B Preferred Stock into shares of Company common stock, and the Company objected to those conversions. Shares held by LASB Family Trust may be deemed to be beneficially owned by Mr. White.</p> 25000 10000 0.40 20000 10000 0.50 50000 25000 0.50 15000 Past due at June 30, 2023 Note is payable in a combination of $2,500 to $6,000 in cash and 5,000 to 15,000 share of common stock Convertible into common stock of the subsidiary, Genvor Inc. Related party EXCEL 41 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 42 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 43 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 44 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 146 193 1 true 37 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://genvor.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://genvor.com/role/BalanceSheets Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://genvor.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://genvor.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Sheet http://genvor.com/role/StatementsOfChangesInStockholdersDeficit Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flow (Unaudited) Sheet http://genvor.com/role/StatementsOfCashFlow Condensed Consolidated Statements of Cash Flow (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION Sheet http://genvor.com/role/OrganizationAndBasisOfPresentation ORGANIZATION AND BASIS OF PRESENTATION Notes 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://genvor.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - BORROWINGS Sheet http://genvor.com/role/Borrowings BORROWINGS Notes 9 false false R10.htm 00000010 - Disclosure - STOCKHOLDERS??? DEFICIT Sheet http://genvor.com/role/StockholdersDeficit STOCKHOLDERS??? DEFICIT Notes 10 false false R11.htm 00000011 - Disclosure - FEDERAL INCOME TAX Sheet http://genvor.com/role/FederalIncomeTax FEDERAL INCOME TAX Notes 11 false false R12.htm 00000012 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://genvor.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 12 false false R13.htm 00000013 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://genvor.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 13 false false R14.htm 00000014 - Disclosure - SUBSEQUENT EVENTS Sheet http://genvor.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 14 false false R15.htm 00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://genvor.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 15 false false R16.htm 00000016 - Disclosure - BORROWINGS (Tables) Sheet http://genvor.com/role/BorrowingsTables BORROWINGS (Tables) Tables http://genvor.com/role/Borrowings 16 false false R17.htm 00000017 - Disclosure - STOCKHOLDERS??? DEFICIT (Tables) Sheet http://genvor.com/role/StockholdersDeficitTables STOCKHOLDERS??? DEFICIT (Tables) Tables http://genvor.com/role/StockholdersDeficit 17 false false R18.htm 00000018 - Disclosure - FEDERAL INCOME TAX (Tables) Sheet http://genvor.com/role/FederalIncomeTaxTables FEDERAL INCOME TAX (Tables) Tables http://genvor.com/role/FederalIncomeTax 18 false false R19.htm 00000019 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) Sheet http://genvor.com/role/OrganizationAndBasisOfPresentationDetailsNarrative ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) Details http://genvor.com/role/OrganizationAndBasisOfPresentation 19 false false R20.htm 00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://genvor.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://genvor.com/role/SummaryOfSignificantAccountingPoliciesPolicies 20 false false R21.htm 00000021 - Disclosure - SCHEDULE OF CONVERTIBLE NOTES PAYABLE (Details) Notes http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails SCHEDULE OF CONVERTIBLE NOTES PAYABLE (Details) Details 21 false false R22.htm 00000022 - Disclosure - SCHEDULE OF CONVERTIBLE NOTES PAYABLE (Details) (Parenthetical) Notes http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical SCHEDULE OF CONVERTIBLE NOTES PAYABLE (Details) (Parenthetical) Details 22 false false R23.htm 00000023 - Disclosure - BORROWINGS (Details Narrative) Sheet http://genvor.com/role/BorrowingsDetailsNarrative BORROWINGS (Details Narrative) Details http://genvor.com/role/BorrowingsTables 23 false false R24.htm 00000024 - Disclosure - SCHEDULE OF CONVERTED SHARES OF COMMON STOCK (Details) Sheet http://genvor.com/role/ScheduleOfConvertedSharesOfCommonStockDetails SCHEDULE OF CONVERTED SHARES OF COMMON STOCK (Details) Details 24 false false R25.htm 00000025 - Disclosure - STOCKHOLDERS??? DEFICIT (Details Narrative) Sheet http://genvor.com/role/StockholdersDeficitDetailsNarrative STOCKHOLDERS??? DEFICIT (Details Narrative) Details http://genvor.com/role/StockholdersDeficitTables 25 false false R26.htm 00000026 - Disclosure - SCHEDULE OF LOSS BEFORE TAXES (Details) Sheet http://genvor.com/role/ScheduleOfLossBeforeTaxesDetails SCHEDULE OF LOSS BEFORE TAXES (Details) Details 26 false false R27.htm 00000027 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details) Sheet http://genvor.com/role/ScheduleOfDeferredTaxAssetsDetails SCHEDULE OF DEFERRED TAX ASSETS (Details) Details 27 false false R28.htm 00000028 - Disclosure - FEDERAL INCOME TAX (Details Narrative) Sheet http://genvor.com/role/FederalIncomeTaxDetailsNarrative FEDERAL INCOME TAX (Details Narrative) Details http://genvor.com/role/FederalIncomeTaxTables 28 false false R29.htm 00000029 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://genvor.com/role/CommitmentsAndContingencies 29 false false R30.htm 00000030 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://genvor.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://genvor.com/role/RelatedPartyTransactions 30 false false R31.htm 00000031 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://genvor.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://genvor.com/role/SubsequentEvents 31 false false All Reports Book All Reports form10-q.htm ex31-1.htm ex32-1.htm gnvr-20230630.xsd gnvr-20230630_cal.xml gnvr-20230630_def.xml gnvr-20230630_lab.xml gnvr-20230630_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 46 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-q.htm": { "axisCustom": 0, "axisStandard": 11, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 533, "http://xbrl.sec.gov/dei/2023": 28 }, "contextCount": 146, "dts": { "calculationLink": { "local": [ "gnvr-20230630_cal.xml" ] }, "definitionLink": { "local": [ "gnvr-20230630_def.xml" ] }, "inline": { "local": [ "form10-q.htm" ] }, "labelLink": { "local": [ "gnvr-20230630_lab.xml" ] }, "presentationLink": { "local": [ "gnvr-20230630_pre.xml" ] }, "schema": { "local": [ "gnvr-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 316, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2023": 117, "http://genvor.com/20230630": 24, "http://xbrl.sec.gov/dei/2023": 4, "total": 145 }, "keyCustom": 31, "keyStandard": 162, "memberCustom": 22, "memberStandard": 12, "nsprefix": "GNVR", "nsuri": "http://genvor.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://genvor.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - STOCKHOLDERS\u2019 DEFICIT", "menuCat": "Notes", "order": "10", "role": "http://genvor.com/role/StockholdersDeficit", "shortName": "STOCKHOLDERS\u2019 DEFICIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - FEDERAL INCOME TAX", "menuCat": "Notes", "order": "11", "role": "http://genvor.com/role/FederalIncomeTax", "shortName": "FEDERAL INCOME TAX", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - COMMITMENTS AND CONTINGENCIES", "menuCat": "Notes", "order": "12", "role": "http://genvor.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - RELATED PARTY TRANSACTIONS", "menuCat": "Notes", "order": "13", "role": "http://genvor.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "14", "role": "http://genvor.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "15", "role": "http://genvor.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - BORROWINGS (Tables)", "menuCat": "Tables", "order": "16", "role": "http://genvor.com/role/BorrowingsTables", "shortName": "BORROWINGS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfConversionsOfStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - STOCKHOLDERS\u2019 DEFICIT (Tables)", "menuCat": "Tables", "order": "17", "role": "http://genvor.com/role/StockholdersDeficitTables", "shortName": "STOCKHOLDERS\u2019 DEFICIT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfConversionsOfStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - FEDERAL INCOME TAX (Tables)", "menuCat": "Tables", "order": "18", "role": "http://genvor.com/role/FederalIncomeTaxTables", "shortName": "FEDERAL INCOME TAX (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative)", "menuCat": "Details", "order": "19", "role": "http://genvor.com/role/OrganizationAndBasisOfPresentationDetailsNarrative", "shortName": "ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": "0", "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)", "menuCat": "Statements", "order": "2", "role": "http://genvor.com/role/BalanceSheets", "shortName": "Condensed Consolidated Balance Sheets (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "menuCat": "Details", "order": "20", "role": "http://genvor.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:CashEquivalentsAtCarryingValue", "span", "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-09-30", "decimals": "0", "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - SCHEDULE OF CONVERTIBLE NOTES PAYABLE (Details)", "menuCat": "Details", "order": "21", "role": "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails", "shortName": "SCHEDULE OF CONVERTIBLE NOTES PAYABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtConversionConvertedInstrumentSharesIssued1", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - SCHEDULE OF CONVERTIBLE NOTES PAYABLE (Details) (Parenthetical)", "menuCat": "Details", "order": "22", "role": "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical", "shortName": "SCHEDULE OF CONVERTIBLE NOTES PAYABLE (Details) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-012023-06-30_custom_NoteholderFMember_srt_MinimumMember", "decimals": "0", "lang": null, "name": "us-gaap:DebtConversionOriginalDebtAmount1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - BORROWINGS (Details Narrative)", "menuCat": "Details", "order": "23", "role": "http://genvor.com/role/BorrowingsDetailsNarrative", "shortName": "BORROWINGS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": "0", "lang": null, "name": "us-gaap:InterestExpenseDebt", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfConversionsOfStockTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-192022-10-19_us-gaap_SeriesBPreferredStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConversionOfStockSharesConverted1", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - SCHEDULE OF CONVERTED SHARES OF COMMON STOCK (Details)", "menuCat": "Details", "order": "24", "role": "http://genvor.com/role/ScheduleOfConvertedSharesOfCommonStockDetails", "shortName": "SCHEDULE OF CONVERTED SHARES OF COMMON STOCK (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfConversionsOfStockTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-192022-10-19_us-gaap_SeriesBPreferredStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConversionOfStockSharesConverted1", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - STOCKHOLDERS\u2019 DEFICIT (Details Narrative)", "menuCat": "Details", "order": "25", "role": "http://genvor.com/role/StockholdersDeficitDetailsNarrative", "shortName": "STOCKHOLDERS\u2019 DEFICIT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-212022-04-21", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - SCHEDULE OF LOSS BEFORE TAXES (Details)", "menuCat": "Details", "order": "26", "role": "http://genvor.com/role/ScheduleOfLossBeforeTaxesDetails", "shortName": "SCHEDULE OF LOSS BEFORE TAXES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)", "menuCat": "Details", "order": "27", "role": "http://genvor.com/role/ScheduleOfDeferredTaxAssetsDetails", "shortName": "SCHEDULE OF DEFERRED TAX ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - FEDERAL INCOME TAX (Details Narrative)", "menuCat": "Details", "order": "28", "role": "http://genvor.com/role/FederalIncomeTaxDetailsNarrative", "shortName": "FEDERAL INCOME TAX (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsHeldInTrust", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "menuCat": "Details", "order": "29", "role": "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsHeldInTrust", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://genvor.com/role/BalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-08-16_custom_BradleyWhiteMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesIssued", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "menuCat": "Details", "order": "30", "role": "http://genvor.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R31": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "menuCat": "Details", "order": "31", "role": "http://genvor.com/role/SubsequentEventsDetailsNarrative", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-07-142023-07-14_us-gaap_InvestorMember_us-gaap_SubsequentEventMember", "decimals": "0", "lang": null, "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfessionalFees", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "menuCat": "Statements", "order": "4", "role": "http://genvor.com/role/StatementsOfOperations", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfessionalFees", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-09-30_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)", "menuCat": "Statements", "order": "5", "role": "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit", "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-10-012021-12-31_us-gaap_CommonStockMember", "decimals": "0", "lang": null, "name": "GNVR:RecapitalizationRtoImpact", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flow (Unaudited)", "menuCat": "Statements", "order": "6", "role": "http://genvor.com/role/StatementsOfCashFlow", "shortName": "Condensed Consolidated Statements of Cash Flow (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": "0", "lang": null, "name": "GNVR:LateFeeCapitalizedIntoNotesPayable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION", "menuCat": "Notes", "order": "7", "role": "http://genvor.com/role/OrganizationAndBasisOfPresentation", "shortName": "ORGANIZATION AND BASIS OF PRESENTATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "8", "role": "http://genvor.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - BORROWINGS", "menuCat": "Notes", "order": "9", "role": "http://genvor.com/role/Borrowings", "shortName": "BORROWINGS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-10-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 37, "tag": { "GNVR_ACTHoldingsLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ACT Holdings LLC [Member]", "label": "ACT Holdings LLC [Member]" } } }, "localname": "ACTHoldingsLLCMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/ScheduleOfConvertedSharesOfCommonStockDetails" ], "xbrltype": "domainItemType" }, "GNVR_AccruedPayrollSettledThroughCommonStockIssuance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued payroll settled through common stock issuance.", "label": "Accrued payroll settled through common stock issuance" } } }, "localname": "AccruedPayrollSettledThroughCommonStockIssuance", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "GNVR_BradleyWhiteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bradley White [Member]", "label": "Bradley White [Member]" } } }, "localname": "BradleyWhiteMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/RelatedPartyTransactionsDetailsNarrative", "http://genvor.com/role/ScheduleOfConvertedSharesOfCommonStockDetails", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "GNVR_CashFlowReportingPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash Flow Reporting [Policy Text Block]", "label": "Cash Flow Reporting" } } }, "localname": "CashFlowReportingPolicyTextBlock", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "GNVR_ClaytonYatesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dr. Clayton Yates [Member]", "label": "Dr. Clayton Yates [Member]" } } }, "localname": "ClaytonYatesMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/RelatedPartyTransactionsDetailsNarrative", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "GNVR_CommonStockIssuedForInterestExpense": { "auth_ref": [], "calculation": { "http://genvor.com/role/StatementsOfCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Common stock issued for interest expense.", "label": "Common stock issued for interest expense" } } }, "localname": "CommonStockIssuedForInterestExpense", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "GNVR_CommonStockIssuedToPriorInvestors": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common stock issued to prior investors.", "label": "Common stock issued to prior S-1 investors" } } }, "localname": "CommonStockIssuedToPriorInvestors", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "GNVR_CommonStockIssuedToPriorInvestorsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock issued to prior investors, shares.", "label": "Common stock issued to prior S-1 investors, shares" } } }, "localname": "CommonStockIssuedToPriorInvestorsShares", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "GNVR_CommonStockRetainingShareValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of common stock retaining.", "label": "Number of common stock retaining" } } }, "localname": "CommonStockRetainingShareValue", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "GNVR_ConsultantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consultant [Member]", "label": "Consultant [Member]" } } }, "localname": "ConsultantMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GNVR_ConsultingAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consulting Agreements [Member]", "label": "Consulting Agreements [Member]" } } }, "localname": "ConsultingAgreementsMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "GNVR_ConversionOfNotePayableIntoCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Conversion of note payable into common stock.", "label": "ConversionOfNotePayableIntoCommonStock", "verboseLabel": "Conversion of note payable into common stock" } } }, "localname": "ConversionOfNotePayableIntoCommonStock", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "GNVR_DebtDefaultPenaltyAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt default penalty amount.", "label": "[custom:DebtDefaultPenaltyAmount]" } } }, "localname": "DebtDefaultPenaltyAmount", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/BorrowingsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GNVR_DesignationAuthorizedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designation authorized shares.", "label": "Designation authorized shares" } } }, "localname": "DesignationAuthorizedShares", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "GNVR_DilutiveSecuritiesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dilutive securities outstanding.", "label": "Additional dilutive securities outstanding" } } }, "localname": "DilutiveSecuritiesOutstanding", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "GNVR_DueToRelatedPartyCurrent": { "auth_ref": [], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Due to related party.", "label": "Due to related party" } } }, "localname": "DueToRelatedPartyCurrent", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "GNVR_FounderSharesIssuedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Founder shares issued amount.", "label": "Founder shares issued" } } }, "localname": "FounderSharesIssuedAmount", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "GNVR_FounderSharesIssuedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Founder shares issued share.", "label": "Founder shares issued, shares" } } }, "localname": "FounderSharesIssuedShares", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "GNVR_FundAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fund amount.", "label": "Fund Amount" } } }, "localname": "FundAmount", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GNVR_FundRaisingServicesAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fund raising services amount.", "label": "419 fund raising services" } } }, "localname": "FundRaisingServicesAmount", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "GNVR_FundRaisingServicesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fund raising services shares.", "label": "419 fund raising services, shares" } } }, "localname": "FundRaisingServicesShares", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "GNVR_IssuanceOfCommonStockForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common stock for services.", "label": "Issuance of common stock for services" } } }, "localname": "IssuanceOfCommonStockForServices", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "GNVR_JasonAdamsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Jason Adams [Member]" } } }, "localname": "JasonAdamsMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "GNVR_JaynesInvestmentLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Jaynes Investment LLC [Member]", "label": "Jaynes Investment LLC [Member]" } } }, "localname": "JaynesInvestmentLLCMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/ScheduleOfConvertedSharesOfCommonStockDetails" ], "xbrltype": "domainItemType" }, "GNVR_JesseJaynesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dr. Jesse Jaynes [Member]", "label": "Dr. Jesse Jaynes [Member]" } } }, "localname": "JesseJaynesMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/RelatedPartyTransactionsDetailsNarrative", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "GNVR_JesseMichaelJaynesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Jesse Michael Jaynes [Member]", "label": "Jesse Michael Jaynes [Member]" } } }, "localname": "JesseMichaelJaynesMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/ScheduleOfConvertedSharesOfCommonStockDetails" ], "xbrltype": "domainItemType" }, "GNVR_LASBFamilyTrustMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "LASB Family Trust [Member]", "label": "LASB Family Trust [Member]" } } }, "localname": "LASBFamilyTrustMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/ScheduleOfConvertedSharesOfCommonStockDetails" ], "xbrltype": "domainItemType" }, "GNVR_LateFeeCapitalizedIntoNotesPayable": { "auth_ref": [], "calculation": { "http://genvor.com/role/StatementsOfCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Late fee capitalized into notes payable.", "label": "Late fee capitalized into notes payable" } } }, "localname": "LateFeeCapitalizedIntoNotesPayable", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "GNVR_LateFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Late fees.", "label": "Late fees" } } }, "localname": "LateFees", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/BorrowingsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GNVR_NoteholderAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note Holder A [Member]", "label": "Note Holder A [Member]" } } }, "localname": "NoteholderAMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "domainItemType" }, "GNVR_NoteholderBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Noteholder B [Member]", "label": "Noteholder B [Member]" } } }, "localname": "NoteholderBMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/BorrowingsDetailsNarrative", "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "domainItemType" }, "GNVR_NoteholderCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Noteholder C [Member]", "label": "Noteholder C [Member]" } } }, "localname": "NoteholderCMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "domainItemType" }, "GNVR_NoteholderDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Noteholder D [Member]", "label": "Noteholder D [Member]" } } }, "localname": "NoteholderDMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "domainItemType" }, "GNVR_NoteholderEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Noteholder E [Member]", "label": "Noteholder E [Member]" } } }, "localname": "NoteholderEMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "domainItemType" }, "GNVR_NoteholderFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Noteholder F [Member]", "label": "Noteholder F [Member]" } } }, "localname": "NoteholderFMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails", "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical" ], "xbrltype": "domainItemType" }, "GNVR_NoteholderHMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Noteholder H [Member]", "label": "Noteholder H [Member]" } } }, "localname": "NoteholderHMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "domainItemType" }, "GNVR_NoteholderIMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Noteholder I [Member]", "label": "Noteholder I [Member]" } } }, "localname": "NoteholderIMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "domainItemType" }, "GNVR_Origination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Origination", "label": "Origination" } } }, "localname": "Origination", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "stringItemType" }, "GNVR_PJAdvisoryGroupMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PJ Advisory Group [Member]", "label": "PJ Advisory Group [Member]" } } }, "localname": "PJAdvisoryGroupMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/ScheduleOfConvertedSharesOfCommonStockDetails" ], "xbrltype": "domainItemType" }, "GNVR_PatentsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Patents [Policy Text Block]", "label": "Patents" } } }, "localname": "PatentsPolicyTextBlock", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "GNVR_PaycheckProtectionProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Paycheck Protection Program [Member]", "label": "Paycheck Protection Program [Member]" } } }, "localname": "PaycheckProtectionProgramMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/BorrowingsDetailsNarrative" ], "xbrltype": "domainItemType" }, "GNVR_PaymentForReversesCapitalization": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment for reverses capitalization.", "label": "Payment for reverse capitalization" } } }, "localname": "PaymentForReversesCapitalization", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "GNVR_Penalties": { "auth_ref": [], "calculation": { "http://genvor.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Penalties.", "label": "Penalties" } } }, "localname": "Penalties", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "GNVR_PrepaidCostsForReverseCapitalizationRecognizedInAdditionalPaidInCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaid costs for reverse capitalization recognized in additional paid in capital.", "label": "Prepaid costs for reverse capitalization recognized in additional paid-in capital" } } }, "localname": "PrepaidCostsForReverseCapitalizationRecognizedInAdditionalPaidInCapital", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "GNVR_RecapitalizationRtoImpact": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Recapitalization rto impact.", "label": "Recapilitalization / RTO impact" } } }, "localname": "RecapitalizationRtoImpact", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "GNVR_RelatedPartyPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Related party payable", "label": "Related party payable" } } }, "localname": "RelatedPartyPayable", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "GNVR_RightOfUseAssetLeaseAssetAndLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Right of use asset lease asset and liability.", "label": "Right of use, lease asset and liability" } } }, "localname": "RightOfUseAssetLeaseAssetAndLiability", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "GNVR_ShareholderMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shareholder [Member]", "label": "Shareholder [Member]" } } }, "localname": "ShareholderMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "GNVR_SharesOutstandingAdjustedBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares outstanding adjusted balance.", "label": "Adjusted balance beginning of period, shares" } } }, "localname": "SharesOutstandingAdjustedBalance", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "GNVR_StockIssuedForCashMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Issued For Cash [Member]", "label": "Stock Issued For Cash [Member]" } } }, "localname": "StockIssuedForCashMember", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "GNVR_StockIssuedForDebtConversion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued for debt conversion.", "label": "Stock issued for debt conversion" } } }, "localname": "StockIssuedForDebtConversion", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "GNVR_StockIssuedForDebtConversionShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued for debt conversion shares.", "label": "Stock issued for debt conversion, shares" } } }, "localname": "StockIssuedForDebtConversionShares", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "GNVR_StockholdersEquityAdjustedBalance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stockholders equity adjusted balance.", "label": "Adjusted balance, beginning of period" } } }, "localname": "StockholdersEquityAdjustedBalance", "nsuri": "http://genvor.com/20230630", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r482" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r480", "r482", "r483" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r481" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r482" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r482" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r484" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r472" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r475" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r488" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r485" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r482" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r476" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r477" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r474" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r473" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r478" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r479" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r487" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://genvor.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_BrokersAndDealersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Broker-Dealer [Abstract]" } } }, "localname": "BrokersAndDealersAbstract", "nsuri": "http://fasb.org/srt/2023", "xbrltype": "stringItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r182", "r183", "r184", "r185", "r232", "r302", "r336", "r367", "r368", "r428", "r429", "r430", "r431", "r432", "r440", "r441", "r446", "r452", "r453", "r457", "r511", "r552", "r553", "r554", "r555", "r556", "r557" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r182", "r183", "r184", "r185", "r232", "r302", "r336", "r367", "r368", "r428", "r429", "r430", "r431", "r432", "r440", "r441", "r446", "r452", "r453", "r457", "r511", "r552", "r553", "r554", "r555", "r556", "r557" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r182", "r183", "r184", "r185", "r230", "r232", "r234", "r235", "r236", "r301", "r302", "r336", "r367", "r368", "r428", "r429", "r430", "r431", "r432", "r440", "r441", "r446", "r452", "r453", "r457", "r460", "r507", "r511", "r553", "r554", "r555", "r556", "r557" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r182", "r183", "r184", "r185", "r230", "r232", "r234", "r235", "r236", "r301", "r302", "r336", "r367", "r368", "r428", "r429", "r430", "r431", "r432", "r440", "r441", "r446", "r452", "r453", "r457", "r460", "r507", "r511", "r553", "r554", "r555", "r556", "r557" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r505", "r548" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://genvor.com/role/RelatedPartyTransactionsDetailsNarrative", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://genvor.com/role/RelatedPartyTransactionsDetailsNarrative", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r12" ], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedPayrollTaxesCurrent": { "auth_ref": [ "r14" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued payroll" } } }, "localname": "AccruedPayrollTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r65", "r456", "r562" ], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r237", "r238", "r239", "r354", "r501", "r502", "r503", "r543", "r566" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r4", "r35" ], "calculation": { "http://genvor.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization", "negatedLabel": "Amortization of debt discount" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r4", "r50", "r73", "r210" ], "calculation": { "http://genvor.com/role/StatementsOfCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r88", "r110", "r133", "r161", "r168", "r172", "r177", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r265", "r269", "r281", "r323", "r390", "r456", "r468", "r509", "r510", "r550" ], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r108", "r115", "r133", "r177", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r265", "r269", "r281", "r456", "r509", "r510", "r550" ], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldInTrust": { "auth_ref": [ "r497" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.", "label": "Assets held in trust" } } }, "localname": "AssetsHeldInTrust", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r56", "r77", "r78" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "ORGANIZATION AND BASIS OF PRESENTATION" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/OrganizationAndBasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r96", "r325", "r365", "r385", "r456", "r468", "r490" ], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r23", "r74", "r130" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash at end of period", "periodStartLabel": "Cash at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r0", "r74" ], "calculation": { "http://genvor.com/role/StatementsOfCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net increase in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r490", "r560" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash uninsured amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r105", "r111", "r112", "r113", "r133", "r151", "r152", "r154", "r156", "r159", "r160", "r177", "r186", "r188", "r189", "r190", "r193", "r194", "r214", "r215", "r218", "r221", "r228", "r281", "r344", "r345", "r346", "r347", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r366", "r377", "r399", "r420", "r433", "r434", "r435", "r436", "r437", "r489", "r498", "r504" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets", "http://genvor.com/role/BalanceSheetsParenthetical", "http://genvor.com/role/ScheduleOfConvertedSharesOfCommonStockDetails", "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [ "r111", "r112", "r113", "r159", "r214", "r215", "r216", "r218", "r221", "r226", "r228", "r344", "r345", "r346", "r347", "r452", "r489", "r498" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/ScheduleOfConvertedSharesOfCommonStockDetails", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r18", "r54", "r324", "r376" ], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies (Note 6)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r80", "r180", "r181", "r439", "r508" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r458", "r459", "r460", "r462", "r463", "r464", "r465", "r501", "r502", "r543", "r561", "r566" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value", "verboseLabel": "Common stock, shares par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheetsParenthetical", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r64", "r377" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheetsParenthetical", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r7", "r64", "r377", "r396", "r566", "r567" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r64", "r327", "r456" ], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.001 par value, 300,000,000 shares authorized, 18,572,821 and 38,678,155 shares issued, issuable and outstanding as of June 30, 2023 and September 30, 2022, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Stock-Based Compensation" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r26", "r27", "r28" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Common Shares Exchanged" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/ScheduleOfConvertedSharesOfCommonStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ConversionOfStockSharesIssued1": { "auth_ref": [ "r26", "r27", "r28" ], "lang": { "en-us": { "role": { "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Series B Issued" } } }, "localname": "ConversionOfStockSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/ScheduleOfConvertedSharesOfCommonStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.", "label": "SCHEDULE OF CONVERTIBLE NOTES PAYABLE" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BorrowingsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleLongTermNotesPayable": { "auth_ref": [ "r17" ], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible notes payable, net of discounts" } } }, "localname": "ConvertibleLongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r14" ], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible notes payable" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertiblePreferredStockTermsOfConversion": { "auth_ref": [ "r10", "r42", "r45", "r63", "r82", "r83" ], "lang": { "en-us": { "role": { "documentation": "Description of conversion terms for preferred stock.", "label": "Conversion share description" } } }, "localname": "ConvertiblePreferredStockTermsOfConversion", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r26", "r28" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Number of shares the notesis convertible into shares", "verboseLabel": "Shares issued during conversion" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails", "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtConversionOriginalDebtAmount1": { "auth_ref": [ "r26", "r28" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Notes payable converted" } } }, "localname": "DebtConversionOriginalDebtAmount1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r9", "r60", "r61", "r89", "r90", "r135", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r290", "r447", "r448", "r449", "r450", "r451", "r499" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BorrowingsDetailsNarrative", "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails", "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r51", "r53", "r195", "r290", "r448", "r449" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Loan Balance", "verboseLabel": "Principal amont" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BorrowingsDetailsNarrative", "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r16", "r51", "r207" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r16", "r196" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "verboseLabel": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BorrowingsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r104", "r447", "r544" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r17", "r135", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r290", "r447", "r448", "r449", "r450", "r451", "r499" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BorrowingsDetailsNarrative", "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails", "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r50", "r53", "r512" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "negatedLabel": "Debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]" } } }, "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r250" ], "calculation": { "http://genvor.com/role/ScheduleOfDeferredTaxAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Total gross deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r541" ], "calculation": { "http://genvor.com/role/ScheduleOfDeferredTaxAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Total net deferred taxes" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r49", "r542" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net operating loss carryforward" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r251" ], "calculation": { "http://genvor.com/role/ScheduleOfDeferredTaxAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Valuation allowance for net deferred tax assets", "negatedLabel": "Less: Deferred tax asset valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/FederalIncomeTaxDetailsNarrative", "http://genvor.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r4", "r36" ], "calculation": { "http://genvor.com/role/StatementsOfCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://genvor.com/role/StatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow", "http://genvor.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r124", "r141", "r142", "r143", "r144", "r145", "r149", "r151", "r154", "r155", "r156", "r157", "r279", "r280", "r320", "r334", "r443" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Net loss per common share - basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r124", "r141", "r142", "r143", "r144", "r145", "r151", "r154", "r155", "r156", "r157", "r279", "r280", "r320", "r334", "r443" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Net loss per common share - diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r29", "r30" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Loss Per Share of Common Stock" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r134", "r246", "r259" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Federal tax statutory rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/FederalIncomeTaxDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r7", "r106", "r119", "r120", "r121", "r136", "r137", "r138", "r140", "r146", "r148", "r158", "r178", "r179", "r229", "r237", "r238", "r239", "r255", "r256", "r271", "r272", "r273", "r274", "r275", "r276", "r278", "r282", "r283", "r284", "r285", "r286", "r287", "r291", "r337", "r338", "r339", "r354", "r420" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Financial Instruments" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r6", "r8" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r4", "r37", "r38" ], "calculation": { "http://genvor.com/role/StatementsOfCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://genvor.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Loss on debt settlement", "negatedLabel": "Loss on debt settlement" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow", "http://genvor.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r134", "r242", "r247", "r248", "r253", "r257", "r260", "r261", "r262", "r349" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "FEDERAL INCOME TAX" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/FederalIncomeTax" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r95", "r103", "r147", "r148", "r165", "r245", "r258", "r335" ], "calculation": { "http://genvor.com/role/ScheduleOfLossBeforeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "totalLabel": "Total" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/ScheduleOfLossBeforeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r118", "r243", "r244", "r248", "r249", "r252", "r254", "r343" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r540" ], "calculation": { "http://genvor.com/role/ScheduleOfLossBeforeTaxesDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Change in valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/ScheduleOfLossBeforeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r246" ], "calculation": { "http://genvor.com/role/ScheduleOfLossBeforeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Tax benefit at the statutory rate" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/ScheduleOfLossBeforeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r540" ], "calculation": { "http://genvor.com/role/ScheduleOfLossBeforeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).", "label": "State income taxes, net of federal income tax benefit" } } }, "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/ScheduleOfLossBeforeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r25" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r3" ], "calculation": { "http://genvor.com/role/StatementsOfCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "auth_ref": [ "r496" ], "calculation": { "http://genvor.com/role/StatementsOfCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in current assets classified as other.", "label": "Increase (Decrease) in Other Current Assets", "negatedLabel": "Other current assets" } } }, "localname": "IncreaseDecreaseInOtherCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r3" ], "calculation": { "http://genvor.com/role/StatementsOfCashFlow": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Liabilities", "verboseLabel": "USDA CRADA liability" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r3" ], "calculation": { "http://genvor.com/role/StatementsOfCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r34", "r303", "r304", "r305", "r307", "r442" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Long-lived Assets" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r52", "r93", "r122", "r164", "r289", "r405", "r466", "r563" ], "calculation": { "http://genvor.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r73", "r208", "r212", "r450", "r451" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BorrowingsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r125", "r128", "r129" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestorMember": { "auth_ref": [ "r546", "r547" ], "lang": { "en-us": { "role": { "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.", "label": "Investor [Member]" } } }, "localname": "InvestorMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://genvor.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LaborAndRelatedExpense": { "auth_ref": [ "r495" ], "calculation": { "http://genvor.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.", "label": "Payroll related expenses" } } }, "localname": "LaborAndRelatedExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r13", "r133", "r177", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r266", "r269", "r270", "r281", "r375", "r444", "r468", "r509", "r550", "r551" ], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r69", "r91", "r329", "r456", "r500", "r506", "r545" ], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r15", "r109", "r133", "r177", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r266", "r269", "r270", "r281", "r456", "r509", "r550", "r551" ], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r9", "r57", "r58", "r59", "r62", "r133", "r177", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r266", "r269", "r270", "r281", "r509", "r550", "r551" ], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total non-current liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-current liabilities:" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LoansPayableCurrent": { "auth_ref": [ "r14" ], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.", "label": "SBA loan" } } }, "localname": "LoansPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r9", "r90", "r202", "r211", "r448", "r449", "r559" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Total loan" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by category of items purchased under a long-term purchase commitment.", "label": "Category of Item Purchased [Axis]" } } }, "localname": "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment." } } }, "localname": "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermPurchaseCommitmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Long-Term Purchase Commitment [Line Items]" } } }, "localname": "LongTermPurchaseCommitmentLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermPurchaseCommitmentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule setting forth key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.", "label": "Long-Term Purchase Commitment [Table]" } } }, "localname": "LongTermPurchaseCommitmentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r127" ], "calculation": { "http://genvor.com/role/StatementsOfCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r74", "r75", "r76" ], "calculation": { "http://genvor.com/role/StatementsOfCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "negatedLabel": "Net cash used in operating activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/OrganizationAndBasisOfPresentationDetailsNarrative", "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r70", "r76", "r92", "r107", "r116", "r117", "r121", "r133", "r139", "r141", "r142", "r143", "r144", "r147", "r148", "r153", "r161", "r167", "r171", "r173", "r177", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r280", "r281", "r333", "r398", "r418", "r419", "r445", "r466", "r509" ], "calculation": { "http://genvor.com/role/StatementsOfCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://genvor.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow", "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit", "http://genvor.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-cash investing and financing activities:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r72" ], "calculation": { "http://genvor.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expense)" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayable": { "auth_ref": [ "r9", "r90", "r559" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.", "label": "Promissory note" } } }, "localname": "NotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://genvor.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r161", "r167", "r171", "r173", "r445" ], "calculation": { "http://genvor.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r48" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Net operating loss carry forwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/FederalIncomeTaxDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r114", "r456" ], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherGeneralAndAdministrativeExpense": { "auth_ref": [ "r71", "r565" ], "calculation": { "http://genvor.com/role/StatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of general and administrative expense classified as other.", "label": "Other general and administrative expenses" } } }, "localname": "OtherGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r14", "r456" ], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "USDA CRADA liability" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r2" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Rent expense" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [ "r458", "r459", "r462", "r463", "r464", "r465", "r561", "r566" ], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r63", "r214" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value", "verboseLabel": "Preferred stock, shares par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheetsParenthetical", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r63", "r377" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheetsParenthetical", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r63", "r214" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheetsParenthetical", "http://genvor.com/role/RelatedPartyTransactionsDetailsNarrative", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r63", "r377", "r396", "r566", "r567" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheetsParenthetical", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r63", "r326", "r456" ], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock value" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockVotingRights": { "auth_ref": [ "r42", "r63" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Number of votes" } } }, "localname": "PreferredStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r1" ], "calculation": { "http://genvor.com/role/StatementsOfCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from sale of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r21" ], "calculation": { "http://genvor.com/role/StatementsOfCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from notes payable" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r466", "r564", "r565" ], "calculation": { "http://genvor.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r107", "r116", "r117", "r126", "r133", "r139", "r147", "r148", "r161", "r167", "r171", "r173", "r177", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r264", "r267", "r268", "r280", "r281", "r321", "r332", "r353", "r398", "r418", "r419", "r445", "r454", "r455", "r467", "r493", "r509" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "verboseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/OrganizationAndBasisOfPresentationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r5", "r322", "r331", "r456" ], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Fixed assets, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r5", "r99", "r102", "r330" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Fixed Assets" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Fixed assets, estimated useful lives" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r231", "r295", "r296", "r370", "r371", "r372", "r373", "r374", "r395", "r397", "r427" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://genvor.com/role/ScheduleOfConvertedSharesOfCommonStockDetails", "http://genvor.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r295", "r296", "r549" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r231", "r295", "r296", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r370", "r371", "r372", "r373", "r374", "r395", "r397", "r427", "r549" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party, Type [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://genvor.com/role/ScheduleOfConvertedSharesOfCommonStockDetails", "http://genvor.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r292", "r293", "r294", "r296", "r297", "r350", "r351", "r352", "r402", "r403", "r404", "r424", "r426" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r22" ], "calculation": { "http://genvor.com/role/StatementsOfCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of Related Party Debt", "negatedLabel": "Repayments of related party payable" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentArrangementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual obligation to provide funding of research and development costs over periods that initially exceed one year or the normal operating cycle, if longer.", "label": "Research and Development Arrangement [Member]" } } }, "localname": "ResearchAndDevelopmentArrangementMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r55", "r241", "r558" ], "calculation": { "http://genvor.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development", "verboseLabel": "Research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfOperations", "http://genvor.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r240" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r66", "r84", "r328", "r340", "r341", "r348", "r378", "r456" ], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets", "http://genvor.com/role/OrganizationAndBasisOfPresentationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r106", "r136", "r137", "r138", "r140", "r146", "r148", "r178", "r179", "r237", "r238", "r239", "r255", "r256", "r271", "r273", "r274", "r276", "r278", "r337", "r339", "r354", "r566" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r123", "r133", "r162", "r163", "r166", "r169", "r170", "r174", "r175", "r176", "r177", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r281", "r321", "r509" ], "calculation": { "http://genvor.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalariesAndWages": { "auth_ref": [ "r494" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Annual salary" } } }, "localname": "SalariesAndWages", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalariesWagesAndOfficersCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Salary and Wage, Excluding Cost of Good and Service Sold" } } }, "localname": "SalariesWagesAndOfficersCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Sale of common stock", "verboseLabel": "Common stock value" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit", "http://genvor.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of common stock, shares", "verboseLabel": "Common stock sold" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit", "http://genvor.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Issue price" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfConversionsOfStockTextBlock": { "auth_ref": [ "r26", "r27", "r28" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information related to converting stock into another financial instrument(s) in a noncash (or part noncash) transaction.", "label": "SCHEDULE OF CONVERTED SHARES OF COMMON STOCK" } } }, "localname": "ScheduleOfConversionsOfStockTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StockholdersDeficitTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": { "auth_ref": [ "r46", "r85" ], "lang": { "en-us": { "role": { "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.", "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]" } } }, "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r87" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "SCHEDULE OF DEFERRED TAX ASSETS" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/FederalIncomeTaxTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "SCHEDULE OF LOSS BEFORE TAXES" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/FederalIncomeTaxTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BorrowingsDetailsNarrative", "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails", "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r39", "r40", "r41", "r42", "r43", "r44", "r45", "r82", "r83", "r84", "r111", "r112", "r113", "r159", "r214", "r215", "r216", "r218", "r221", "r226", "r228", "r344", "r345", "r346", "r347", "r452", "r489", "r498" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/ScheduleOfConvertedSharesOfCommonStockDetails", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r491", "r492", "r513" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets", "http://genvor.com/role/BalanceSheetsParenthetical", "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r491", "r492", "r513" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets", "http://genvor.com/role/BalanceSheetsParenthetical", "http://genvor.com/role/ScheduleOfConvertedSharesOfCommonStockDetails", "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r3" ], "calculation": { "http://genvor.com/role/StatementsOfCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://genvor.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow", "http://genvor.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BorrowingsDetailsNarrative", "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetails", "http://genvor.com/role/ScheduleOfConvertibleNotesPayableDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r77", "r131" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r105", "r111", "r112", "r113", "r133", "r151", "r152", "r154", "r156", "r159", "r160", "r177", "r186", "r188", "r189", "r190", "r193", "r194", "r214", "r215", "r218", "r221", "r228", "r281", "r344", "r345", "r346", "r347", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r366", "r377", "r399", "r420", "r433", "r434", "r435", "r436", "r437", "r489", "r498", "r504" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets", "http://genvor.com/role/BalanceSheetsParenthetical", "http://genvor.com/role/ScheduleOfConvertedSharesOfCommonStockDetails", "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r7", "r20", "r106", "r119", "r120", "r121", "r136", "r137", "r138", "r140", "r146", "r148", "r158", "r178", "r179", "r229", "r237", "r238", "r239", "r255", "r256", "r271", "r272", "r273", "r274", "r275", "r276", "r278", "r282", "r283", "r284", "r285", "r286", "r287", "r291", "r337", "r338", "r339", "r354", "r420" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r136", "r137", "r138", "r158", "r306", "r342", "r366", "r369", "r370", "r371", "r372", "r373", "r374", "r377", "r380", "r381", "r382", "r383", "r384", "r386", "r387", "r388", "r389", "r391", "r392", "r393", "r394", "r395", "r397", "r400", "r401", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r420", "r461" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets", "http://genvor.com/role/BalanceSheetsParenthetical", "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r136", "r137", "r138", "r158", "r306", "r342", "r366", "r369", "r370", "r371", "r372", "r373", "r374", "r377", "r380", "r381", "r382", "r383", "r384", "r386", "r387", "r388", "r389", "r391", "r392", "r393", "r394", "r395", "r397", "r400", "r401", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r420", "r461" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets", "http://genvor.com/role/BalanceSheetsParenthetical", "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r26", "r27", "r28" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Principal and interest settled through common stock issuance" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r7", "r19", "r42", "r84", "r205" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Conversion of note payable into common stock, shares", "verboseLabel": "Issuance of common stock" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": { "auth_ref": [ "r7", "r42", "r63", "r64", "r84" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Conversion of common stock into Series B preferred stock, shares" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Common stock issued for services, shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r7", "r63", "r64", "r84", "r344", "r420", "r434" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Common stock issued for cash, shares", "terseLabel": "Number of shares issued", "verboseLabel": "Shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Common stock issued for settlement, shares" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares (or other type of equity) forfeited during the period.", "label": "Number of common stock cancel" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r7", "r63", "r64", "r84", "r233" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Exercise of options, shares" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r7", "r20", "r84" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Conversion of note payable into common stock", "verboseLabel": "Conversion of common stock" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": { "auth_ref": [ "r7", "r20", "r84" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Conversion of common stock into Series B preferred stock" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Common stock issued for services" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r7", "r63", "r64", "r84", "r354", "r420", "r434", "r467" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Common stock issued for cash", "verboseLabel": "Shares issued, value" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit", "http://genvor.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Common stock issued for settlement" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r7", "r20", "r84" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Exercise of options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r64", "r67", "r68", "r79", "r379", "r396", "r421", "r422", "r456", "r468", "r500", "r506", "r545", "r566" ], "calculation": { "http://genvor.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total stockholders\u2019 deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets", "http://genvor.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 deficit:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r81", "r132", "r213", "r215", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r227", "r229", "r277", "r423", "r425", "r438" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "STOCKHOLDERS\u2019 DEFICIT" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StockholdersDeficit" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubordinatedBorrowingsDisclosureTextBlock": { "auth_ref": [ "r94" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for borrowings under subordinated debt agreements that qualify as available in computing net capital under SEC's uniform net capital rule, including restrictive covenants, collateral, interest rates and due dates, amounts due by date and amount owed in total.", "label": "BORROWINGS" } } }, "localname": "SubordinatedBorrowingsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/Borrowings" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [ "r288", "r299" ], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r288", "r299" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r288", "r299" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r288", "r299" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r288", "r299" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r298", "r300" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r31", "r32", "r33", "r97", "r98", "r100", "r101" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r150", "r156" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted average common shares outstanding - diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r149", "r156" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average common shares outstanding - basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://genvor.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "730", "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org//740/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "808", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org//850/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(16))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(15))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org//1943274/2147483070/710-10-25-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r469": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r471": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r472": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r473": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r474": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r475": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r476": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r477": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r478": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r479": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r481": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r482": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r483": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r484": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r485": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r486": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r487": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r488": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(4))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(b))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r508": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r56": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org//205/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org//1943274/2147483043/710-10-30-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480876/942-470-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 47 0001493152-23-027320-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-027320-xbrl.zip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end